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CHAPTER 1
DIAGNOSIS OF VULNERABLE PLAQUES IN THE
CARDIAC CATHETERIZATION LABORATORY
CHAPTER 1 VULNERABLE PLAQUE IN THE LAB
Based on: 
Schaar JA, van der Steen AFW, Arampatzis CA, Kram R, Slager CJ, ten Have AG, van der 
Poll SW, Gijsen FJ, Wentzel JJ, de Feyter PJ, Serruys PW.
Diagnosis of Vulnerable Plaque in the Cardiac Catheterization Laboratory.
In Saijo Y, van der Steen AFW (Eds): Vascular Ultrasound. 2003 Springer ISBN 4-431-
70328-4
and
Schaar JA, Regar E, Arampatzis CA, van der Ven ARA, Slager CJ, Gijsen FJ, Wentzel JJ, de 
Feyter PJ, van der Steen AFW, Serruys PW.
Diagnosis of Vulnerable Plaque in the Cardiac Catheterization Laboratory.
In Khachigian LM (Ed): High-Risk Atherosclerotic Plaques: Mechanisms, Imaging, Models, 
and Therapy. 2005 CRC Press ISBN 0-8493-3028-9
 CHAPTER 1 VULNERABLE PLAQUE IN THE LABRupture of thin-
cap fibroathero-
mas is the main 
cause of acute cor-
onary syndrome 
and myocardial 
infarction.
Rupture of thin-cap fibroatheromas is the main cause of acute cor-
onary syndrome and myocardial infarction. Identification of this
form of vulnerable plaque is therefore essential to enable the devel-
opment of treatment modalities to stabilize such plaque. Because
myocardial infarction and its consequences are so important, we
must investigate options to identify those areas that will be respon-
sible for future events. The vulnerable plaque contains certain fea-
tures that could be diagnosed by various specialized methods. The
ideal technique would provide morphological, mechanical and
chemical information, however at present, no diagnostic modality
providing such all-embracing assessment is available. In this chapter
the current available techniques in the cathlab are discussed with
special emphasis on angiograms, angioscopy, optical coherence to-
mography, intravascular ultrasound, palpography, thermography,
Raman Spectroscopy, near-infrared spectroscopy and magnetic res-
onance imaging. All these techniques are still under development
and at present, none of them can identify a vulnerable plaque alone
or predict its further development. This is related to fundamental
methodological insufficiencies that may be resolved in the future.
From a clinical point of view, most techniques currently assess only
one feature of the vulnerable plaque. Thus the combination of sev-
eral modalities will be of importance in the future to ensure a high
sensitivity and specificity in detecting vulnerable plaque.
A wide variety exists in the stability of coronary atherosclerotic
plaques, which will be extensively discussed in chapter 2. A plaque
may be stable for years, however abrupt disruption of his structure
is the main cause of acute coronary syndrome (Libby 1995).
There are three 
forms of vulnera-
ble plaques
There are three forms of vulnerable plaques:
A) The thin-cap fibroatheroma7
 Thin-cap fi-
broatheroma = 
TCFA
Pathologic studies of plaque rupture with thrombosis suggest that
prior to a thrombotic event, the plaque was an inflamed, thin-cap
fibroatheroma (TCFA). TCFA appear in 75% of all cases. The ma-
jor components of such TCFA are: (i) an atheromatous core, (ii) a
thin fibrous cap, with macrophage and lymphocyte infiltration and
decreased smooth muscle cell content, (iii) expansive remodelling. 
B) Erosion
Pathologic studies have shown that prior to an event the endotheli-
um was injured at the place where a thrombus was formed. This en-
dothelium consists of proteoglycan rich endothelial cells. Erosion
occurs in 30% of all cases.
C) Calcified nodule
Pathologic studies of plaques with thrombosis covering a calcified
nodule suggest that the plaque appeared to be heavily calcified with
a calcified nodule projecting into the lumen prior to 5% of all
events.
This chapter will discuss the current development of imaging tech-
niques that have the potential to detect vulnerable plaques. The vul-
nerable plaque contains certain features that could be diagnosed by
various specialized methods. The ideal technique would provide
morphological, mechanical and chemical information, however at
present, no diagnostic modality providing such all-embracing as-
sessment is available.
The characteristics of vulnerable plaque have been described by nu-
merous reviewers (Falk 1999) (Virmani 2002). It is important to
characterize the following features:
1 size of the lipid core (40% of the entire plaque)
2 thickness of the fibrous cap
3 presence of inflammatory cells
4 amount of remodelling and extent of plaque free vessel wall
5 3D morphology8
 CHAPTER 1 VULNERABLE PLAQUE IN THE LABAngiography
The culprit lesion 
prior to a myocar-
dial infarction has 
in 48-78% of all 
cases a stenosis 
smaller than 50%
Coronary angiography has been so far the gold standard to assess
the severity of obstructive lumenal narrowing. Furthermore it
serves as a decision tool to direct therapy such as PTCA or CABG.
Using coronary angiography we can assess the lumen boundaries,
but cannot assess information about plaque burden, plaque deline-
ation and plaque components. The predictive power of occurrence
of myocardial infarction is rather low since 70% of acute coronary
occlusions are in areas that were previously angiographically nor-
mal, and only a minority occur where there was severe stenosis (Lit-
tle 1988). Other studies have affirmed, that the culprit lesion prior
to a myocardial infarction has, in 48-78% of all cases, a stenosis
smaller than 50% (Nobuyoshi 1991, Ambrose 1988, Giroud
1992). Coronary angiograms also often fail to identify the culprit
lesion of nontransmural myocardial infarction (Kerensky 2002).
The majority of ulcerated plaques are not big enough to be detected
by angiography, but can be well assessed pathologically (Frink
1994). 
The presence of 
multiple complex 
plaques is associ-
ated with an in-
creased incidence 
of recurrent acute 
coronary syn-
drome. 
Furthermore, we have to take into account that the predictive pow-
er of angiography is strongly dependent on the time interval be-
tween the angiogram and the myocardial infarction, because both
time and interim therapy can influence atherosclerosis. In one
study, the angiograms were performed between 1 and 77 months
before the event and showed that atherosclerosis can be a rapidly
progressive process. A recent study evaluated angiograms made one
week before acute myocardial infarction showing that signs of
thrombosis and rupture were present in a majority of patients (Ojio
2000). During the year after myocardial infarction, the presence of
multiple complex plaques is associated with an increased incidence
of recurrent acute coronary syndrome (Goldstein 2000). 
Thus, patients with silent non-obstructive coronary atherosclerosis
harbour vulnerable plaques that cannot be detected by angiograms,
but which are associated with adverse clinical outcomes. If a dis-
rupted ulcerated plaque is seen on angiography, the existence of ad-
ditional rupture prone plaques is to be expected.9
 Angiography has a 
low discriminato-
ry power to identi-
fy the vulnerable 
plaque
Angiography therefore, has a low discriminatory power to identify
the vulnerable plaque, but does provide information about the en-
tire coronary system and serves as guide for invasive imaging tech-
niques and therapy.
In the future non-invasive luminography and vessel wall assessment
may become an integral part of our daily diagnostic procedure (Kim
2001).
Angioscopy
Intracoronary angioscopy offers a direct visualization of the plaque
surface and intra-lumenal structures like tears and thrombi. It al-
lows assessment of the color of the plaque and thrombus (Mizuno
1992) with a sensitivity in detecting such structures higher than
when compared to angiography (Sherman 1986). Angioscopic
plaque rupture and thrombus have been shown to be associated
with adverse clinical outcomes in patients with complex lesions
(Feld 1996). Furthermore yellow plaques seem to have an increased
instability, in comparison between IVUS and angioscopy (Tacano
2001). In patients with myocardial infarction all three coronary ar-
teries are widely diseased and have multiple yellow plaques (Asaku-
ra 2001). In a 12-month follow-up study of 157 patients with stable
angina, acute coronary syndrome occurred more frequently in pa-
tients with yellow plaques than in those with white plaques.
Acute coronary 
syndromes occur 
more frequently in 
patients with yel-
low plaques
These results indicate that acute coronary syndromes occur more
frequently in patients with yellow plaques, which can be imaged
with angioscopy, but not angiography (Uchida 1995). However,
angioscopy is difficult to perform, invasive and only a limited part
of the vessel tree can be investigated. Most importantly, to enable
clear visualization of the vessel wall, the vessel has to be occluded
and the remaining blood flushed away with saline, thereby poten-
tially inducing ischaemia. Information regarding the degree of
plaque extension into the vessel wall is not provided by angioscopy.
IVUS
Intravascular coronary ultrasound (IVUS) provides real-time high-
resolution images of the vessel wall and lumen (Bom 1998). The10
 CHAPTER 1 VULNERABLE PLAQUE IN THE LABsize of IVUS catheters is between 2.9 to 3.5 French. Depending on
the distance from the catheter the axial resolution is about 150 mi-
crons, the lateral 300 microns. The images appear real time at a fre-
quency of up to 30 frames/sec. Features of the vessel can be detected
based on the echogenicity and the thickness of the material. Small
structures can be visualized, however only those sized over 160 mi-
crons can be estimated accurately. The normal thickness of the me-
dia is about 125-350 mm.
IVUS provides some insight into the composition of coronary
plaques. In IVUS images, calcification is characterized by a bright
echo signal with distal shadowing which hides plaque components
and deeper vessel structures. In comparative studies between histol-
ogy and IVUS, plaque calcification can be detected with a sensitiv-
ity of between 86 and 97% (Di Mario 1992) (Sechtem 1993). The
sensitivity to detect micro-calcification ranges around 60% (Frie-
drich 1994).
IVUS can detect-
ed lipid deposi-
tions with a 
specificity of 30%. 
In IVUS images lipid depositions are described as echolucent zones
and can be detected with a sensitivity of between 78% and 95% and
specificity of 30% (Potkin 1990) (Rasheed 1995). This sensitivity
is dependent on the amount of lipid and can drop down further if
the echo-lucent area is smaller than a quarter of the plaque. Echo-
lucent zones can also be caused by loose tissue and shadowing from
calcium, which makes the interpretation of echolucent areas diffi-
cult. The sensitivity to differentiate between fibrous and fatty tissue
is between 39 and 52% (Hiro 1996).
The detection of vulnerable plaques by IVUS is mainly based on a
series of case reports (Ge 1995) (Jeremias 1997). The main focus of
these reports is the detection of already ruptured plaques. To eval-
uate the role of IVUS in detecting plaque rupture, a study was per-
formed of 144 patients with angina. Ruptured plaques were
characterized by a cavity (echolucent area within the plaque) and a
tear of the thin fibrous cap. They were identified in 31 patients of
whom 23 (74%) presented with unstable angina. Plaque rupture
was confirmed by injecting contrast medium and seeing filling of
the plaque cavity on IVUS. Of the patients without plaque rupture
(n = 108), only 19 (18%) had unstable angina. The echolucent area
(cavity) to total plaque area ratio was larger in the unstable group
than in the stable group. The thickness of the fibrous cap in the un-11
 stable group was also found to be smaller than in the stable group
(Ge 1999). 
The problem of these studies is the lack of prospectivity and follow
up. Only Yamagishi et al. have performed a prospective study with
a follow up period of about two years. Large eccentric plaques con-
taining an echolucent zone by IVUS were found to be at increased
risk of instability even though the lumen area was preserved at the
time of initial study (Yamagishi 2000). 
Intravascular ul-
trasound assess-
ment of vascular 
remodelling may 
help to classify 
plaques with the 
highest probabili-
ty of spontaneous 
rupture.
It has been demonstrated, that suspected to be vulnerable plaques
are associated with positive remodelling. Intravascular ultrasound
assessment of vascular remodelling may help to classify plaques with
the highest probability of spontaneous rupture (von Birgelen
2001). 
A number of groups have investigated the potential of ultrasound
radio-frequency signal analysis for tissue characterization (Nair
2001) (Landini 1986) (Wilson 1994) (Jeremias 1999) (Wickline
2000) (Bridal 2000) (Spencer 1997). Many of these studies re-
vealed the potential to identify calcified plaques, but although
promising, none has yet produced a technique with sufficient spa-
tial and parametric resolution to identify a lipid pool covered by a
thin fibrous cap.
Thermography
Inflammation produces a temperature rise in the affected tissue.
Since atherosclerosis is accompanied by inflammation the hypoth-
esis was created that a temperature rise could be measured at the
surface of a plaque. As vulnerable plaque is a very active metabolic
area, the hypothesis was extended that vulnerable plaques may have
an even higher temperature rise.
There was a nega-
tive correlation 
between tempera-
ture difference 
and cap thickness 
(R2= -0.34)
Casscells et al. reported that carotid plaques taken at endarterecto-
my from 48 patients have temperature heterogeneity (Casscells
1996). The temperature difference between different areas was up
to 2.2 °C, and correlated with cell density (R2= -0.47, p=0.0001).
There was a negative correlation between temperature difference
and cap thickness (R2= -0.34, p=0.0001). The same group reported
approximately the same in vitro findings in atherosclerotic rabbits12
 CHAPTER 1 VULNERABLE PLAQUE IN THE LAB(Casscells 1999). A correlation between temperature rise and mac-
rophage infiltration has also been suggested in an in-vivo rabbit trial
(Verheye 2002). Stefanadis et al. performed studies in humans. Pa-
tients with stable angina, unstable angina, and acute myocardial in-
farction were studied. The thermistor of the thermography catheter
has a temperature accuracy of 0.05 °C, a time constant of 300 ms,
and a spatial resolution of 0.5 mm. The thermistor of the catheter
was driven against the vessel wall by the force of blood flow, with-
out the help of a mechanical device like a balloon. Temperature was
constant within the arteries of the control subjects, whereas most
atherosclerotic plaques showed higher temperatures compared with
healthy vessel wall. Temperature differences between atherosclerot-
ic plaque and healthy vessel wall increased progressively from stable
angina to patients with acute myocardial infarction with a maxi-
mum difference of 1.5 +/- 0.7 °C (Stefanadis 1999). Furthermore
patients with a high temperature gradient have a significantly worse
outcome than patients with a low gradient (Stefanadis 2001). How-
ever, this data has yet to be confirmed prospectively in other cent-
ers, and the influence of parameters such as coronary blood flow
(Diamantopulos 2003) or catheter design has to be studied in the
future.
Optical Coherence Tomography
OCT can provide 
images with ultra-
high resolution
Optical Coherence Tomography (OCT) can provide images with
ultrahigh resolution. The technique measures the intensity of back-
reflected light in a similar way as IVUS measures acoustic waves
(Huang 1991). It is an invasive technique with a catheter advanced
over a 0.014'' wire. With a Michelson interferometer light is split
into two signals. One is sent into the tissue and the other to a refer-
ence arm with a mirror. Both signals are reflected and cross-corre-
lated by interfering the light beams. To achieve cross correlation at
incremental penetration depths in the tissue, the mirror is dynami-
cally translated. The intensity of the interfering signals at a certain
mirror position represents backscattering at a corresponding depth.
High-resolution images with a resolution ranging from 4-20 mm
can be achieved (Boppart 1998) with a penetration depth up to 2
mm. Images can be acquired real time at 15 frames/sec.
Early attempts were made to validate OCT using histology. A lipid
pool generates decreased signal areas, and a fibrous plaque produces13
 a homogenous signal rich lesion (Jang 2000). In vitro comparison
of OCT with IVUS demonstrated superior delineation by OCT of
structural details like thin caps or tissue proliferation (Brezinski
1997). 
Limitations of OCT are the low penetration depth, which hinders
studying large vessels, and the light absorbance by blood which cur-
rently needs to be overcome by saline infusion or balloon occlusion
with associated potential for ischaemia. Special techniques like in-
dex matching may improve imaging through blood (Brezinski
2001). 
Raman Spectroscopy
Raman spectroscopy is a technique that can characterize the chem-
ical composition by utilizing the Raman effect (Baraga 1992). The
Raman effect is created when incident light (wave length 750 - 850
nm) excites molecules in a tissue sample, which backscatter the light
while changing wave length. This change in wave length is the Ra-
man effect (van de Poll 2002). The wave length shift and the signal
intensity are dependent on the chemical components of the tissue
sample. Due to this unique feature, Raman spectroscopy can pro-
vide quantitative information about the molecular composition of
the sample (Hanlon 2000). The spectra obtained from tissue re-
quire post-processing to differentiate between plaque components.
Even in the presence of blood, Raman spectra have been shown to
be obtainable in vivo from the aortic arch of sheep (Buschman
2000). In a study using mice that received a high-fat/high-choles-
terol diet for 0, 2, 4, or 6 months, Raman spectroscopy showed
good correlation between cholesterol accumulation and total serum
cholesterol exposure (r approximately 0.87, P<0.001). In female
mice (n=10) that were assigned to an HFC diet, with or without
0.01% atorvastatin, a strong reduction in cholesterol accumulation
(57%) and calcium salts (97%) (P<0.01) was demonstrated in the
atorvastatin-treated group. Raman spectroscopy can therefore be
used to quantitatively study the size and distribution of depositions
of cholesterol and calcification (van de Poll 2001).14
 CHAPTER 1 VULNERABLE PLAQUE IN THE LABLimitations of the technique are the limited penetration depth (1 -
1.5 mm), the long acquisition time and the absorbance of the light
by blood. Raman spectroscopy gives no geometrical information.
Near-Infrared Spectroscopy
NIR spectroscopy 
obtains informa-
tion on the chemi-
cal components of 
the coronary vessel 
wall.
Near-infrared (NIR) spectroscopy also obtains information on the
chemical components of the coronary vessel wall. Molecular vibra-
tional transitions measured in the NIR region (750 - 2500 nm) give
qualitative and quantitative results on plaque composition. NIR
spectroscopy sensitivity and specificity for the histological features
of plaque vulnerability were 90% and 93% for lipid pool, 77% and
93% for thin cap, and 84% and 89% for inflammatory cells
(Moreno 2002). A differentiation between vulnerable and non-vul-
nerable carotid plaques could be achieved ex vivo (Wang 2002). Fu-
ture studies will address the question whether NIR spectroscopy is
feasible in vivo. Problems like acquisition time, blood scattering, in-
fluence of pH and temperature must be addressed.
Magnetic Resonance Imaging
High-resolution magnetic resonance imaging (MRI) is a non-inva-
sive modality to characterize atherosclerotic plaques. Combining
information from T1 and T2-weighted imaging can permit in vitro
identification of the atheromatous core, collageneous cap, calcifica-
tion, media, adventitia, and perivascular fat (Toussaint 1995). In a
small number of patients (n=6) a matching between in vivo and in
vitro measurements of carotid arteries was seen (Toussaint 1996).
Yuan et al. determined the accuracy of in vivo MRI for measuring
the cross-sectional maximum wall area of atherosclerotic carotid ar-
teries in a group of 14 patients undergoing carotid endarterectomy.
The authors showed a strong correlation between in vivo and in vit-
ro measurements (Yuan 1998). Although not perfect, it may be
possible to identify carotid plaques at high risk for stroke using
MRI (Yuan 2001). Images of carotid arteries can be further im-
proved using a coil placed close to the carotid artery at the surface
of the neck (Hayes 1996). An in-plane resolution of 0.4 x 0.4 mm
and a slice thickness of 3 mm may allow an assessment of fibrous
cap thickness and integrity (Hatsukami 2000).15
 Imaging of coro-
nary arteries with 
MRI is more diffi-
cult than imaging 
carotid plaques
Imaging of coronary arteries with MRI is more difficult than imag-
ing carotid plaques since cardiac and respiratory motion, the small
plaque size, and the location of the coronary arteries can cause ac-
quisition problems. Nevertheless, high resolution MRI of the hu-
man coronary wall of angiographically normal and abnormal vessels
has been shown to be feasible. In a study by Botnar et al. the coro-
nary wall thickness and wall area were significantly enlarged in pa-
tients with coronary artery disease demonstrated by angiography
(Botnar 2000). Small plaque structures like fibrous caps cannot yet
be assessed using current MR techniques. Thinner slices and higher
in plane resolution are needed to better delineate coronary plaques.
ANGUS and Shear Stress
High-resolution reconstruction of 3D coronary lumen and wall
morphology is obtained by combining angiography and IVUS
(Slager 2000). Briefly a biplane angiogram of a sheath-based IVUS
catheter taken at end-diastole allows reconstruction of the 3D pull-
back trajectory of the catheter. Combining this path with lumen
and wall information derived from IVUS images that are succes-
sively acquired during catheter pullback at end-diastole gives accu-
rate 3D lumen and wall reconstruction with resolution determined
by IVUS. Filling the 3D lumen space with a high resolution 3D
mesh allows calculation of the detailed blood velocity profile in the
lumen (Thury 2001).
Shear stress influ-
ences a variety of 
biological process-
es.
For this purpose absolute flow and blood viscosity need to be pro-
vided as boundary conditions. From the blood velocity profile local
wall shear stress on the endothelium can be accurately derived. Wall
shear stress is the frictional force, normalized to surface area that is
induced by the blood passing the wall. Although from a mechanical
point of view shear stress is of a very small magnitude compared to
blood pressure induced tensile stress it has a profound influence on
vascular biology (Malek 1999) and explains the localization of
atherosclerotic plaque in the presence of systemic risk factors (Asa-
kura 1990). Many of these biological processes also influence the
stability of the vulnerable plaque including inflammation, throm-
bogenicity, vessel remodelling, intimal thickening or regression and
smooth muscle cell proliferation. Therefore, the study of this pa-
rameter as derived by image-based modelling is of utmost impor-
tance.16
 CHAPTER 1 VULNERABLE PLAQUE IN THE LABConcluding remarks
Assessment of atherosclerosis by imaging techniques is essential for
in vivo identification of vulnerable plaques. Several invasive and
noninvasive imaging techniques are currently in development.
OCT has the advantage of high resolution, thermography measures
metabolism and NIR spectroscopy obtains information on chemi-
cal components. IVUS is easy to perform and can assess morpholo-
gy. Shear stress is an important mechanical parameter deeply
influencing vascular biology. MRI and CT have the advantage of
non-invasive imaging.
Nevertheless all techniques are still under development and at
present, none of them can identify a vulnerable plaque alone or pre-
dict its further development. 
This is related to fundamental methodological insufficiencies that
may be resolved in the future. From a clinical point of view, most
techniques currently assess only one feature of the vulnerable
plaque. Thus the combination of several modalities will be of im-
portance in the future to ensure a high sensitivity and specificity in
detecting vulnerable plaque.17
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CHAPTER 2 TERMINOLOGY VULNERABLE PLAQUES
Based on:
Johannes A. Schaar, James E. Muller, Erling Falk, Renu Virmani, Valentin Fuster, Patrick W. 
Serruys, Antonio Colombo, Christodoulos Stefanadis, S. Ward Casscells, Pedro R. Moreno, 
Attilio Maseri, Anton F.W. van der Steen
Terminology for high-risk and vulnerable coronary artery plaques
Report of a Meeting on the Vulnerable Plaque, June 17 and 18, 2003, Santorini, Greec 
European Heart Journal (2004) 25, 1077–1082
 CHAPTER 2 TERMINOLOGY VULNERABLE PLAQUESA group of investigators met for two days in Santorini,Greece, to
discuss progress in the field of identification and treatment of high
risk/vulnerable atherosclerotic plaques and patients. Many differ-
ences in the manner in which terms are being utilized were noted.
It was recognized that increased understanding of the pathophysi-
ology of coronary thrombosis and onset of acute coronary syn-
dromes has created the need for agreement on nomenclature.
The participants spent considerable time discussing the topic and
reached agreement on their own usage of the terms as described be-
low. It is the hope that this usage might be of value to the larger
community of scientists working in this field, and that widespread
adoption of a common nomenclature would accelerate progress in
the prevention of acute coronary events.
Conceptual terms
OverviewThe terms in Fig. 1 are proposed for use on a conceptual basis. The
progression from asymptomatic atherosclerosis,to a high-risk/vul-
nerable plaque, to a thrombosed plaque, and to clinical events is
presented. It is of note that the later stages of the progression may
be repeated in a relatively short time interval as documented by the
high short-term risk of a recurrent event in patients with acute cor-
onary syndromes. This may be caused by rethrombosis of the lesion
causing the index event, and/or the simultaneous occurrence of
multiple high-risk/vulnerable plaques and/or thrombosed plaques,
that have not previously caused symptoms. An acute coronary syn-
drome may be a clinical marker of widespread (multifocal) disease
activity in the coronary arteries, possibly related to inflammation
(Maseri 2003) (Asakura 2001) (Goldstein 2002) (Rioufol 2002)
(Buffon 2003) (Casscells 2003a) (Krams 2003) (Libby 2002b).21
 The vulnerable patient
The primary clinical and preventive goal is to identify patients who
are vulnerable to acute coronary thrombosis. Such patients are like-
ly to have a high atherosclerotic burden, high-risk/vulnerable
plaques, and/or thrombogenic blood (Maseri 2003). Traditional
and newly identified risk factors (Pearson 2003) and imaging, both
invasive and non-invasive, are likely to be of increasing utility in
identifying such patients (Naghavi 2001) (Fayad 2001) (de Feyter
2002) (Sosnovsk 2002) (Arampatzis 2003) (MacNeill 2003). It is
well established that patients with the recent onset of an acute cor-
onary syndrome remain at risk of suffering recurrent events in the
weeks and months following their initial presentation. 
There is an important need to improve diagnostic methods to iden-
tify vulnerable patients, and the plaques, which contribute to their
increased risk.
High-risk/vulnerable plaques
Studies indicate that there are plaques at increased risk of thrombo-
sis and rapid progression, which often lead to symptomatic disease.
It is proposed that the terms “high-risk” or “vulnerable” be used as
Normal Coronary Arteries
Asymptomatic Atherosclerosis
High-risk/Vulnerable Plaques
An Acute Coronary Syndrome
•Unstable Angina
•Myocardial Infarction
•Sudden Cardiac Death
Progression of stenosis
causing Stable Angina
Pectoris
Asymptomatic progression of
stenosis
Over decades may develop
Which, over years, may lead to
Which may progress, in an unpredictable manner, to
Thrombosed Plaques
Which lead to
Fig. 1: Development of
atherosclerosis and
progression to throm-
bosis and clinical
events.22
 CHAPTER 2 TERMINOLOGY VULNERABLE PLAQUESsynonyms to describe a plaque that is at increased risk of thrombosis
and rapid stenosis progression. The term “thrombosis-prone” may
also be applied to such plaques.
At the present time, there is no widely accepted diagnostic method
to prospectively identify such “highrisk”/“vulnerable” plaques. Un-
til such information is provided, these terms should only be used to
describe the concept and function of such plaques, and not their
histologic basis. 
In addition, the complicated thrombi that occur in non-disrupted
predominantly fibrotic and severely stenotic plaques may well be
dependent on a thrombogenic state which can be considered to be
a condition of “highrisk blood”. Thus, an individual patient can be
“highrisk” because of the presence of high-risk/vulnerable plaques
and/or high-risk blood and/or an increased conventional risk factor
profile (Maseri 2003).
Histologic features of plaques causing coronary artery 
thrombosis
At present, the most detailed evidence concerning the plaques caus-
ing coronary thrombosis and rapid lesion progression, or sympto-
Fig.2a: Ruptured
plaque with thrombo-
sis. Cross-section of a
coronary artery cut just
distal to a bifurcation.
The athero-sclerotic
plaque to the left (cir-
cumflex branch) is fi-
brotic and partly
calcified whereas the
plaque to the right
(marginal branch) is li-
pid-rich with a non-oc-
cluding thrombus
super-imposed.23
 matic disease, is derived from autopsy studies (van der Wal 1994)
(Arbustini 1999) (Falk 1999) (Davies 2000) (Virmani 2000).
While this evidence is retrospective, the findings have established
the nature of
the lesions
causing most
clinical events.
Such plaques
are called
“culprit le-
sions”. In
most cases,
culprit lesions
can be identi-
fied by angi-
ography
combined
with other
clinical findings and/or at autopsy.
In the acute coronary syndromes, the culprit lesion is often a plaque
complicated by thrombosis extending into the lumen (Falk 1999)
(Davies 2000) (Virmani 2000) Libby 2001). Such plaques are
termed “thrombosed plaques”. In some cases, multiple thrombosed
plaques may exist, only one of which is acting as the culprit lesion.
A plaque may also develop thrombosis, which remains asympto-
matic due to the presence of collaterals, or failure of the thrombus
to significantly impede blood flow. However, such sub-clinical
thrombosis may contribute to the rapid progression of stenosis
Fig 2b: Higher magni-
fication of the plaque–
thrombus interface re-
veals that the fibrous
cap over the lipid-rich
core is extremely thin,
inflamed and ruptured
with a real defect – a
gap – in the cap. Both
arteries contain con-
trast medium injected
postmortem. Tri-
chrome stain, staining
collagen blue and
thrombus red.
Fig. 3 Eroded plaque
with thrombosis. (a,b)
Plaque erosion lesions
from two different pa-
tients showing in (a) a
lesion with lipid pool
(Lp) and in (b) a
necrotic core (Nc) with
lumenal thrombi (Th). Note a thick fibrous cap above the necrotic core in (b) and a lack of communica-
tion between it and the lumenal. (c) A high power view of the lesion (shown in (a)), note that the lesion
is rich in proteoglycan and smooth muscle cells beneath the thrombus.24
 CHAPTER 2 TERMINOLOGY VULNERABLE PLAQUES(Burke 2001) (Mann 1999). In cases of stable angina, the culprit le-
sion is often a non-thrombosed plaque.
The plaque, including its endothelium, is not the only determinant
of thrombosis – the loss of the normal thrombotic–thrombolytic
equilibrium in the circulating blood, and local flow conditions are
also important contributors to thrombosis.
The following terms are proposed to describe the thrombosed
plaques causing the coronary syndromes: 
“A ruptured plaque”. A plaque with deep injury with a real defect
or gap in the fibrous cap that had separated its lipid-rich atherom-
atous core from the flowing blood, thereby exposing the thrombo-
genic core of the plaque (Fig. 2a/b). This is the most common cause
of coronary thrombosis (Arbustini 1999) (Falk 1999) (Davies
2000).
“An eroded plaque”. A plaque with loss and/or dysfunction of the
lumenal endothelial cells leading to thrombosis (Fig. 3). There is no
structural defect (beyond endothelial injury) or gap in the plaque,
which is often rich in smooth muscle cells and proteoglycans (Vir-
mani 2000).
“A plaque with a calcified nodule”. A heavily calcified plaque with
the loss and/or dysfunction of endothelial cells over a calcified nod-
Fig. 4: Calcified nod-
ule. (left) Section of
the mid right coro-
nary artery showing
an eccentric lesion
with extensive calcifi-
cation (calcified plate)
and surface calcified
nodules with loss of
fibrous cap and lume-
nal fibrin deposition
(red). (right) High
power view of the boxed area in (a) showing calcified nodules (*) intermingled, and on the surface of the
nodules fibrin deposition can be observed.
Nodule
*
*
*
*
*
*
*
Fibrin
Calcified
plate25
 ule (Fig. 4). This is the least common of the three causes of throm-
bosis described here (Virmani 2000).
Prospective identification of a high-risk/vulnerable plaque
There is considerable interest in the identification of plaques prior
to the occurrence of thrombosis, since their early detection would
lead to trials of novel preventive measures. As described above, it is
proposed that such plaques be termed “high-risk”, “vulnerable” or
“thrombosis-prone” plaques with the three terms used as syno-
nyms.
On the basis of knowledge of the types of plaques identified as caus-
es of thrombosis (ruptured, eroded and calcific nodule plaques), the
following types of plaques are suspected to be high-risk/vulnerable
plaques:
A plaque prone to 
rupture
Retrospective pathologic studies of plaque rupture with thrombosis
suggest that prior to the event, the plaque was an inflamed, thin-cap
fibroatheroma (TCFA)(Fig. 5) (Arbustini 1999) (Falk 1999) (Dav-
ies 2000) (Virmani 2000) (Varmana 2002) (Ambrose 1991) (Val-
labhajosula 1997).
The major components of such TCFA are:
*
**
Fig. 5: Inflamed thin-
cap fibroatheroma.
(left) Coronary artery
containing a large lip-
id-rich core that is cov-
ered by in thin fibrous
cap. The lumen con-
tains contrast medium
injected postmortem.
(right) Higher magnifi-
cation reveals that the
fibrous cap is severely
inflamed, containing
many macrophage foam cells, and extravasated erythrocytes are seen within the necrotic and avascular
core just beneath the cap, indicating that the cap is ruptured nearby. Trichrome stain, rendering lipid
colorless, collagen blue, and erythrocytes red.26
 CHAPTER 2 TERMINOLOGY VULNERABLE PLAQUES• A lipid-rich, atheromatous core
• A thin fibrous cap, with
macrophage and lymphocyte infiltration
decreased smooth muscle cell content
• Expansive remodelling.
A plaque prone to 
erosion
Retrospective pathologic studies of plaque erosion with thrombosis
suggest that, prior to the event, the plaque was often rich in prote-
oglycans, but, in most cases, lacked a distinguishing structure such
as a lipid pool or necrotic core. If a lipid-rich core is present, the fi-
brous cap is usually thick and rich in smooth muscle cells (Virmani
2000). These plaques are often associated with constrictive remod-
eling.
A plaque with a 
calcified nodule
Retrospective pathologic studies of plaques with thrombosis cover-
ing a calcified nodule suggest that, prior to the event, the plaque ap-
peared to be heavily calcified with a calcified nodule protruding
into the lumen (Virmani 2000).
While such plaques (an inflamed TCFA, a proteoglycan-rich
plaque, and a plaque with a calcified nodule) are suspected to be
high risk/vulnerable/thrombosis-prone plaques, they cannot be
designated as such until prospective studies provide the necessary
supporting data. Hence, an inflamed TCFA is best described as a
“suspected” high risk/vulnerable plaque, since, while confirmatory
data are lacking, its structure definitely resembles that of ruptured
plaques.
Novel imaging 
techniques will 
provide addition-
al information on 
vulnerable 
plaques
Multiple new technologies to improve characterization of plaque in
patients are under development (Ambrose 1991) Vallabhajosula
1997) (Huang 2001) (Schmermund 2001) (Jang 2002) (Nair
2002) (Nieman 2003) Moreno 2003) (Schaar 2003a) (Stefanadis
2003) Naghavi 2003) (Casscells 2003b) (Burke 2003). These tech-
niques seek to identify the histologic features, discussed above, of
plaques suspected to represent vulnerability, and provide additional
information about plaques that has not heretofore been available
(data on structure, composition, deformability, pathophysiology,
metabolism, temperature, etc.). The novel information will expand
the list of features suspected to represent high-risk/vulnerability.27
 TERMS DEFINITION
Culprit lesion A lesion in a coronary artery considered, on
the basis of angiographic, autopsy or other
findings, to be responsible for the clinical
event. In unstable angina, myocardial inf-
arction and sudden coronary death, the cul-
prit lesion is often a plaque complicated by
thrombosis extending into the lumen.
Eroded plaque A plaque with loss and/or dysfunction of
the lumenal endothelial cells leading to
thrombosis. There is usually no additional
defect or gap in the plaque, which is often
rich in smooth muscle cells and proteogly-
cans.
High-risk,
vulnerable
and thrombosis-
prone plaque
These terms can be used as synonyms to
describe a plaque that is at increased risk of
thrombosis (or rethrombosis) and rapid ste-
nosis progression.
Inflamed thin-
cap fibroath-
eroma (TCFA)
An inflamed plaque with a thin cap cover-
ing a lipid-rich, necrotic core. An inflamed
TCFA is suspected to be a high-risk/vulner-
able plaque.
Plaque with a
calcified nodule
A heavily calcified plaque with the loss and/
or dysfunction of endothelial cells over a
calcified nodule, resulting in loss of fibrous
cap, that makes the plaque at high-risk/vul-
nerable. This is the least common of the
three types of suspected high-risk/vulnera-
ble plaques.
Ruptured plaque A plaque with deep injury with a real defect
or gap in the fibrous cap that had separated
its lipid-rich atheromatous core from the
flowing blood, thereby exposing the throm-
bogenic core of the plaque. This is the most
common cause of thrombosis.
TABLE 1: DEFINITIONS28
 CHAPTER 2 TERMINOLOGY VULNERABLE PLAQUESProspective clini-
cal trials are re-
quired
All features suspected to represent high-risk/vulnerability require
validation in longitudinal, prospective, clinical trials that will doc-
ument the natural history of plaques with features suspected to
make them high-risk and vulnerable. If such trials are positive, it
may then be possible to identify a high risk/vulnerable plaque pro-
spectively in an individual patient.
It is also recognized that high-risk/vulnerability may vary over time.
The use of systemic markers of inflammation may assist in assess-
ment of the currently unknown time-course of risk. It is hoped that
the terminology defined above and summarized in Table 1 will di-
minish the need for the use of several other terms (plaque disrup-
tion, plaque fissuring and unstable plaque) that have been less
specifically defined in previous usage.
Treatment
Potential new treatments with systemic, regional, and local ap-
proaches have been proposed and also require evaluation in clinical
trials (Meier 1997) (Mercado 2003). Improved identification and
treatment of high-risk/vulnerable plaques is a goal of great impor-
tance since it would result in major decreases in coronary artery dis-
ease morbidity and mortality.
Thrombosed
plaque
A plaque with an overlying thrombus
extending into the lumen of the vessel. The
thrombus may be occlusive or non-occlu-
sive.
Vulnerable
patient
A patient at high-risk (vulnerable, prone) to
experience a cardiovascular ischemic event
due to a high atherosclerotic burden, high-
risk/vulnerable plaques, and/or thrombo-
genic blood.
TERMS DEFINITION
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CHAPTER 3
EFFECT OF TEMPERATURE INCREASE AND
FREEZING ON ELASTOGRAPHY
CHAPTER 3 TEMPERATURE AND ELASTOGRAPHY
Based on:
Johannes A. Schaar, Chris L. de Korte, Frits Mastik, Anton FW van der Steen
Effect of temperature increase and freezing on intravascular elastography
Ultrasonics (2002) 40, 879–881
 CHAPTER 3 TEMPERATURE AND ELASTOGRAPHYAs an extension of the current intravascular ultrasound (IVUS)
technique, intravascular elastography is capable to measure strain
using the high frequency rf-ultrasound signal. The radial strain is
obtained from cross-correlation analysis of rf-signals recorded at
different intravascular pressures (de Korte 1998a). Physiologically
applied pressure changes the vascular wall after every heartbeat. The
changes are dependent on the composition of the vascular wall
(Wada 1997). The structure and the composition of the vessel
changes with age, physical activities, components of nutrition, hy-
pertension, diabetes mellitus and many other factors (Schmermund
1999). Since composition of the vessel wall engenders the mechan-
ical properties of a vessel, measurement of this mechanics may in-
fluence our understanding of the pathophysiology of the diseases
and their treatment. Because atherosclerosis is one of the leading
causes of vessel changes and in this respects also a main cause for
death, measurement of elasticity in vessels is of major impact.
Arteries were 
stored at -80 oC, 
but experiments 
were performed at 
room temperature
For validation extensive experiments with coronary and femoral ar-
teries were performed. In vitro experiments demonstrated that dif-
ferent strain values were measured in fibrous, fatty and fibro-fatty
tissue indicating the potential of intravascular elastography to dis-
tinguish different plaque morphologies (de Korte 2000a). For these
experiments artery segments were excised within 24 h after death,
measured and after that stored at -80 oC. The arteries were thawed,
connected to the experimental setup and experiments were per-
formed at room temperature in a watertank.
Aim of the study 
was to investigate 
the influence of 
temperature on 
elastography
The aim of the present study was to investigate the influence of
storage and measurement temperatures on intravascular elastogra-
phy. As measurement points were chosen: 23 oC (room tempera-
ture), 37 oC (body temperature) and 23 oC after freezing at -80 oC.35
 Methods
Cross sections 
were marked with 
a needle
Atherosclerotic human femoral (n=1), carotid (n=1) and coronary
(n=4) artery segments were excised within 24 h post mortem and
measured within 3 h after excision. After closing side branches with
suture material the arteries were scanned at different positions, with
a gap of more than 10 mm. These cross-sections (n =12) were
marked with a surgical needle, inserted tangentially in the adventi-
tia, which is clearly visible in the echogram. Inserting the needle
into the adventitia doesn’t destroy the vascular wall and has no in-
fluence on the mechanical properties of the vessel. This surgical
needle was inserted till the end of the experiment, to make sure, that
the spots of interest were retrieved. The ultrasound experiments
were performed in a physiological saline solution in a water tank at
room temperature (23 ± 1 oC).
A water column system, containing a de-gassed physiological saline
solution, was connected to the proximal sheath: Intraluminal pres-
sures of 80 and 100 mm Hg were applied. This sheath also was used
to insert the IVUS catheter. The arteries were scanned with an In-
Vision 20-MHz IVUS catheter (Jomed Inc., Rancho Cordova,
CA). The pressure was monitored with the use of a pressure gauge
(DTX/plus, Ohmeda) connected to the distal sheath.
Radio frequency 
data were sam-
pled at 100 MHz
The catheter was connected to an InVision echo apparatus (Jomed
Inc., Rancho Cordova, CA); 512 angles containing 10 s of radio
frequency data sampled at 100 MHz were acquired at 30 frames/s.
First, an IVUS frame was acquired at 80 mm Hg intravascular pres-
sure. After 10 µs, an IVUS frame was acquired at 100 mmHg to
achieve different strain levels of the material. The data were cap-
tured using a PC-based acquisition system, connected to the digital
interface of an InVision Echo machine. The acquisitions were
stored on a CD-ROM for off-line processing. 
The resolution of 
the strain in the 
radial direction is 
200 µm
Elastograms were calculated as described before (de Korte 1999).
The local strain was calculated from the gated radio frequency trac-
es and displayed using color code from red for low strain through
green for 2% strain and plotted as a complementary image to the
IVUS echogram. The resolution of the strain in the radial direction
is 200 µm.36
 CHAPTER 3 TEMPERATURE AND ELASTOGRAPHYAfter the first recording of an elastogram the saline in the watertank
was heated from room temperature to 37 oC. Due to the surround-
ing saline the vessel temperature also increased to 37 oC. Thirty
minutes later the measurements were repeated as described above.
Temperature was measured in the water bath by a thermometer
(ITI 20-2 B, AoiP Mesures, France).
The vessel was disconnected from the sheath and frozen at -80 oC
for 12–24 h. The vessels were thawed and the measurements were
repeated at the same spot, which was marked by a surgical needle.
The mean strain in the plaques was determined for all acquisitions.
All statistical analysis was performed with the use of SPSS 10.1.4
software. First, the distribution of the average strain was tested for
normality using the Shapiro–Wilk test (Altman 1997). These tests
revealed that the strain was normally distributed in each group of
temperature (p=0.34 for 23 oC, p=0.20 for 37 oC, p=0.35 for 23
oC after freezing).
IVUS
37 °C
ROOM TEMPERATURE
ROOM TEMPERATURE AFTER FREEZING
Fig. 1: Intravascular elas-
tograms under influence
of different tempera-
tures.37
 To test the differences between the groups a paired samples t-test
was performed. Values of p < 0:05 were considered significant.
Results
In this study, 12 cross-sections were analyzed from six arteries. One
measurement in the 37 oC group and in the 23 oC after freezing
group failed due to recording problems. In the cross-section the re-
gion of interest was defined by the size of the plaque. The mean
strain of the region of interest was determined for every tempera-
ture group shortly after each other to ensure measurement in iden-
tical areas. An IVUS echogram and elastogram of a carotid artery
cross-section at different temperatures is presented in Fig. 1. The
echogram shows an eccentric plaque between the 6 and 9 o’clock
positions. 
A qualitative comparison between the elastograms at different tem-
peratures and after freezing reveals that the strain in the plaque
looks similar. A slightly increased strain is found in the elastogram
of the fresh artery. The white lines indicate the region used for the
statistical analysis.
Table 1 shows the frequencies, the mean strain value and the devi-
ation for the different groups. Table 2 presents the results of the of
the paired sample t-test. For comparison the 23 oC group, the 37
oC group and the 23 oC group after freezing was chosen. The dif-
ference between the groups was not statistically significant.
23 OC 37 OC 23 OC
AFTER FREEZING
Number of valid measurements 12 11 11
Mean strain in % 0.93 0.91 0.79
Standard error of mean strain in % 0.20 0.21 0.21
Standard deviation mean strain in % 0.68 0.71 0.69
TABLE 1: MEAN STRAIN AND THE INFLUENCE OF FREEZING AND DIFFERENT 
TEMPERATURES38
 CHAPTER 3 TEMPERATURE AND ELASTOGRAPHYDiscussion
Imaging the atherosclerotic plaque with IVUS gave important in-
sights into the morphology of atherosclerosis (Kinlay 2001). Elas-
tography can add mechanical information to the current used
IVUS pictures and lead into the direction of tissue characterization
(de Korte 2000b). Since intravascular elastography may play an im-
portant role in the future for characterizing mechanical properties
of vascular tissue a proper validation is necessary. One part of this
validation process is the accomplishment of in vitro experiments
with vessels of human nature. The experimental setup should be on
one side convenient to use, on the other side reflect also clinical cir-
cumstances.
In this study we examined the influence of different temperatures
on the elastograms to be sure, that temperature effects do not harm
our experimental setup and curtail the results of the validation
process.
We measured vessels in a scenario, which was chosen in previously
published studies, where the experiments were performed at room
temperature (de Korte 2000c). Fatty tissue has different elastic
properties in vivo and in vitro, most likely related to different tem-
peratures. Since the body temperature is approximately at 37 oC,
we performed a measurement in a human body like environment at
body temperature to establish the original state of the tissue as close
as possible and prove the effect of temperature changes. Also of in-
MEAN 
STRAIN
DIFFERENCE 
IN %
STANDARD
DEVIATION 
IN %
STANDARD 
ERROR
OF MEAN 
IN %
P
Pair 1 23°C vs. 37°C 0.01 0.15 0.05 0.848
Pair 2 23°C - at 23°C 0.12 0.36 0.11 0.313
TABLE 2: MEAN STRAIN DIFFERENCES39
 terest was the effect of freezing on mechanical properties since it is
convenient to store vessel specimens before an investigation.
There is no statis-
tically difference 
between different 
temperature in-
fluence on elasto-
grams
There is no statistically difference between 23 and 37 oC. We con-
clude that future in vitro experiments can be performed at room
temperature without affecting strain measurements. Also no influ-
ence on strain measurements of freezing was seen. The average
strain in the region of interest was not significant different in the
measurement after a freezing period. We conclude that specimens
can be stored in a -80 oC refrigerator before a experiment, without
affecting the mechanical properties. This results lead into the direc-
tion of a convenient use of arterial specimens in experimental setups
of IVUS elastography.40
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 CHAPTER 4 CHARACTERIZING PLAQUEMyocardial infarction, sudden cardiac death, and unstable angina
have in common a genesis of coronary thrombosis, which develops
as a result of a ruptured vulnerable or an eroded atherosclerotic
plaque. As long as atherosclerotic lesions do not rupture and eroded
plaques do not induce thrombosis, coronary artery disease may be
a clinically silent disease associated with low mortality (Virmani
2001). Whenever plaques start to rupture and thrombogenic mate-
rial is coming in contact with circulating blood, a situation is creat-
ed that may lead to acute coronary syndrome associated with high
mortality (Falk 1999)
Plaque rupture is 
related to a fragi-
lization process of 
the cap over an 
atheromatous core
Plaque rupture is related to a fragilization process of the cap over an
atheromatous core (Loree 1992). This process is triggered by an ac-
cumulation of inflammatory cells like macrophages, which produce
metalloproteinases (matrix-degrading enzymes) (Libby 1995). To
understand the mechanisms of plaque destabilization and guide a
pharmacological treatment, it would be of major interest to image
the fragile part of the atheromatous plaque and to differentiate be-
tween high-risk and low-risk plaques (Muller 1994).
Physiological pres-
sure strains the 
vascular wall dur-
ing every heart-
beat
As an add-on to intravascular ultrasound (IVUS), intravascular
elastography is able to measure strain using cross-correlation analy-
sis of radio frequency ultrasound signals recorded at different intra-
vascular pressures (de Korte 1998a). Physiological pressure strains
the vascular wall during every heartbeat (Lendon 1993). The un-
derlying principle is that the strain of the tissue is a function of its
mechanical properties. The local strain of the tissue is displayed as
an additional image (elastogram) to the IVUS echogram (de Korte
2000c). Preliminary experiments revealed that it is feasible to dis-
criminate between fatty, fatty fibrous, and fibrous material with this
technique (de Korte 2000a).43
 Aim of the study is 
to evaluated the 
ability of intra-
vascular elastog-
raphy to identify 
vulnerable plaque 
features
The structure and the composition of the vessel change with age,
hypertension, diabetes mellitus, and many other factors (Schmer-
mund 1999). Because composition of the vessel wall affects the me-
chanical properties of a vessel, the analysis of mechanical behaviour
of the vessel wall may enhance our understanding of the pathophys-
iology of atherosclerotic disease. Furthermore, rupture of plaques
may occur in regions with increased mechanical stress (Burleigh
1992).
In this study, we evaluated the ability of intravascular elastography
to identify vulnerable plaque features. We tested the hypothesis that
a pattern consisting of a high-strain region at the surface adjacent
to low-strain regions corresponds to vulnerable plaque in histology.
Furthermore, we looked at the relation between vulnerable plaque
features and local high strain regions.
Methods
Atherosclerotic human coronary (n=24) artery segments of 23 pa-
tients were excised and measured within 24 hours postmortem. All
patients (mean age, 65±6 years) died of non-coronary causes, such
as
pneumonia (n=9), cancer (n=11), aortic dissection (n=1), and liver
Fig 1: Vulnerable
plaque marked in
IVUS (a), elastogram
(b), macrophage
staining (c), and colla-
gen staining (d). In
the elastogram, a vul-
nerable plaque is indi-
cated by a high strain
on the surface. In the
corresponding histol-
ogy, a high amount of
macrophages (c) is
visible with a thin cap
(d) and a lipid pool.44
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failure (n=2). Fifteen left coronary arteries and 9 right coronary ar-
teries were used. The arteries were mounted between 2 sheaths. Be-
fore a defined constant pressure in the artery was achieved, the
vessel was pressurized several times to detect leakage caused by even
the smallest side branches still left open. After closing the remaining
side branches, the vessel was pressurized several times to ensure the
absence of leakage. Immediately after the ultrasound, experiments
were performed in physiological saline solution in a water tank at
room temperature.
A water column system, also containing physiological saline solu-
tion, was connected to the proximal sheath. This sheath was used
to insert an 20-MHz IVUS catheter (Jomed Inc, Rancho Cordova,
CA, USA) connected to an InVision echo apparatus (Jomed Inc,
Rancho Cordova, CA, USA).
IVUS frame was 
acquired at 80 
and 100 mmHg
First, an IVUS frame was acquired at 80 mm Hg intravascular pres-
sure. After 10 seconds, another IVUS frame was acquired at 100
mm Hg to obtain the incremental strain of the material. The data
were captured using a PC-based acquisition system, connected to
the digital interface of the echo machine, and stored on a CD-
ROM for off-line processing.
58 cross sections 
were scanned
Fifty-eight cross sections were scanned with an interval of more
than 10 mm to ensure uncorrelated observations. After the elasto-
graphic acquisition, the position of the ultrasonic cross sections was
marked in the echogram with a clearly visible surgical needle insert-
ed in the adventitia. On the surgical needle, a suture was mounted.
Before cutting, the needle was removed but the suture remained in
place. This suture was used as a marker for sectioning location.
Coronary arteries 
were pressure-
fixed 
Subsequently, the coronary arteries were pressure-fixed (80 mmHg)
and imaged segments were stained for the presence of collagen and
fat (picro Sirius red and polarized microscopy), smooth muscle cells
(α-actin), and macrophages (CD 68).
Elastograms were calculated as described before (de Korte 1998b).
The local strain was calculated from the gated radio frequency trac-
es and displayed color-coded from blue for 0% strain via red to yel-
low for 2% strain and plotted as a complementary image to the
 IVUS echogram. The resolution of the strain measurement in the
radial direction was 200 µm.
Observers blind-
ed for the outcome 
of each respective 
technique ana-
lyzed elastograms 
and histology.
Observers blinded for the outcome of each respective technique an-
alyzed elastograms and histology. The thickness of the plaque cap
and the atheroma size were measured using quantitative analysis of
light microscopic images (Clemex Vision PE 3.5). To compare his-
tology with elastography, matching between IVUS pictures and
histology was performed using anatomical or artificial landmarks
like calcium spots or the above-described suture. The matching was
performed without knowledge of the elastographic results. Cross
sections (n=4), for which a match between histology and IVUS ech-
ogram was not obvious, were excluded from the study.
In histology, a vulnerable plaque was defined as a plaque whose
content consists of more than 40% atheroma covered by a thin cap
with moderate to heavy macrophage infiltration, as described by
Davies (Davies 1995). A thin cap was defined as smaller than 250
µm (Mann 1996). Smooth muscle cells (SMCs), collagen, and mac-
rophages were graded as none, minor, moderate, and heavy accord-
ing to their staining (Pasterkamp 1998).
In elastography, the potentially vulnerable location was defined as
the region with the highest strain at the surface with adjacent low-
strain regions (Figure 1). These spots were correlated with tissue
components, which indicate vulnerability.
A ROC curve 
analysis was per-
formed to evalu-
ate the value of 
local strain for the 
prediction of 
plaque vulnera-
bility
For statistical analysis, SPSS 11.0.1 (SPSS Inc, Chicago, MI, USA)
was used. Continuous variables are presented as median values and
corresponding 25th and 75th percentiles. A receiver operator char-
acteristic (ROC) curve analysis was performed to evaluate the value
of local strain for the prediction of plaque vulnerability. According
to this method, sensitivity (number of identified vulnerable plaques
per total number of vulnerable plaques) and specificity (number of
identified nonvulnerable plaques per total number of nonvulnera-
ble plaques) were determined over the entire range of strain meas-
urements using each observed value as a diagnostic threshold and
plotted against each other. The area under the obtained curve,
which may range from 0.5 to 1.0, represents the diagnostic accuracy
of local strain. The strain value with the highest sum of sensitivity46
 CHAPTER 4 CHARACTERIZING PLAQUEand specificity was considered to best discriminate between vulner-
able and nonvulnerable plaques.
Subsequently, multiple linear regression analyses were performed to
evaluate the relationship between local strain and several plaque
components, such as macrophages, smooth muscle cells, collagen
content, and cap thickness. Regression coefficients with corre-
sponding standard errors are reported, as well as significance levels.
Nonlinear regression was used to test the relation between cap
thickness and strain according to the model of Loree et al. (Loree
1992). The Kolmogorov-Smirnov test was used to assess normal
distribution.
Fig 3: Relation be-
tween strain (per-
cent) and macro-
phages of the poten-
tially vulnerable loca-
tions.
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Fig 2: Relation be-
tween strain, sensi-
tivity (Sens) and
specificity (Spec)
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 Results
Predictive value 
of intravascular 
elastography to 
detect vulnerable 
plaque
Average strain was obtained in the high-strain region of the plaques
(n=54) of 24 diseased coronary arteries and compared with the his-
tological grading of vulnerability. Twenty six vulnerable plaques
and 28 nonvulnerable plaques were found. The optimal sensitivity
and specificity were obtained for a threshold value of 1.26% strain
(Figure 2). The area under the curve of the ROC analysis was 0.85
(95% CI, 0.74 to 0.97).
Fig 4: Relation be-
tween strain (per-
cent) and smooth
muscle cells of the
potentially vulnera-
ble locations.
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Fig 5: Relation be-
tween strain (per-
cent) and collagen
of the potentially
vulnerable loca-
tions.
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 CHAPTER 4 CHARACTERIZING PLAQUERegarding vulnerable plaques, elastography was positive in 23 cases
but negative in 3 cases. This results in a sensitivity of 88%. Nonvul-
nerable plaque were seen by histology in 28 cases and detected by
elastography in 25 cases but were falsely diagnosed as positive in 3
cases. This results in a specificity of 89%. Intravascular elastography
has a positive predictive value of 88% and negative predictive value
of 89% based on comparison with histology. Comparing vulnera-
bility in elastograms with cap thickness measured in histology, vul-
nerable plaques have a statistically thinner cap (258.7±18.1 µm)
than nonvulnerable plaques (362.7±29.7 µm), with P< 0.005.
Relation between 
features associat-
ed with plaque 
vulnerability and 
strain
The box-and-whisker plots show the relation between the 4 classes
of macrophage content divided versus strain (Figure 3), SMC ver-
sus strain (Figure 4), and collagen versus strain (Figure 5). The re-
lation between strain and cap thickness is reported in Figure 6.
There is an inverse relationship between strain and cap thickness. A
curve estimation, based on finite element modelling (Loree 1992),
showed R=0.68 with P<0.0001. It should be noticed that a cap
>400 µm results in a strain <1%, whereas the data are more scat-
tered for lower cap thickness. The R of the linear regression model
with all tissue components mentioned above as independent varia-
bles and strain as dependent variable is 0.48, with a value of
P<0.0001. Detailed analysis is given in Table 1.
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Fig 6: Relation be-
tween strain (per-
cent) and cap
thickness (micro-
grams)
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 Discussion
There is a need for a technique to diagnose the vulnerability of a
plaque. With the availability of such a technique, a vulnerable
plaque can be identified and followed and treatment can be moni-
tored. Studies have shown that different strain values were obtained
with intravascular elastography for different plaque components in
vitro and in vivo (de Korte 2002a+b).
One aim of the study was to assess the predictive value of IVUS
elastography to identify the vulnerable plaque. This study demon-
strates that intravascular elastography can accurately diagnose vul-
nerable plaques, as defined by Davies (Davies 1995) in vitro with a
MODEL COEFFICIENT SD P VALUE
Cap thickness, µm -0.0004 0.001 0.14
Macrophages 0.552 0.192 0,006
SMC -0.738 0.177 0.0001
Collagen -0.217 0.177 0.227
Table 1: Description of the Linear Regression Model Regarding
the Influence of Tissue Components (Cap Thickness, Macro-
phages, SMCs, Collagen) on Strain
Fig 7: A typical obser-
vational example of
an eccentric plaque
with high strain spots
on the shoulders is
given.
The image was re-
corded in a patient
with unstable angina
pectoris (Braunwald
IIIb).50
 CHAPTER 4 CHARACTERIZING PLAQUEhigh sensitivity and specificity. Because detection of vulnerability is
presently not feasible in vivo with other available techniques, intra-
vascular elastography may offer an unique opportunity to learn
more about the aetiology of plaque rupture and to assess the effect
of pharmacological agents on plaque stabilization.
We measured the 
mechanical prop-
erties of plaques, 
as depicted by the 
strain in an elas-
togram. 
Rupturing of a lipid-rich plaque may initiate the development of
acute cardiac ischemic events. We measured the mechanical prop-
erties of plaques, as depicted by the strain in an elastogram. The
vulnerable plaque is characterized by a high strain value on the sur-
face of the plaque (Figure 7); conversely, a stable plaque has a low
strain caused by a stable cap.
Another aim of the study was to find out which anatomical features
in particular generate the high strain spots in an elastogram. To an-
swer this question, elastograms and histology were compared in 54
cross sections of human coronary arteries. The principal findings of
this part of the study were as follows. First, there is a high correla-
tion between the strain in the cap of coronary plaques and the
amount of macrophages. Second, there is an inverse correlation be-
tween the amount of SMC and strain. Third, plaques, which are
declared vulnerable in elastography, have a thinner cap than non-
vulnerable plaques and a higher macrophage concentration.
High correlation 
between strain 
and macrophages 
The high correlation between strain and macrophages can be ex-
plained by weakening of the cap. Macrophages play a central role in
the degradation process of the extra cellular matrix by secreting pro-
teolytic enzymes (Galis 1994). In our study, this is reflected by the
relationship between the amount of macrophages and the level of
strain in the high strain spot in the elastogram.
High strain is cor-
related with a low 
amount of SMC
Compared with macrophages, less is known about the influence of
SMCs on the vulnerable plaque. Nevertheless, it has been suggested
that plaques are more likely to break if fewer SMCs are present
(Davies 1993). The reason is not quite clear, but it seems that
SMCs play an important role in preserving the integrity of the extra
cellular matrix in the cap (Geng 1997) (Seshiah 2002). Further-
more, mechanical overstretching has proven to induce apoptosis in
isolated vascular smooth muscle cells (Sotoudeh 2002). In our
study, this phenomenon may be exemplified by the fact that high
strain is correlated with a low amount of SMCs.51
 Significant rela-
tion between 
strain and colla-
gen
There is also a significant relation between strain and collagen.
However, after correcting for the confounding effect of macrophag-
es and smooth muscle cells, no statistically significant effect of col-
lagen on strain could be demonstrated. Thus, these results
demonstrate that high strain is mainly caused by the presence of
macrophages and the paucity of smooth muscle cells.
Inverse relation 
between cap 
thickness and 
strain.
Rupture of the plaque occurs mostly at the thinnest part of the cap.
In our study, we found an inverse relation between cap thickness
and strain. Loree et al. (Loree 1992) have already shown using a fi-
nite element model that a reduction of the fibrous cap thickness un-
der 250 µm dramatically increases peak circumferential stress in the
plaque. However, this relation was never demonstrated by measure-
ments in coronary plaques. In our study, the cap thickness of
plaques that are considered vulnerable was 250 µm. Furthermore,
no regions with a strain higher than 1% were found in plaques with
a cap thickness of greater than 260 µm.
In this study, all patients died from noncoronary causes. This pop-
ulation was chosen to detect rupture-prone plaques and not al-
ready-ruptured plaques. However, taking into account that plaque
rupture is a process triggered by inflammation, using cap thickness
as an exclusive marker may be too simple. The often-used upper
bound of 65 µm, as defined by Burke et al. (Burke 1997), described
that it was not likely to have ruptured caps thicker than 65 µm.
However, their conclusion was not that caps that are larger than 65
µm could not be considered vulnerable. Davies et al. (Davies 1993)
focused more on the presence of inflammation rather than the cap
thickness, which degrades the integrity and leads to a rupture. Nev-
ertheless, in vulnerable patients who died from coronary artery dis-
ease, Mann and Davies (Mann 1996) found that the mean minimal
cap thickness, i.e., the thinnest part of a cap, was 250 µm. In view
of this, we considered caps thinner than 250 µm with moderate or
heavy infiltration of macrophages as rupture prone. Studies have
shown that inflammation contributes extensively to mechanical be-
haviour of fibrous caps (Lendon 1991). Therefore, an exact cap
thickness and the relation to triggering processes-like inflammation
have to be exactly investigated in the future.
The impact of a diagnostic technique is highly dependent on its fea-
sibility in vivo. Intravascular elastography has been applied in pa-52
 CHAPTER 4 CHARACTERIZING PLAQUEtients (de Korte 2002b). Because IVUS is a commercially available
technique that is routinely used by cardiologists, no additional
catheters are needed to perform elastography. Elastography is able
to detect vulnerable plaque features. This may enable us to follow
the natural history of plaques suspected to be vulnerable (Figure 7).
Furthermore, the influence of treatment of vulnerable plaques can
be studied. Because palpography is based on computer processing,
it can be easily implemented in the daily diagnostic procedure of
patients with acute coronary syndrome.
Motion, either 
from the heart or 
the catheter, can 
lead to unreliable 
results in the clin-
ical setting.
Motion, either from the heart or the catheter, can lead to unreliable
results in the clinical setting. These motion artifacts can be avoided
by acquisition of the signals in end diastole, where a pressure change
still exists but the catheter motion reaches its minimum (de Korte
2002b). Furthermore, contrary to light-based techniques, ultra-
sound at the frequency used in this study does not suffer from the
presence of blood in the artery.
However, the use of intravascular elastography is limited by its in-
vasive nature. In the future, noninvasive tests like computed tom-
ography or MRI may serve as screening tests to identify high-risk
lesions and triage the patients to a more invasive testing once they
have reached sufficient spatial and parametric resolution.
OCTOther intravascular techniques are presently under development to
detect vulnerable plaque features. Optical coherence tomography
has a much higher resolution (approximately 10 µm) than IVUS
and may provide a more detailed description of the morphology of
a plaque. However, it has limited penetration depth and requires
flushing the lumen with saline or inflating a balloon before images
can be acquired (Jang 2002).
AngioscopyThe same problems occur with angioscopy, where flushing is need-
ed to identify yellow plaques, which are associated with acute coro-
nary syndromes (Uchida 1995).
ThermographyThermography can detect plaques with high temperature, which is
related to inflammation (Casscells 1996). Results of preliminary in-
vestigation in humans have been reported (Stefanadis 2001). How-
ever, the method needs additional validation, especially regarding
the influence of external parameters like intracoronary blood flow. 53
 Near-infrared 
spectroscopy
Near-infrared spectroscopy obtains pictures based on absorbance of
light by organic molecules. This technique has proven to detect
plaque components with a high accuracy in vitro, although blood
particles may hinder light waves to reach the plaque (Moreno
2002), a fact that limits all light-emitting diagnostic tools in their
ability to detect plaque components.
Several groups have investigated the potential of radiofrequency
signal analysis for tissue characterization (Nair 2001) (Landini
1986) (Wilson 1994) (Jeremias 1999) Wickline 1994) (Bridal
2000) (Spencer 1997). Many of these studies revealed the potential
to identify calcified plaques, but although promising, none of them
has converged yet to a technique with sufficient spatial and para-
metric resolution to identify a lipid pool covered by a thin fibrous
cap. The power of elastography is that it is assessing the weak spot
of a plaque and thus not needing high resolution.
Limitations
Strain estimation in this study is based on tissue mechanics ex vivo.
The level of deformation of tissue in vivo may be different to the in
vitro measurements. This may be attributable to lack of external pa-
rameters, such as innervations, tonus, and pulsatility. Future studies
will address these questions. To extrapolate the results to a clinical
situation, a prospective study is needed as in vivo validation. All
measurements of this study were performed at room temperature
(23°C). In a previous study, we found that this temperature differ-
ence in vitro does not affect strain measurements (Schaar 2002).
The phrase and definition of vulnerable plaque are critically chosen.
From a prospective view, it is unknown which plaques are rupture
prone. The result of the ROC analysis may have been different if
another definition were chosen. The arteries are preconditioned by
repetitively pressurizing them from baseline. The arteries were ini-
tially pressurized at 80 mm Hg and then pressurized 10 seconds lat-
er to 100 mm Hg. The effects of preconditioning and hysteresis
were not assessed in these experiments, limiting our ability to di-
rectly extrapolate to steady-state pulsatile environment. Although
there is a difference between the static and dynamic mechanical
properties of vascular tissue, the ratio between the different plaque
components remains similar (Lee 1991) (Lee 1992). Nevertheless,54
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change between static or pulsatile experiments. However, the opti-
mal threshold value (1.26% strain) for detecting a vulnerable
plaque cannot be directly transferred from static in vitro experi-
ments to pulsatile in patient recordings. This is corroborated by the
initial elastographic in vivo acquisitions, where similar strain values
were measured as in the in vitro experiments but with a significantly
lower pressure differential (de Korte 2002a). This study shows that
you can get sensitivity and specificity of approximately 90%. For in
vivo measurements in patients, the strain threshold still has to be
determined.
Plaques, in which elastography was assessed, were selected from the
IVUS pictures. However, because the coronary artery specimens
were short and recording close to the sheets was avoided, only a lim-
ited number of plaques were suited for recording and a preselection
of certain plaque features was hindered.
Conclusions
Intravascular elastography identifies successfully vulnerable plaque
features in postmortem coronary arteries. Thus, intravascular elas-
tography may play an important role in diagnosing the vulnerable
plaque and help to gain deeper insight in the pathophysiology of
acute coronary syndrome and identify the high-risk patient.
If unstable angina, plaque progression, and myocardial infarction
are to be understood and prevented, vulnerable plaques must be
identified and stabilized. Endeavours to prevent acute events are
limited by identifying the high-risk plaque. The identification of
vulnerable plaques may allow establishing therapies to reduce the
risk of cardiac death in the future and opens the door to a preven-
tive strategy for our patients.55
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 CHAPTER 5 ELASTOGRAPHY IN VIVOThe composition of an atherosclerotic plaque is an important de-
terminant for clinical syndromes. Determinants of ruptured
plaques are a large lipid core covered by a thin fibrous cap with a
dense infiltration of macrophages (Davies 1993). Although some
promising invasive and noninvasive techniques (Pasterkamp 2000)
are being developed, no technique is currently clinically available to
identify these vulnerable plaques.
Intravascular ultrasound (IVUS) has proven to be a powerful tech-
nique to assess the geometry of the vessel wall and plaque. However,
the sensitivity and specificity to detect lipid cores remains low
(Komiyama 2000) (Prati 2001). IVUS elastography assesses the lo-
cal radial strain in the tissue caused by an intraluminal pressure dif-
ferential. In vitro experiments revealed different strain values in
fibrous and fatty plaques in human coronary and femoral arteries
(de Korte 2000a). Feasibility experiments in patients showed that
reproducible elastograms could be obtained (de Korte 2002b).
The aim of this study was to validate IVUS elastography in vivo
with an atherosclerotic Yucatan minipig model. Additionally, we
studied whether atheroma and macrophages were related with
strain values.
Methods
AnimalsSix atherosclerotic Yucatan pigs, average weight 40 kg, were stud-
ied. To induce atherosclerosis, pigs were put on an atherogenic diet.
Two weeks thereafter, the external iliac and femoral arteries were
denuded with a 4-F endothelial Fogarty catheter. The atherogenic61
 diet was continued for 9 to 10 months after which femoral and in-
ternal iliac arteries were stented for the purpose of another study.
Subsequently, the atherogenic diet was replaced by a regular diet.
No intervention was performed in the denuded external iliac arter-
ies that were visualized for the present study. The following 42
days, 3 pigs were treated with a drug and 3 pigs served as controls
for the purpose of another study. ANOVA revealed that the intake
of the drug had no influence on the measurements performed in
this study. After the elastographic acquisition, animals were eutha-
nized and vessels were harvested. The Ethical Committee on Ani-
mal Experimentation of the Faculty of Medicine, Utrecht
University, approved the investigation.
Atherogenic Diet In addition to essential nutrients, vitamins, salts, 2% cholesterol,
18% casein, and 6% peanut oil formed the basic atherogenic com-
ponents of the diet.
Anesthesia During denudation, intervention, and termination, the animals
were anesthetized with intravenous midazolam 0.3 mg/kg per h and
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Fig 1: IVUS echogram
(A) and elastogram (B)
of cross-section with an
advanced fibrous le-
sion. Low-strain values
were found in this-
plaque. The plaque is
mainly composed of
collagen and no macro-
phages were found.
Histology picro-Sirius red [C], picro-Sirius red imaged with polarized light microscopy [D], and acid
phosphatase [E]) reveals that the plaque was imaged froma false lumen that was created during the inter-
vention. The region in the elastogram with no strain values corresponds to the original lumen.62
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sufentanil 2.5 µg/kg per h and ventilated with a mixture of
O2:air=1:1 and 1% halothane after a premedication with 4 mg/kg
azaperone, 10 mg/kg ketamine, and 4 mg/kg thiopental.
Elastographic Ac-
quisition
At termination, the arterial tree was accessed through a left carotid
approach. An arterial 8-F sheath was introduced into the descend-
ing aorta, and an 8-F guiding catheter was advanced to the aortic
bifurcation. Through the guiding catheter, contrast angiography
was performed and a 20-MHz Visions catheter (JoMed, Rancho
Cordova, CA, USA) was advanced. IVUS data were acquired in the
external iliac and the proximal, unstented part of the femoral artery.
The position of the IVUS catheter was registered with angiography
and radiopaque rulers.
Frames that contained 512 angles with high-frequency raw ultra-
sound signals (7.5 mm) were acquired at 30 frames/second. The
data were captured together with the pressure and ECG signals with
a workstation that contained a framegrabber (Coreco Inc) connect-
ed to the digital interface of an InVision Echo machine (JoMed,
Cordova, CA, USA). Blood pressure was measured with the intro-
duction sheath that was located distally from the aortic arch. Each
acquisition of 4 seconds that contained 120 frames was stored on a
CD-ROM for off-line processing. The animals were euthanized by
an overdose of pentobarbital.
strain
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Fig 2: IVUS echogram
(A) and elastogram (B)
of an early fatty plaque.
The strain in this
plaque is high, which
indicates soft material.
Histology (picro-Sirius
red [C], picro-Sirius
red imaged with polar-
ized light microscopy
[D], and acid phos-
phatase [E]) reveals a
lack of collagen in this
plaque and a heavy
staining of macrophag-
es. The geometry of the
cross-section is distort-
ed, because of shrink-
age caused by freezing.
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 After euthanization, the surrounding tissue was removed from the
arteries without changing the position of the legs. The investigated
cross-sections were identified by angiography by comparison with
the stored angiogram and the anatomic landmarks and radio-
opaque rulers. The investigated locations were marked with suture
in the adventitia. Next, the artery was excised and frozen in liquid
nitrogen.
Histology Cross-sections (7 µm) were stained for general morphology (elastin
van Gieson), collagen (picro-Sirius red and imaged with polarized
light), and macrophages (acid phosphatase). The lipid content was
assessed by the empty spaces in the picro-Sirius red stain imaged
with polarized light microscopy (Davies 1993). A lesion was classi-
fied as fatty when >40% of the plaque area consisted of fat. A lesion
had positive macrophage staining when the acid phosphatase stain
revealed clusters of cells with >10 cells. A lesion was classified as ad-
vanced when occupying an area within the internal elastic lamina of
>40%; otherwise, it was classified as early lesions. Plaques were clas-
sified as absent, early fatty lesions, early fibrous lesions, and ad-
vanced fibrous plaques by observers blinded to the elastographic
results. In this animal model, no advanced fatty plaque and no cal-
cified components were found.
Data Analysis Elastograms were determined with 2 frames acquired near end-di-
astole because motion of the catheter is minimal in this phase (de
Korte 2002b). Strain values up to 2% were obtained for a pressure
differential of 4 mmHg (±0.5) (100 milliseconds interframe time).
These strain values are detectable with the chosen window length
(Cespedes 1999). For each angle, the radial strain is determined
with cross-correlation analysis of the high frequency ultrasound
data (de Korte 2000c). All signal processing was performed in Mat-
lab (MathWorks). The strain values were color coded from red for
low strain via yellow to green for 2% strain and were plotted as a
complementary image to the IVUS echogram. The resolution of an
elastogram in the radial direction is 200 µm.
The strain value of a plaque was determined by averaging all strain
values found in the plaque. Additionally, the presence of a high-
strain spot (strain >1%) in the elastogram was related to the pres-
ence of fat and macrophages. The alignment of the ultrasound data64
 CHAPTER 5 ELASTOGRAPHY IN VIVOand the histologic cross-sections was performed by the use of the
IVUS echogram and the histology as described earlier (de Korte
2000a+b).
StatisticsAll statistical analysis was performed with SPSS statistical software.
Values are expressed as mean and the range. Bivariable linear regres-
sion analysis was performed to study the relation between the pres-
ence of fat and macrophages and the mean radial strain. Receiver
operating characteristic analysis was performed to assess the optimal
strain value and to evaluate the predictive power to identify fatty
plaques. Furthermore, the sensitivity and specificity of a high-strain
spot to identify fat and macrophages was determined.
Results
In 50% of the arterial segments, early plaques were found (n=12).
Nine of these early lesions were classified as fatty. Advanced fibrous
lesions were found in 25% of the segments (n=6), and the remain-
ing 25% contained no plaque (n=6). Macrophages were found in
cross-sections with early plaque (n=11) and in 1 fibrous plaque.
Typical examples of an advanced fibrous plaque and an early fatty
plaque are shown in Figures 1 and 2. The elastogram (Figure 1)
shows low-strain values, which indicate relatively hard material.
The histology reveals the presence of collagen. Macrophages and fat
are not found. High-strain values were found in a cross-section with
early fatty plaque (Figure 2).
STRAIN %
PLAQUE MEAN RANGE
Absent (n = 6) 0.21 0.13–0.33
Early fatty lesions (n = 9) 0.46 0.28–0.80
Early fibrous lesions (n = 3) 0.24 0.21–0.27
Advanced fibrous plaque (n = 6) 0.22 0.17–0.28
Table 1: Mean Strain Value in Plaque Types and Normal Artery65
 Higher average strain values were found in the fatty plaques with
fatty material than in the other pathologies that showed similar
mean strain values (Table 1). Regression analysis revealed a highly
significant difference in average strain values between plaques with
and without fat (P=0.007). After correction for the confounding ef-
fect of fat, the presence of macrophages had no additional effect
(P=0.966). Receiver operating characteristic analysis revealed a
maximum sensitivity of 100% with a corresponding specificity of
80% to identify fatty plaques for a strain value of 0.35%. The area
under the curve was 0.952.
A high-strain spot has 75% sensitivity and 100% specificity to iden-
tify fat (Table 2). A 92% sensitivity and 92% specificity was found
to identify the presence of macrophages.
Discussion
In this study, IVUS elastography is validated in vivo with an athero-
sclerotic Yucatan minipig model. An earlier in vitro study revealed
different mean strain values in fibrous, fibrofatty, and fatty plaques
in human coronary and femoral arteries (de Korte 2000a). In this
in vivo study, significant higher strain values were found in fatty
plaques than in fibrous plaques.
In this animal model, only homogeneous plaque types and no cal-
cified material were found. Because human plaques are mainly het-
erogeneous, these results cannot be directly transferred to the
human situation. However, the main components of rupture prone
plaques (i.e., fibrous and fatty tissue and macrophages) were all
present in this model.
FAT MACROPHAGES
HIGH STRAIN 
SPOT PRESENT ABSENT PRESENT ABSENT
Present 9 3 11 1
Absent 0 12 1 11
Table 2: Relation Between a High Strain Spot and Fat or Macrophages66
 CHAPTER 5 ELASTOGRAPHY IN VIVOElastography has a high sensitivity to identify fatty material: A max-
imum sensitivity of 100% with corresponding specificity of 80%
was achieved when the threshold was set at a mean strain in the
plaque of 0.35%. This sensitivity and specificity is higher than val-
ues obtained with conventional IVUS in vitro. Prati et al. (Prati
2001) found a sensitivity of 65% and a specificity of 95%. In an-
other study (Komiyami 2000), a sensitivity and a specificity of 53%
and 72%, respectively, were found. This corroborates our findings
in vitro in which we found a high correlation between strain and
plaque composition and no relation between echogenicity and
plaque components (de Korte 2000a).
No independent relation between mean strain of the plaque and
macrophages was found. These results indicate that the mean strain
value of the plaque is dominated by the tissue type (fibrous or fatty).
However, a high-strain spot has a sensitivity and specificity of 92%
to identify macrophages. It should be realized that the presence of
macrophages should not necessarily be interpreted as plaque in-
flammation. However, increased strain values probably refer to the
presence of active macrophages, because these cause plaque weak-
ening.
Conclusions
With the use of in vivo intravascular elastography, higher mean
strain values were found in fatty plaques than in fibrous plaques.
Elastography has a high sensitivity and specificity to identify fatty
plaques. The presence of macrophages results in localized high-
strain spots.67
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 CHAPTER 6 3D PALPOGRAPHYRupture of a thin-cap fibroatheroma (suspected to be a vulnerable,
high-risk or rupture-prone plaque) is a major cause of acute coro-
nary syndrome and stroke (Schaar 2004b). Much current research
activity is focused on the identification and treatment of these vul-
nerable plaques, before rupture occurs, in order to prevent clinical
events. At present, there is no clinically available technique with a
high sensitivity and specificity to identify such plaques.
There is evidence that most vulnerable plaques are suspected to be
characterized by the presence of a large atheroma that is shielded
from the blood by a thin fibrous cap (Davies 1996). Inflammation
involving accumulation of macrophages weakens the cap and in-
creases the susceptibility of these plaques to rupture (Lendon
1991). These highly deformable plaques may rupture, if the cap is
unable to withstand the oscillatory stress due to the pulsatory na-
ture of the blood pressure. In support of this concept, regions with
increased circumferential stress are found in plaques with the typi-
cal morphology of a vulnerable plaque (Arroyo 1999). An increase
in circumferential stress is associated with an increase in the radial
strain (deformability) of the tissue.
Intravascular elastography is a technique that allows assessment of
the local strain of the plaque using intravascular ultrasound (de Ko-
rte 2000a). In contrast to other techniques that assess only one or
more of the plaque features like geometry, composition or inflam-
mation, elastography may be capable of identifying the deformable
plaque by direct assessment of the immediate cause of rupture. An
in vitro study revealed 88% sensitivity and 89% specificity using
elastography to identify the vulnerable plaque (Schaar 2003a). Re-
cently, elastography was validated in vivo using an atherosclerotic
animal model (de Korte 2002a) and the feasibility of clinical appli-71
 cation was shown in patients undergoing cardiac catheterization (de
Korte 2002b) (Schaar 2004a). In these studies, strain was measured
Fig 1A to 1E: Princi-
ple of palpography.
The artery is de-
formed by the physi-
ologically pulsating
intraluminal pressure
(A). Intravascular ul-
trasound (IVUS)
echograms are pro-
duced from radio fre-
quency (rf) signals
acquired at high (B)
and low (C) pressure.
Using cross-correla-
tion analysis of these
rf signals, the strain (deformation) in the inner layer of tissue is determined (D). This strain is color-
coded and superimposed on the IVUS echogram at the lumen/vessel wall boundary (E). In this partic-
ular example, high strain is found at the shoulders of this eccentric plaque.
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Fig 2A and 2B: Longi-
tudinal IVUS image
with superimposed pal-
pogram (A) and three-
dimensional palpogram
(B) of a tissue-mimick-
ing phantom. The lon-
gitudinal view shows
the soft plaque that is
covered by a harder
cap. The superimposed
palpogram shows high
strain values in the
thinnest part of the cap.
The three-dimensional
palpogram shows low
strain values in the
phantom with a high-
strain region corre-
sponding to the area
with the thin cap.The
dotted line indicates
the cross-sectional im-
aging plane of the lon-
gitudinal echogram.72
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at one cross section of a single plaque. This is clearly not sufficient
to assess whether a patient is at risk, as multiple deformable plaques
frequently coexist in a single patient.
Since this catheter-based technique provides only a single cross-sec-
tional image, the catheter needs to be pulled back to obtain three-
dimensional information. However, moving the catheter during ac-
quisition introduces out-of-plane motion that is considered the
main source for decorrelation of the signals and thus produces a de-
crease in the quality of the strain estimate (Konofagou 1998).
Therefore, the position of the transducer has to be kept as stable as
possible and only motion in the direction of the beam is allowed
during elastographic acquisitions (Ophir 1991). For that reason, it
was considered impossible to obtain valid intravascular elastograms
while performing a continuous pullback of the catheter. In the
present study, we describe a scanning technique that provides a full
three-dimensional reconstruction of the distribution of high-strain
regions in atheromatous plaques in coronary arteries in vivo. Direct
detection of these high-strain regions may improve risk stratifica-
tion for patients that are at high risk of myocardial infarction.
Material and Methods
We developed and evaluated three-dimensional intravascular ultra-
sound palpography using phantom experiments and measurements
in atherosclerotic rabbits. Furthermore, we performed initial stud-
ies in patients during interventional procedures.
Phantom Experi-
ments
A phantom with the morphology of a vessel wall containing a soft
plaque was made of PolyVinyl Alcohol Cryogel (Chu 1997). The
soft area was isolated from the lumen by a thin cap. The thickness
of the cap varied from 2 mm to 100 µm. The phantom was put in
a water tank and strain was applied using a pulsatile intraluminal
pressure. Palpographic data was acquired at a pullback speed of 1
mm/s.
Animal Experi-
ments
3 days before denudation the rabbits started a high (2%) cholesterol
diet, for a period of 2 months. On the day of experimentation,
NZW rabbits (n = 8; weight: 3.1 ± 0.2 kg) were premedicated with
fentanyl (0.315 mg/ml) and fluanisone (10 mg/ml; Hypnorm® 0.5
 ml/kg i.m.) and anaesthetized with propofol i.v. (10 mg/ml, infu-
sion rate 10–15 ml/h, Abbott, Hoofddorp, The Netherlands) and
fentanyl i.a. (0.2 mg/kg/h, B. Braun, Melsungen, Germany) and a
2 : 1 mixture of N2O : O2 after intubation (3.0-mm tube). The
marginal ear artery was cannulated for arterial pressure measure-
ment with a fluid-filled catheter (Amatek Inc., Philadelphia, PA,
USA), and for arterial blood withdrawal. The reduction in mean ar-
terial blood pressure induced by the anaesthetics was compensated
for by an infusion of epinephrine (1 mg/ml, infusion rate 2–12 ml/
h, Centrafarm, Etten Leur, The Netherlands) titrated to achieve a
mean arterial pressure of 70 mmHg. A 4-F guiding catheter was ad-
vanced from the dissected femoral artery to the renal artery. After
performing angiography, a Fogarty balloon (3 F, Applied Medical,
Laguna Hills, CA, USA), attached to a manometer (2–2.5 A) was
located just below the renal artery and endothelial denudation was
performed by pulling back and twisting the inflated Fogarty bal-
loon three times over a length of 5 cm. After an 8-week follow-up
period, the right carotid artery was dissected for the introduction of
a 5-F sheath. An angiographic overview image of the infrarenal aor-
ta was performed and markers were located to indicate the previ-
ously denuded region. The intravascular ultrasound catheter was
positioned in the atherosclerotic part of the aorta and a pullback at
1.0 mm/s was performed. The catheter was removed, inserted again
and positioned for the second acquisition. During these acquisi-
tions, pressure was measured using a fluid-filled line, connected to
the 5-F introduction sheath.
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Fig 3A and 3B: Orthogonal regression analysis of the strain values acquired during subsequent acquisi-
tions. Combining all acquisitions revealed the relation ε2= 0.92 ε1 + 0.01 (n = 624, R2 = 0.81), with ε1 being the
strain measured
during first acquisi-
tion and ε2 being
the strain measured
during second ac-
quisition (A). The
residual plot (B)
shows that the
standard deviation
of the measured
strain with respect
to the estimated av-
erage strain value is
0.04%.74
 CHAPTER 6 3D PALPOGRAPHYSubsequently, the rabbit was sacrificed (Euthasate®, 20 ml/kg) and
perfusion fixation (formaldehyde 4%) was performed in the aorta
at a controlled arterial pressure of 70–80 mmHg for 20–30 min.
Next, the infrarenal aorta was dissected and stored in 4% formalde-
hyde for further analysis. All experiments were performed in ac-
cordance with institutional regulations and the “Guiding principles
for the care and use of animals” as approved by the Council of the
American Physiological Society.
After dissection, the tissue was embedded in 4% formaldehyde. To
compare the location of tissue slices with the elastography-derived
three-dimensional reconstruction, we measured the degree of axial
vessel shrinkage by comparing the length of the vessel segment, as
obtained by radiopaque markers, before and after excision. Immu-
nohistochemistry was performed applying monoclonal antibodies
for macrophages (RAM-11, DAKO, Glostrup, Denmark), for
smooth muscle cells (α-actin IA4, DAKO) and for collagen (picro-
sirus red, Klinipath, Duiven, The Netherlands). The latter stain
was evaluated after polarizing the light. Quantitative software was
developed applying the Clemex Vision software package. The first
600 µm of tissue from the internal elastic membrane was selected
for analysis. Areas of macrophages, smooth muscle cells and colla-
gen were calculated and related to the area of the region of interest
and reported as densities (%). A high-strain area was defined as an
area with an average strain > 0.5%. This corresponds to the upper
5% of the observed strain values.
Patient StudiesPullbacks at 1.0 mm/s were performed in patients (n = 2) referred
for an interventional procedure after signing informed consent.
The local medical ethics committee approved this study. Three-di-
mensional palpograms were acquired before the therapeutic proce-
dure. 
Statistical Analy-
sis
Scanning an identical part of the rabbit aorta twice tested the repro-
ducibility of three-dimensional palpography. Between acquisitions,
the catheter was removed, reintroduced and the same part was
scanned again. Quantitative analysis of the reproducibility of the
three-dimensional strain map was performed using orthogonal re-
gression (Slager 2000)75
 Calculating a 
Palpogram
All data were acquired using an Avanar 20 MHz catheter (Volcano,
Rancho Cordova, CA, USA). Radio frequency (rf)-data were ob-
tained with a Magellan Workstation. For calculating reproducible
strain estimates, data acquired in the decreasing part of the pressure
cycle were selected automatically and analyzed for phantoms,
animals, and patients. In animals and patients we limited process-
ing to data from subsequent frames with high similarities, as quan-
tified by a likelihood curve to decrease the influence of catheter
motion on the three-dimensional palpogram. High likelihood val-
ues correspond to the end-diastolic phase of the heart cycle (de Ko-
rte 2002).
Strain is determined using cross-correlation analysis of subsequent
ultrasound data (de Korte 2000). Since the strain between frames is
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Fig 4A to 4C: Three-dimensional palpography of a rabbit aorta. The three-dimensional palpogram is cut
open and plotted as a two-dimensional strain map (A). The palpogram of two regions with high strain is
superimposed on the IVUS echogram (B). Comparison with histology (C) reveals a high correlation be-
tween presence of superficial macrophages (brown in RAM11 staining) and high-strain regions. Note that
the macrophages deeper in the core of the plaque are not correlated with high strain. Analysis of the ech-
ograms revealed that the gray regions in this two-dimensional strain map correspond to a bifurcation re-
gion.76
 CHAPTER 6 3D PALPOGRAPHYlow, the conventional echogram is not suitable for this analysis.
However, using the rf raw ultrasound signals that contain not only
the amplitude but also the phase information, minute strains can be
determined (lower bound for strain estimation of this intravascular
ultrasound system is 0.05%) (Cespedes 1995). Intravascular ultra-
sound images contain 512 angles with ultrasound information. For
each ultrasound signal, the boundary between lumen and vessel
wall is automatically detected using a frame-by-frame gradient-
based algorithm. From this point, the strain in the inner 600 µm of
tissue is determined. This 600 µm is divided into two windows. For
each window, the displacement between the acquisition obtained at
low and high pressure is calculated. The difference in displacement
results in the radial strain of the tissue. Repeating this procedure for
all 512 angles results in a partial palpogram. This partial palpogram
0° 90° 180° 270° 360°
Po
si
tio
n 
[m
m
]
Angular position
strain
2%
0%
A
C
B
Po
si
tio
n 
[m
m
]
Fig 5A to 5C: Three-di-
mensional palpography
of a human coronary ar-
tery obtained in vivo.
The three-dimensional
palpogram is cut open
and plotted as a two-di-
mensional strain map
(A). The strain map
shows low- and high-
strain regions. A two-di-
mensional palpogram
superimposed on the
IVUS echogram of a distal cross section with a large eccentric plaque (B) reveals no high strain values.
Although the proximal plaque (C) has a similar appearance in the echogram, the palpogram shows high
strain at one shoulder, indicating an unstable plaque. The gray regions in the two-dimensional strain map
correspond to regions where side branches are present as identified from the echograms.77
 have missing strain values for some angles due to erroneous strain
estimates. These erroneous strain estimates are automatically de-
tected using a previously described principle (de Korte 2000). All
partial palpograms for one heart cycle were averaged to determine a
compound palpogram (Doyley 2001) (Figure 1).
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sional palpogra-
phy of a human
coronary artery
obtained in vivo.
The three-di-
mensional palpo-
gram is cut open
and plotted as a
two-dimensional
strain map (E to
H). The strain
map before inter-
vention (E)
shows high- and
low-strain re-
gions. A two-di-
mensional
palpogram super-
imposed on the
IVUS echogram
of a distal cross
section with a
large eccentric
plaque (A) reveals
high strain values
at the shoulder.
The proximal le-
sion (B) has low
strain values. The
side branch visi-
ble in the echo-
gram (C) causes
erroneous strain
values indicated with gray. After the procedure, increased strain values are found (F) in the region where
atherectomy was performed (indicated with the circle) at the shoulder of the plaque (D). After stenting,
low strain values are found in the entire segment (G). However, high strain values are still present at the
shoulders of the distal plaque: the overlay of the IVUS echogram demonstrates
that this high strain is found in tissue not covered78
 CHAPTER 6 3D PALPOGRAPHYThree-Dimen-
sional Palpogra-
phy
If a pullback is performed, each compound palpogram represents
the strain information for a certain cross section [van der Steen
1997). The longitudinal resolution of the three-dimensional acqui-
sitions is dependent on the heart rate and the pullback speed. A
heart rate of 60 beats/min. and a pullback speed of 1.0 mm/s results
in a palpogram for each 1.0 mm. The influence of performing a
pullback was investigated using a phantom experiment. The corre-
lation between signals acquired at the different intraluminal pres-
sures was determined for a static position of the catheter and while
performing a pullback. The peak value of the cross-correlation
function can directly be related to signal-to-noise ratio (the better
the signal-to-noise ratio, the higher the peak value of the cross-cor-
relation function) (Cespedes 1997). If the signal-to-noise ratio is
known, the standard deviation of the strain estimate can be deter-
mined using the lower bound of strain estimation (Cespedes 1995).
In coronary arteries, the natural motion of the catheter due to in-
creasing blood flow and the contraction of the heart is as follows:
during the systolic phase, the blood flow is low, the heart is con-
tracting, and the catheter moves toward the ostium. In the diastolic
phase, blood flow is increasing, the heart is relaxing, and the cathe-
ter moves deeper into the coronary artery away from the ostium
(Arab-Zadeh 1999). For intravascular palpography, data are ac-
quired in the diastolic phase of the heart cycle. In this phase, the
motion due to pulling back the catheter is in the opposite direction
to the natural motion of the catheter. Therefore, the pullback will
decrease the out-of-plane motion and may not deteriorate but in-
crease the quality of the palpogram. 
During the experiments, data is continuously acquired at a pullback
speed of 1.0 mm/s using a mechanical pullback device (Trakback
II, Volcano Imaging, Rancho Cordova, CA, USA). Simultaneous-
ly, the ECG and intraluminal pressure are registered. The data is
subdivided in heart cycles using the R-wave of the ECG signal.
After calculating all the compound palpograms of the full scan, the
data can be plotted as a three-dimensional structure representing
the lumen/vessel wall boundary (Figure 2B) or as a color-coded
map representing the angles versus longitudinal position (Figure 4).
Furthermore, a longitudinal crosscut can be made having the echo79
 information with the strain information on the lumen/vessel wall
boundary (Figure 2A).
Results
A tissue-mimicking phantom with the typical morphology of a
thin-cap fibroatheroma was scanned to evaluate the possibility to
assess reliable palpographic data while introducing motion that is
perpendicular to the imaging plane. The phantom allows quantita-
tive evaluation of three-dimensional palpography, since it provides
exact knowledge of geometry and acoustic and mechanical proper-
ties of the tissue. Although performing an acquisition while moving
the catheter introduces no bias, the standard deviation of the strain
estimate is increased from 0.10% to 0.14% (for strain values rang-
ing from 0 to 2%). The three-dimensional palpogram (Figure 2B)
shows a large increase in strain at the site with minimal cap thick-
ness. The longitudinal cross section (Figure 2A) shows a good de-
lineation of the soft inclusion. An inverse relation between cap
thickness and strain was observed, thereby confirming experiments
from Loree et al. (Loree 1992), who already demonstrated an in-
verse relationship between cap thickness and peak circumferential
stress using finite element model simulations. In conclusion, the in
vitro experiments showed that catheter motion does not bias the
three-dimensional palpograms, identify soft and hard tissue and
produce data in accordance with the literature.
We validated three-dimensional palpography in vivo using experi-
ments in the aorta of an atherosclerotic rabbit model. First, the re-
producibility of three-dimensional palpography was investigated by
performing repetitive pullbacks in the same region of the aorta for
all rabbits. Orthogonal regression revealed a high correlation be-
tween repeat acquisitions in all rabbits (R2 = 0.81, p < 0.001; Figure
3A). Residual analysis revealed a standard deviation of the differ-
ence between acquisitions of 0.04% (Figure 3B). This error is two
times smaller than the error of the strain estimate, thus indicating
an excellent reproducibility. In three animals, additional pullbacks
at a speed of 0.5 mm/s and 1 mm/s were performed. These acqui-
sitions revealed that the speed had no influence on the palpographic
values. 80
 CHAPTER 6 3D PALPOGRAPHYSecond, correlating the measured strain values with histological fea-
tures validated palpographic results. Palpograms with low strain (0–
0.3%) were found in aortic segments with low-deformable plaques
(rich in collagen and smooth muscle cells with almost no macro-
phages). Regions with increased strain (0.5–1%) were observed in
segments with deformable plaque (atheroma, highly infiltrated by
macrophages; Figure 4). Increased macrophage density was found
in cross sections with a high-strain spot (p = 0.009). 
In conclusion, these animal experiments showed that it is feasible
and accurate to perform three-dimensional palpography in vivo.
Furthermore, these experiments showed that three-dimensional
palpograms identify regions with inflammation, which is a marker
for vulnerable plaques.
In the atherosclerotic rabbit experiments we proved that three-di-
mensional palpography is feasible in an aorta in vivo. In these ex-
periments the catheter motion is minimal as compared to
acquisitions in coronary arteries in patients. However, acquisitions
in patients (n = 2) provided evidence that three-dimensional pal-
pography in coronary arteries is feasible. In a patient with unstable
angina pectoris, plaques with low and high strain values were found
(Figure 5). Three-dimensional palpography identified a deformable
region in the distal part of this coronary artery (between 3 and 4
mm) at one of the shoulders of this plaque. The large eccentric
plaque between 12 and 13 mm is characterized by low strain values.
This information is not available from the conventional echogram,
since in both cases it reveals an eccentric plaque with low echo-
genicity at the shoulders. After an atherectomy procedure at the
proximal plaque, increased strain values are found that may be
caused by damage to the structure of the plaque due to the inter-
vention. After stenting, this region is characterized by low strain
values except for the deformable shoulder of the distal plaque visible
between the stent struts.
A three-dimensional acquisition of 6 cm in the dominant epicardial
part of the LAD in a patient with unstable angina pectoris revealed
plaques with low and high strain values (Figure 6). Three-dimen-
sional palpography identified a soft region in the proximal part of
this coronary artery (between 47 and 55 mm) corresponding to a
mechanically unstable shoulder of this plaque. This information81
 is not available from the conventional echogram, since in both cases
it reveals an eccentric plaque with low echogenicity at both shoul-
ders.
Discussion
Plaque vulnerability is currently considered a ubiquitous phenom-
enon and therefore lesions can be present anywhere in the coronary
tree (Buffon 2002). Therefore, it is important to have a technique
that can identify these vulnerable plaques in all three major epicar-
dial coronaries. Intravascular ultrasound elastography has proven to
be able to identify fatty and fibrous plaques both in vitro (de Korte
2000) and in vivo (de Korte 2002). However, this technique only
provides information on the strain distribution in a single cross sec-
tion of the vascular wall. Using three-dimensional palpography, the
deformable plaque can be scanned and imaged three-dimensionally
in vivo allowing investigation of the distribution of strain over the
total plaque surface.
Over time, the geometry and composition of the plaque may
change. If the analysis is based on one cross section, repositioning of
the catheter using angiography can only be performed in an unreli-
able manner. Conventional three-dimensional intravascular ultra-
sound has proven that longitudinal monitoring is clinically feasible
using acquisitions with side branches as anatomic landmarks.
Therefore, three-dimensional palpography will allow longitudinal
monitoring of plaque development. Furthermore, the capacity to
obtain a three-dimensional representation of the strain allows iden-
tification of the most deformable part of a particular plaque.
Producing a three-dimensional palpogram takes three times as long
as performing the pullback procedure (typically 3–5 min.). Al-
though the current processing time is already fast enough to be clin-
ically useful, long-term prospective studies are needed to prove that
high-strain spots are associated with increased risk and demonstrate
that this diagnostic tool has prognostic value.
Limitations Palpograms cannot be determined in all cases. Erroneous strain es-
timates are determined, when the arterial wall is thin in the absence
of plaque, when tissue is in the shadow region behind a large calci-
fied deposit, or when the out-of-plane motion of the catheter is82
 CHAPTER 6 3D PALPOGRAPHYlarge. However, a thin arterial wall and presence of a large calcified
deposit are not related to plaque vulnerability. The algorithm auto-
matically identifies these erroneous strain estimates, resulting in
gray regions in the palpograms.
High-strain regions are not only expected at locations with a de-
formable plaque, but also at regions with different mechanical be-
haviour due to either particular artery geometries or underlying
anatomic structures. We found regions with increased strain at bi-
furcations and in non-diseased coronary artery segments where
there was a vein directly outside the adventitia. Since these situa-
tions can be identified on the conventional intravascular echogram,
this causes no fundamental problem because the three-dimensional
palpograms are acquired and displayed in conjunction with the
echogram.
The data are meant to prove feasibility in a clinical environment.
Due to the limited number of patients in the study no conclusion
on the clinical significance of the technique can be made.
Conclusion
Three-dimensional palpography provides information on the pres-
ence and distribution of high- and low-strain areas in coronary ar-
teries in patients. Since high strain is highly correlated with
increased numbers of macrophages and decreased cap thickness,
three-dimensional palpography might identify plaques that are
prone to rupture.83
 84
CHAPTER 7
REPRODUCIBILITY OF
3D PALPOGRAPHY IN HUMANS
CHAPTER 7 REPRODUCIBILITY
Based on:
Johannes A Schaar, Frits Mastik, Evelyn Regar, Patrick W. Serruys, Anton F.W. van der Steen
Reproducibility of 3D Palpography in Humans
submitted
 CHAPTER 7 REPRODUCIBILITYIntravascular palpography can measure strain using cross-correla-
tion analysis of radio-frequency ultrasound signals recorded at dif-
ferent intravascular pressures (de Korte 1998b). The underlying
principle is that the strain of the tissue as a result of a pressure var-
iation is a function of its mechanical properties. The local strain of
the tissue is displayed color-coded (palpogram) on the lumenal
boundaries of the IVUS echogram (Doyley 2001) (Cespedes 1995).
Rupture of thin-cap fibroatheromas (TCFA) is the main cause of
acute coronary syndrome and myocardial infarction. Identification
of this form of vulnerable plaque is therefore essential to enable the
development of treatment modalities to stabilize such plaque
(Kolodgie 2004). In palpography a typical strain pattern has been
described which has a high (88%) sensitivity and specificity (89%)
for the detection of these thin cap fibroatheromas (TCFA) (Schaar
2005).
Rupture of thin cap fibroatheroma is related to weakening of the
cap of an atheromatous plaque (Falk 1999) (Loree 1992). This
process may be triggered by an accumulation of inflammatory cells
such as macrophages, which produce metalloproteinases (Libby
1995). Rupture of caps is particularly prone to occur in regions
with increased mechanical stress (Burleigh 1992). This stress is
caused by the pulsatile intravascular blood pressure, which strains
the vessel wall (Lendon 1993).
Three-dimensional intravascular palpography allows scanning of
coronary arteries in patients to identify and localize mechanically
highly deformable regions (Schaar 2005). Patients with stable angi-
na have less highly deformable plaques than patients with unstable
angina and patients after acute myocardial infarction (Schaar
2004a).87
 The reproducibility of a method is a prerequisite for further scien-
tific evaluation and usage in clinical trials (Popper 2002).
In the current paper we evaluate the reproducibility of three-di-
mensional palpography in coronary arteries of patients.
Fig 1: Description of
the different steps test-
ing the reproducibility
of palpography
Step 3: Matching the data
Step 2: Aligning the recordings
Step 1: Two IVUS recordings
at the same spot 
processing88
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Single center pro-
spective and ob-
servational study
This study was a single center prospective and observational study,
which was approved by the medical ethics committee of the Eras-
musMC. All patients provided written informed consent. The pal-
pographic recordings were acquired after successful intervention.
The region, in which palpography was performed, was defined on
the basis of identifiable landmarks, such as side branches or edges
of stents. All data were acquired using a 20 MHz Jovus Avanar F/X
IVUS catheter (Volcano, Rancho Cordova, CA, USA), which was
connected to an InVision Gold IVUS console. Recordings were ob-
tained at a pullback speed of 1 mm/sec using a mechanical pullback
device (Trackback II, Volcano, Rancho Cordova, CA, USA). Si-
multaneously, the ECG and intraluminal pressure signals were re-
corded. Acquisition was done with a custom made dedicated
workstation connected to the digital interface of the IVUS machine
recording fundamental IVUS data (rf-data). Analysis was done as
previously described (Schaar 2004a).
Matching was 
done on the IVUS 
frames
At analysis of the second recording the begin end the end of the re-
gion of interest were matched based on the previously described
landmarks. Within the ROI, for every millimeter along the full
pullback length, the matching cross section of the follow up record-
ing was determined (see figure 1). This matching was done on the
IVUS frames reconstructed from rf-data unaware of the palpo-
graphic results. The matching included also a correction of the ro-
tational orientation of the follow up registration to allow an analysis
not only for the entire cross section, but also for positions along the
circumference of the lumen. The resulting strain values were de-
picted in a strain map (see figure 1). Along the longitudinal axis the
position in the artery is displayed, while on the horizontal axis the
position of the strain values according to the circumference of the
cross section is displayed. Over this strain map a grid of 16 by 6 el-
ements was put. On each of this elements the median strain was cal-
culated, which was used as the variable for further analysis. 
For statistical analysis, SPSS 11.0.1 (SPSS Inc., Chicago, USA) was
used. The Bland and Altman plot was used to assess the reproduci-
bility of a method by comparing repeated measurements.To de-89
 scribe the relationship between the two recordings a linear
regression analysis was performed. 
Results
In 14 patients 19 recordings with a length of 1.8 cm were done re-
sulting in 909 sections to compare. The Blant-Altman test showed
a mean of 0.042 of strain differences with a standard deviation of
0.07 (see figure 2). The regression analysis between the 909 sections
revealed an R-square of 0.89 with a p < 0.0001 (see figure 3). The
t-test showed no significant difference between the data with a p =
0.07. The Pearson correlation of the data showed a R = 0.84 with a
p < 0.0001.
Discussion
Reproducibility is 
a fundamental 
and indispensa-
ble requirement of 
a technique
Reproducibility is a fundamental and indispensable requirement of
a technique, which is used for decision making in a clinical environ-
ment. For a technique like 3D palpography absolute reproducibili-
ty cannot be reached in coronary arteries since disturbing factors
like small pressure differences, catheter motion, the movement of
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test of 909 palpo-
graphic recordings
Strain (%)
St
ra
in
 D
iff
er
en
ce90
 CHAPTER 7 REPRODUCIBILITYthe heart and electrical noise will influence the results. Nevertheless
for patient follow up, which is needed to study treatment effects,
the right parameters have to be chosen and their reproducibility
needs to be assessed. The results of this study represent different ap-
proaches to look at reproducibility of strain data in human coro-
nary arteries. The Blant-Altman analysis reveals a very good
reproducibility since the variation of the data was low given by a
low standard deviation. Another way looking to the data is regres-
sion analysis, which shows the relation of the two recordings, giving
a more that 80% overlap of the data. Comparing the results of both
recordings leaves us with no statistical difference using a t-test. The
different approaches to evaluate the reproducibility were chosen
since the ideal
test does not ex-
ist for this kind
of dataset. Nev-
ertheless, we
think that look-
ing from differ-
ent angles to the
subject gives us
enough confi-
dence to claim
that intravascu-
lar palpography
is a reproduci-
ble enough
technique to be
used in the clin-
ic. This study tested the question, if palpography recordings in pa-
tients are reproducible. Future investigations will address the intra-
and inter observer variability of the technique.
Conclusion 
Three-dimension-
al intravascular 
palpography is re-
producible
Three-dimensional intravascular palpography is reproducible up to
the quality to be useful in the clinical environment as well as in clin-
ical trials.
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Fig 3: Regression
analysis of 909 palpo-
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R2 = 0.89
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 CHAPTER 8 INCIDENCEAccumulating evidence suggests that acute coronary syndromes,
the clinical presentation of which ranges from unstable angina to
sudden cardiac death, are commonly related to thrombosis super-
imposed on rupture or erosion of atheromatous plaques. Anato-
mopathological studies have shown that such events are associated
with ruptured thin-cap fibroatheroma, plaque erosions, and the
presence of superficial calcium spots (Virmani 2001).
Plaque rupture is related to weakening of the cap of an atheroma-
tous plaque (Falk 1999) (Loree 1992). This process may be trig-
gered by an accumulation of inflammatory cells such as
macrophages, which produce metalloproteinases (Libby 1995).
Rupture of caps is particularly prone to occur in regions with in-
creased mechanical stress (Burleigh 1992). This stress is caused by
the pulsatile intravascular blood pressure, which strains the vessel
wall (Lendon 1993).
Intravascular palpography can measure strain using cross correla-
tion analysis of radio frequency ultrasound signals recorded at dif-
ferent intravascular pressures (de Korte 1998b). The underlying
principle is that the strain of the tissue is a function of its mechan-
ical properties. The local strain of the tissue is displayed color coded
(palpogram) on the luminal boundaries of the intravascular ultra-
sound (IVUS) echogram (Doyley 2001) (Cespedes 1995).
In palpography, a typical strain pattern has been described that has
a high sensitivity and specificity (89%) for the detection of thin-cap
fibroatheroma in vitro in postmortem coronary arteries (Schaar
2003a).
We designed the present study to evaluate the incidence of this typ-
ical strain pattern in patients undergoing percutaneous coronary in-97
 tervention (PCI) for stable angina, unstable angina, or acute
myocardial infarction (AMI).
Methods
Three-Dimen-
sional Palpogra-
phy
A 20-MHz IVUS catheter connected to an InVision echo apparatus
(both from Volcano Inc., Rancho Cordova, CA, USA) was used to
obtain palpograms in patients undergoing PCI. Palpograms were
obtained as described previously (van der Steen 2003). Digital radio
frequency data were acquired using a custom-designed workstation.
The local strain was calculated from the gated radio frequency trac-
es using cross-correlation analysis and displayed, color coded, from
blue (for 0% strain) through yellow (for 2% strain) via red. This
color-coded circumferential image was superimposed on the cross-
sectional IVUS image. The resolution of the strain measurement in
the radial direction is 400 µm.
The cross-sectional data can be reconstructed as a 3D structure re-
presenting either the lumen vessel-wall boundary or as a color cod-
ed map representing the angles versus longitudinal position. Fur-
thermore, a longitudinal crosscut can be made having the echo
information with the strain information on the lumen vessel-wall
boundary (Figure 1).
When a pullback is performed, each palpogram represents the
strain information for a certain cross section over the full cardiac cy-
cle. The longitudinal resolution of the 3D acquisitions depends on
heart rate and pullback speed. With a heart rate of 60 bpm and a
pullback speed of 1.0 mm/s, the longitudinal resolution is 1.0 mm.
Movement of the catheter in the artery during acquisition introduc-
es out-of-plane motion. For palpography, this motion is the main
source of signal decorrelation and thus a source of error in strain es-
timation (Konofagou 1998). Ideally, the position of the transducer
should be as stable as possible, with motion only in the direction of
the beam during acquisitions.
In coronary arteries, the natural motion of the catheter, related to
blood flow pattern during systole and diastole and to the contrac-
tion of the heart, is predictable. During systole, blood flow is low,
the heart is contracting, and the catheter moves toward the ostium.98
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and the catheter moves distally away from the ostium (Arbab-Za-
deh 1999). For intravascular palpography, data are acquired in the
diastolic phase of the heart cycle. In this phase, catheter motion re-
lated to the motorized pullback opposes the natural motion of the
catheter, related to the cardiac cycle. During the recordings, data
were continuously acquired at a pullback speed of 1.0 mm/s using
a mechanical pullback device (Trak Back II, Volcano Therapeutics)
with simultaneous recording of the ECG and the aortic pressure.
The data set is subdivided into heart cycles by use of the R wave of
the ECG signal.
Analysis included the complete length of the study vessel, starting
with the IVUS pullback distally (in the left anterior descending cor-
onary artery [LAD] at segment 7, American Heart Association clas-
sification, and in the right coronary artery [RCA] at segment 3) and
ending at the ostium.
Definition of the 
High-Strain Spot
A region was defined as a high-strain spot when it had high strain
(>1.2% at 4 mm Hg pressure difference) that spanned an arc of at
least 12° at the surface of a plaque (identified on the IVUS record-
ing) adjacent to low-strain regions (<0.5% at 4 mm Hg pressure
difference). The highest value of strain was taken as the strain level
of the spot.
Study PopulationThis cross-sectional study included 55 patients. Seventeen patients
had stable angina and underwent elective coronary angioplasty.
Nineteen patients had unstable angina, defined as symptomatic
transient ST-segment depression with normal biochemical markers
of myocardial damage. In stable and unstable patients, palpography
was performed in the treated vessel before intervention. Nineteen
patients presented with acute ST-segment elevation MI and under-
went primary angioplasty <12 hours after onset of symptoms. Pal-
pography was performed in a non-culprit vessel.
No patient was taking anti inflammatory drugs other than aspirin.
Our institutional review board approved the protocol, and all pa-
tients gave written informed consent.99
 Lipid and hsCRP 
Measurements
Venous blood samples were obtained before catheterization. Lipid
levels (total cholesterol, LDL) and high-sensitivity C-reactive pro-
tein (hsCRP) were determined routinely with standard methods
(Rothkrantz-Kos 2002).
Statistical Analy-
sis
For statistical analysis, SAS version 8.02 (SAS Institute) was used.
Data are expressed as mean ±SD. Variables were tested for normal
distribution with the Shapiro-Wilk test. Values of P<0.05 were
considered statistically significant. Continuous variables are also
presented as median values with the corresponding 25th and 75th
percentiles. To test for independence between categorical groups,
Fisher’s exact test was used. Univariate ANOVA was used to com-
pare continuous data among groups.
Results
We studied 55 patients (29 male, 26 female). Patients were divided
into 3 groups on the basis of clinical presentation (stable or unstable
angina, AMI). Mean age (mean, 61±9 years) did not differ among
groups. In the stable angina group, the study vessel was the LAD in
8 patients and the RCA in 9 patients. In the unstable angina group,
the study vessel was the LAD in 10 patients and the RCA in 9 pa-
tients. In patients with AMI, the non–infarct-related study vessel
was the RCA in 9 and the LAD in 10 patients.
 Fig 1: Angiogram (A)
shows an intermediate
plaque. (B) 3D palpo-
gram of vessel seg-
ment between white
lines in angiogram.
(C) Cross section of
2D palpogram plus
echogram as indicated
in 3D palpogram. A
high-strain plaque on
shoulders of eccentric
plaque (yellow) can be
clearly identified.100
 CHAPTER 8 INCIDENCEPalpography in 55 vessels (28 LAD, 27 RCA) identified 97 typical
high-strain patterns (spots). In 8 vessels, no high strain spot was de-
tected; in 21 vessels, 1 spot; in 29 vessels, 2 spots; and in 6 vessels,
3 spots.
Patients with stable angina had 0.6±0.6 highly deformable plaques,
with the typical high-strain pattern of a suspected vulnerable
plaque. Significantly more highly deformable plaques (1.6±0.7)
were found in unstable angina patients (P=0.0019) and in AMI
(P<0.0001) patients (2.0±0.7) compared with stable angina pa-
tients (Figure 2). There was no significant difference between un-
stable and AMI patients with regard to the number of highly
deformable lesions (P=0.27). Gender had no influence on the
number of highly deformable lesions (P=0.90).
There was no significant difference (P=0.54) in the overall number
of high-strain spots detected in the LAD (n=1.6±0.9) and the RCA
(1.3±0.9). The mean length of vessel studied did not differ signifi-
cantly (P=0.496, ANOVA) among groups: stable angina, 52±14
mm; unstable angina, 51±13 mm; and AMI, 47±14 mm.
hsCRP levels differed significantly among groups (P<0.0001).
They were significantly higher in patients with unstable angina
(1.2±0.8 µg/mL; P=0.02) or AMI (1.8±0.5 µg/mL; P<0.0001)
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Fig 2: Relation be-
tween number of
high-strain spots and
clinical presentation.101
 compared with patients with stable angina (0.6±0.4 µg/mL).
hsCRP levels also differed significantly between the unstable angina
group and the AMI group (P=0.03). The number of high-strain
spots per artery was positively correlated with the hsCRP level
(R2=0.65, P<0.0001). For zero high-strain spots, the hsCRP level
was 0.3±0.2 µg/mL; for one, 0.8±0.5 µg/mL; for two, 1.7±0.5 µg/
mL; and for three, 2.2±0.3 µg/mL. With multivariate analysis, the
interaction between clinical presentation, number of deformable
plaques, and hsCRP was tested. The clinical presentation did not
have a significant effect on the relationship between number of
high-strain spots and hsCRP levels (P=0.06). Separate analysis
showed, in the stable angina patients, a Pearson correlation of 0.69
with a value of P<0.002; in the unstable angina group, of 0.83 with
a value of P<0.0001; and in the AMI group, of 0.50 with a value of
P<0.031.
There was no relation between individual risk factors such as hyper-
cholesterolemia (P=0.82), smoking (P=0.73), diabetes (P=0.31),
and hypertension (P =0.42) and the number of high-strain spots.
The level of LDL among groups did not differ significantly
(P=0.26). In the stable angina group, 70.6% were on statins; in the
unstable angina group, 68.4%; and in the AMI group, 52.6%. A
univariate analysis showed no significant influence of statin use on
the number of high-strain spots (P=0.153).
Discussion
This is the first clinical study using 3D palpography to assess the in-
cidence of possible vulnerable plaque, defined as plaques with high-
strain spots. The major findings of the study are that the incidence
of high-strain spots is related both to clinical presentation and to
levels of hsCRP, a marker of inflammation.
Intravascular palpography, by its capacity to evaluate the mechani-
cal properties of the plaque, can detect thin-cap fibroatheromas.
Validation studies in vitro and in vivo have shown that palpography
can identify such plaques with high sensitivity and specificity
(Schaar 2003a) (de Korte 2002a). Until now, this method was ap-
plied only to the analysis of single cross sections. Because athero-
sclerosis is a 3D process, the extension of palpography from a 2D to
a 3D technique was a necessary prerequisite to its introduction as a102
 CHAPTER 8 INCIDENCEpotential clinical modality. This technique now permits us to assess
the number of suspected vulnerable plaques in the entire coronary
artery.
Incidence of 
High-Strain Pat-
terns: Relation to 
Clinical Presenta-
tion
We found that the incidence of high-strain patterns was strongly re-
lated to the clinical presentation. Patients with acute coronary syn-
dromes (unstable angina, AMI) had significantly more high-strain
patterns than did patients with stable angina. In the unstable group,
there was no significant difference in the number of high-strain pat-
terns in the nonculprit vessel of AMI patients compared with the
culprit vessel in unstable angina patients; this supports the hypoth-
esis that inflammation in acute coronary syndromes is a multifocal
process (Buffon 2002). The number of high-strains spots we de-
scribe is consistent with the number of thin-cap fibroatheromas ob-
served in autopsy studies (Virmani 2003) (Falk 1983) and with the
number of yellow plaques observed in angioscopic studies (Takano
2001) (Asakura 2001) (de Feyter 1995).
Incidence of 
High-Strain Pat-
terns: Relation to 
hsCRP Levels
Inflammation plays an important role in destabilizing plaques. A
clear connection between inflammation and cap stability has been
described (Lendon 1991). There is increasing evidence that hsCRP
not only is a reactive marker but also has proatherogenic character-
istics by its pro-oxidative effect (Kobayashi 2003). hsCRP has a
positive predictive value for cardiac events in patients presenting
with unstable angina (Liuzzo 1994) (Ridker 1998a). We found a
positive correlation between the number of high-strain patterns and
levels of hsCRP. Our study was not powered to validate a relation-
ship between hsCRP and the number of suspected vulnerable
plaques. Furthermore, the high hsCRP level in the AMI group may
partly reflect an increase in hsCRP because of myocyte necrosis.
However, this reactive increase starts approximately 16 hours after
the onset of MI (Oldgren 2003), whereas blood samples for hsCRP
levels in the present study were obtained <12 hours after the onset
of symptoms (Nijmeijer 2001).
Future prospective studies should address the value of intravascular
palpography in the detection of rupture-prone thin-cap fibroath-
eromas, in the prediction of clinical events, and as a tool to follow
the natural progression and the effect of pharmacological or other
interventions (MacNeill 2003).103
 Limitation of the 
Study
We assessed only 1 coronary artery per patient. Risk stratification
ideally requires evaluation of the total vulnerable plaque burden.
Because of the invasive character of intravascular palpography, this
assessment can be justified only if the predictive power of the tech-
nique is high enough. Nevertheless, assessment of all coronary ar-
teries in 1 patient is feasible and safe with IVUS, a widely available
technique (rioufol 2002). The left circumflex artery was not inves-
tigated in this study because of the increased motion of this vessel.
A motion compensation method is being developed for future stud-
ies.
Conclusions
Three-dimensional intravascular palpography can detect high-
strain spots, consistent with plaque vulnerability, in vivo in human
coronary arteries. The incidence of such possible vulnerable plaques
is correlated with both clinical presentation and markers of inflam-
mation. Additional validation is needed to assess the predictive val-
ue of the technique to identify vulnerable patients.104
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 CHAPTER 9 METHODOLOGY IBISAlthough coronary atherosclerosis is common, clinical events are
relatively rare and not linearly related to either the extent or severity
of atherosclerosis. The majority of acute coronary events arise from
non-flow limiting lesions and are often the first clinical manifesta-
tion of previously sub clinical atherosclerosis (Ambrose 1988) (Haft
1988) (Little 1988) (Falk 1995) (Kullo 1998). These observations,
among others, led to the concept of the vulnerable atherosclerotic
plaque, a plaque that has a high probability of causing a clinical
event (Naghavi 2003b+c) (Schaar 2004b). The most common
post-mortem histological features in such plaques are the presence
of a thin fibrous cap, a lipid-rich core, and infiltration by inflam-
matory cells (Virmani 2000) (Ross 1999a) (Kolodgie 2001) (Libby
2002a+b) (Davies 1996). Less common pathological substrates for
fatal clinical events are plaque erosion, nodular calcification and in-
traplaque haemorrhage (Virmani 2000)(Kolodgie 2003).
Coronary angiography is the standard technique to define the pres-
ence and to assess the extent of coronary atherosclerosis; however,
it can only detect plaques that impinge on the lumen. Given the dif-
fuse nature of coronary atherosclerosis and the phenomenon of ar-
terial remodelling, an extensive amount of plaque can be present yet
go undetected on angiography (Glagov 1987) (Schoenhagen
2001). To detect potentially vulnerable plaque before it impinges
on the lumen, other diagnostic modalities are needed (Nissen
2001) (de Feyter 2000). Furthermore, accurate evaluation of the
composition or biomechanical characteristics of such plaques could
aid in the detection of high-risk lesions.
Several circulating plasma biomarkers related to increased inflam-
matory burden, platelet activation or endothelial activation corre-
late with the risk of cardiovascular events both in patients who have
previously had an acute coronary event and in apparently healthy
individuals (Ross 1999b) (Pearson 2003) (Ridker 2002) (Ridker107
 2003) (Biasucci 1996) (Cesari 2003) (Bayes Genis 2001). Despite
these epidemiological results, little data exist on the relation be-
tween circulating biomarkers and local biomechanical or other
structural characteristics of coronary plaques.
The aim of the IBIS study is to characterize non flow limiting sub-
clinical coronary lesions by invasive and non-invasive imaging tech-
niques in conjunction with multiple biomarkers.
GENERAL AND CLINICAL CRITERIA
Braunwald class IA, IIA, IIIA (Unstable angina caused by noncardiac illness)
Pregnant women or women of childbearing potential who do not use adequate con-
traception
Known allergies to aspirin, clopidogrel bisulfate (PlavixTM), Ticlopidine (TiclidTM),
heparin, stainless steel, copper or a sensitivity to contrast media, which cannot be ade-
quately premedicated
Life expectancy of less than one year or factors making clinical and/or angiographic
follow-up difficult
Planned coronary bypass surgery or major non-cardiac surgery
Impaired renal function (creatinine >2 mg/dl or >150 µmol/L)
A history of bleeding diathesis or coagulopathy
Previous disabling stroke within the past year
Table 1a: Exclusion criteria
CRITERIA RELATED TO INVASIVE IMAGING
Severe 3-vessel coronary artery and/or left main disease with ‡50% stenosis
 Minimal lumen diameter <2 mm in the segments to be analyzed within the study ves-
sel
 Diameter stenosis >70% or total occlusion of the study vessel
In case the study-vessel has been stented previously more than 1/3 (outside the length
of the stent plus 5 mm proxintal and distal to the stent) of the study vessel should be
available for examination
Ejection fraction <30%
Table 1b: Exclusion criteria108
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Patients and study 
protocol
From March to November 2003 we enrolled 90 patients in IBIS a
prospective, single center, non-randomized, observational study.
No formal ample size calculations have been performed. Follow-up
will be completed in summer 2004. Patients 18 years of age or older
were eligible for inclusion if (1) they presented with stable angina
pectoris, documented silent ischaemia or an acute coronary syn-
drome (unstable angina pectoris, non ST segment elevation or ST
segment elevation myocardial infarction) and (2) they underwent
successful percutaneous coronary intervention (PCI) of one or
more lesions in the native coronary circulation. Successful PCI was
defined as attainment of residual diameter stenosis <20% (visual as-
sessment), TIMI 3 flow and no residual dissection. Exclusion crite-
ria are listed in Table 1. Patients who met all the inclusion criteria
and none of the exclusion criteria were enrolled. The study was per-
formed in accordance with the principles set out in the Declaration
of Helsinki and was approved by the Medical Ethics Committee of
Moderate to severe tortuosity (moderate: 2 bends >75_ or one bend >90_) of the
proximal vessel in the segment(s) to be analyzed
Known tendency to coronary vasospasm
CRITERIA RELATED TO INVASIVE IMAGING
Table 1b: Exclusion criteria
CRITERIA RELATED TO NON-INVASIVE IMAGING
Heart rate >70 beats/min. 1 h after administration of an oral beta-blocker
Contra-indication to iodinated contrast material (.g. known allergy, serum creatinine
>150 µmol/l, thyroid disorders)
Inability to hold breath for 20 s
Irregular heart rate (e.g. atrial fibrillation or very frequent PVCs)
Table 1c: Exclusion criteria109
 the Erasmus
MC. All pa-
tients gave
written in-
formed con-
sent.
A coronary
artery, other
than the ves-
sel that was
the target for
PCI, was des-
ignated as
‘the study
vessel’. In or-
der of prefer-
ence, the left
anterior de-
scending artery (LAD), right coronary artery (RCA) or circumflex
artery (CX, including large intermediate branches) were selected. In
addition, interrogation of the PCI vessel could be undertaken at the
discretion of the investigator. All invasive imaging procedures (cor-
onary angiography, IVUS, and palpography) were performed im-
mediately after the PCI procedure or the morning following the
PCI (where PCI was performed for STEMI). MSCT was preferably
performed prior to invasive imaging; otherwise it was done within
21 days after PCl. Blood samples were obtained, whenever possible,
prior to PCI from the arterial sheath before administration of un-
fractionated heparin. In order to correlate the different imaging
techniques, a region of interest (ROI) in the study vessel was de-
fined. This was based on the MSCT scan; a side branch was chosen
as the distal boundary of the region of interest and a second side
branch, or the ostium of the vessel, as the proximal boundary. An
example is provided in Figure 1.
Clinical follow-up visits were scheduled at 3 and 6 months. At each
visit, an ECG and blood samples for biomarker analysis were ob-
tained and data collected on clinical events. At 6 months, repeat
MSCT was performed, followed by repeat invasive imaging proce-
dures on the study vessel.Whenever clinically driven angiography
Fig 1: The region of in-
terest (ROI) within the
study vessel, in this ex-
ample the LAD, as de-
termined by MSCT
(A) is appropriately
matched with the angi-
ographic (B) and IVUS
(C) image. This ROI is demarcated by clear distal (in this example the first diagonal
branch) and proximal (in this example the ostium of the Cx) anatomical landmarks.
LAD=left anterior descending artery; Cx=circumflex artery; diag=diagonal branch.110
 CHAPTER 9 METHODOLOGY IBISwas performed before the 3-month follow-up, patients were asked
to return for the previously scheduled angiogram at 6 months.
When angiography was performed after 3 months follow-up, this
angiogram was considered as the final follow-up angiogram. All dif-
ferent invasive imaging techniques (angiography, IVUS, palpogra-
phy) were repeated at follow-up; when PCI of the ‘study vessel’ was
indicated at follow-up, the imaging procedures were performed be-
fore intervention. Patients who failed to attend the follow-up visits
were contacted by phone or by letter or information was obtained
Fig 2: Longitudinal view (a) of the ROI on IVUS, as obtained by the IntelligateTM method. The tissue be-
tween the external elastic membrane (EEM), depicted in green, and the lumen–intima interface, depicted
in red, is defined as the coronary plaque plus media volume. For the purpose of this study, significant
coronary plaque was defined as a plaque that occupied >50% of the area within the EEM. This is indicated
in the longitudinal view by P1 (plaque 1) and P2 (plaque 2) and shown in a cross-sectional image of P2
(b). LII = lumen–intima interface.
Figure 3. Panel A shows
a histogram of the distri-
bution of the grey level
intensities of the pixels
in the adventitia, which
is located outside the
EEM contour, in all the
cross-sections of the
ROI. In order to obtain
a reliable reference val-
ue, parts of the adventi-
tia with reduced
intensity, due to acous-
tic shadowing, are ex-
cluded. When the
distribution of the grey values in the histogram follows a normal distribution, shown here as a red line, the
ultrasound images can be reliably used for image based tissue characterization. An example of a calcified
plaque with acoustic shadowing of the adventitia is provided in panel B and C. The non-shadowed part of
the adventitia is colored white (panel C).111
 through the general practitioner, the patient’s next of kin or refer-
ring cardiologist. The patient was considered lost to follow-up if all
these avenues were unsuccessful.
Coronary angiog-
raphy
Conventional selective coronary angiography was performed with
standard techniques. In order to obtain accurate and reproducible
quantitative coronary angiographic (QCA) measurements, each an-
giogram was preceded by the intra-coronary injection of nitrates
(1–3 mg isosorbide dinitrate) and the catheter tip was cleared of
contrast. QCA analysis was performed by the core laboratory using
the Cardiovascular Angiography Analysis System II algorithm
(CAAS II), as previously described in detail (de Feyter 1991).
QCA: Definitions The mean and minimal lumen diameters of the ROI were measured
in all individual suitable projections. The average of these values for
all available projections was calculated to provide an overall mean
and minimal luminal diameter for the ROI diameter. A plaque was
defined as luminal narrowing that resulted in >20% diameter sten-
Fig 4: Examples of tissue types as defined by the computer-aided grey scale analysis program. Panels 1A,
2A and 3A show the delineation of the lumen-intima (red), EEM (green) and adventitia (blue). Panels 1B,
2B and 3B are the corresponding cross sections and depict the different tissue types in different colors: red
structures are hypoechogenic; green spots are hyperechogenic. Panel 3B also explains the principle of un-
known tissue, colored
yellow: tissue that can-
not be characterized
due to acoustic shadow-
ing from calcium. The
histograms (C panels)
are divided in three
portions, each portion
showing the main tissue
type of the plaque. 1C,
the majority of the
plaque is located in the
left portion of the histo-
gram and is therefore
hypoechogenic. 2C, ex-
ample of hyperecho-
genic plaque. 3C,
example of a mainly hy-
poechogenic plaque,
with a rim of calcium112
 CHAPTER 9 METHODOLOGY IBISosis within the ROI with respect to the interpolated reference diam-
eter. The reproducibility for QCA has previously been reported
(Reiber 1994).
An additional qualitative analysis will be performed on the pre-in-
tervention angiogram(s) to assess the presence and severity of
atherosclerosis, based on angiography, in the study population in
order to allow comparison of the ‘tota1 plaque burden’ on angiog-
raphy with that on MSCT. All segments of the coronary tree were
analyzed by an independent experienced cardiologist. Each seg-
ment was classified as normal (smooth or tapering borders), as
atheromatous without an identifiable plaque (<20% diameter sten-
osis visually), as atheromatous with a distinct but <50% stenosis, as
atheromatous with a >50% stenosis but without occlusion or as oc-
cluded.
Fig 5: (a), the intravas-
cular palpogram is su-
perimposed on the
IVUS image. This tech-
nique measures the de-
formation of the
underlying vessel wall
and plaque in the radial
direction. The resulting
strain values are plotted as a color-coded contour at the lumen vessel boundary. (b) is an example of a
plaque with a low strain on the surface. (c) shows a plaque with high strain.
Fig 6: (a), using the
same region of interest
as in Figure 1, different
plaque types can be
identified on MSCT.
(b), cross-section at lo-
cation 1, showing non-
calcified plaque (23
HU). C, cross-section at
location 2, showing cal-
cified plaque (579 HU)113
 IVUS imaging The IVUS catheter used was a commercially available mechanical
sector scanner with a 30 or 40 MHz transducer (UltracrossTM 2.9F
30 MHz catheter or CVIS AtlantisTM SR Pro 2.5F 40 MHz catheter,
Boston Scientific Corporation, Santa Clara, USA), connected to
Fig 7: Atheroma mor-
phology by IVUS (a)
and IVUS virtual his-
tology (VH) (b). (a),
Concentric plaque
with soft ()) and fi-
brous (+) components.
(b), The same cross-
section in IVUS VH shows that this plaque has a more heterogeneous composition: fibrous (green), fi-
brolipidic (light green), lipid core (red) and calcified (white) components can be identified
Fig 8: Integration of the different imaging modalities, used in IBIS, into one graph provides a more com-
prehensive view on coronary atherosclerosis. Visualizing the same coronary artery segment, it becomes
clear that the coronary angiogram grossly underestimates the coronary plaque burden: a significant
amount of plaque on IVUS (plaque/EEM ratio >50%) and MSCT (plaque thickness >2 mm) produces
only a mild lumen reduction on angiography. The palpogram provides additional information on the
plaque surface: in this patient two high strain areas (ROC 4) were identified. The ROI is shown in the
x-axis (in this patient 22 mm). The percent EEM-area reduction (on IVUS) and diameter reduction (on
angiography) is depict-
ed on the left y-axis.
The right y-axis visual-
izes the plaque thick-
ness in mm (MSCT)
and the ROC score
(palpography). Distal
and proximal indicate
the distal and proximal
reference point the cor-
onary artery, with re-
spect to the coronary
ostium.114
 CHAPTER 9 METHODOLOGY IBISthe GalaxyTM ultrasound console from Boston Scientific. Using an
automated pullback device, the transducer was withdrawn at a con-
tinuous speed of 0.5 mm/s. Cine runs before and during contrast
injection were performed to define the position of the IVUS cathe-
ter before the pullback was started. IVUS data were acquired after
the intracoronary administration of isosorbide dinitrate and the
data were stored on S-VHS videotape. The videotapes were digi-
tized on a computer system, transformed into the DICOM medical
image standard and stored on an IVUS Picture Archiving and
Communications System (PACS).
Quantitative cor-
onary ultrasound 
(QCU) analysis
QCU analysis was performed by the core laboratory using validated
software (Curad, version 3.1, Wijk bij Duurstede, the Nether-
lands), which allows semi-automated detection of luminal and ex-
ternal elastic membrane boundaries in reconstructed longitudinal
planes (L-mode views) (Hamers 2001). Due to catheter motion
during the cardiac cycle, non-gated IVUS pullbacks result in a saw-
tooth-appearance of the coronary segment on the longitudinal
views and thus interfere with the contour detection algorithms used
in most QCU software packages. This phenomenon can also lead
to inaccurate measurements. In order to obtain a smooth appear-
ance of the vessel wall structures in the longitudinal views, the In-
telligateTM imagebased gating method was applied (Bruining 1998)
(de Winter 2004). This validated technique eliminates catheter-in-
duced image artefacts, by retrospectively selecting end-diastolic
frames, thus resulting in more reliable volumetric measurements.
Assuming a heart rate of 60 beats per minute and given a pullback
speed of 0.5 mm/s, the IntelligateTM method selects 2 IVUS frames
per millimeter for data analysis. After performing QCU, the bor-
ders of the external elastic membrane (EEM) and the lumen–intima
interface enclose a volume that was defined as the coronary plaque
plus media volume (Figure 2). The intra- and inter observer varia-
bility in our institution for measurements of lumen, EEM and
plaque + media cross-sectional area has been reported in a previous
study (von Birgelen 1997). Because of recent adjustments and im-
provements in the whole IVUS imaging chain, from catheter until
final analysis, the observer-related variability data will again be de-
termined for a subset of patients included in the IBIS study (de
Winter 2004) (Bruining 2004).115
 IVUS plaque 
characterization: 
Computer-aided 
grey-scale analysis
In addition to plaque volume, IVUS also provides information on
plaque echogenicity, a potential source of information on plaque
composition. The acoustic characterization of a coronary plaque
has been investigated by in vitro and in vivo studies that support a
role for echogenicity as a predictor of-histological plaque composi-
tion (Nissen 2001) (Nishimura 1990) (Prati 2001) (Okimoto
2002) (Schartl 2001). In the present study, we used a computer-
aided grey scale value analysis program for plaque characterization
(de Winter 2003). Using the mean grey level of the adventitia as a
threshold, five main tissue types can be characterized (Figure 3): (1)
hypoechogenic tissue has a mean grey level lower than that of the
adventitia, (2) hyperechogenic tissue, defined as tissue with a mean
grey value higher than that of the adventitia, (3) calcified tissue, de-
fined as a tissue with a mean grey value higher than that of the ad-
ventitia with associated acoustic shadowing, (4) unknown tissue,
defined as tissue shadowed by calcification and (5) ‘upper’ tissue,
defined as tissue that has a mean grey value higher than the mean
adventitial intensity plus two times its standard deviation but is not
typical calcified tissue with acoustic shadowing. An example of a re-
cording illustrating some of the types of tissue described is present-
ed in Figure 4. 
Plaque size and 
composition by 
IVUS: Defini-
tions
For the purpose of the IBIS protocol, significant plaque was defined
as the presence of echolucent media and echogenic plaque area that
resulted in a >50% reduction in the cross-sectional area circum-
scribed by the external elastic membrane (EEM). Plaque composi-
tion was classified, as defined previously, based on tissue
echogenicity. Plaque within the ROI was considered calcified if it
contained calcium in at least two consecutive cross-sections (0.5
mm < calcified plaque < 1 mm) and was scored in a binary fashion.
Palpography Intravascular palpography is a new parametric imaging technique
based on lVUS that assesses the local mechanical properties of the
vessel wall and plaque. The underlying principle is that soft material
will deform more compared with hard material when force is ap-
plied to the tissue. The naturally occurring pulsatile arterial pres-
sure provides the force. The relative deformability of coronary
plaque components can be estimated by measuring the relative dis-
placements of radio frequency (RF) signals, recorded during IVUS
acquisition, at two different pressure levels (de Korte 2002a). Post-
processing of RF signals derives data regarding deformation of the116
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er’ (low strain) and ‘softer’ regions (high strain) can be identified.
The local strain is displayed color coded from blue for 0% strain via
red to yellow for 2% strain as a complementary image to the IVUS
echogram (Figure 5) (Schaar 2003a). The resolution of the strain
measurement in the radial direction is 200 µm. In vitro and in vivo
studies have validated the technique and found higher strain values
in fatty as compared to fibrous plaques (de Korte
2000a+2002a+2002b). A recent in vitro study demonstrated the di-
agnostic potential of palpography to identify thin cap fibroathero-
mas (Schaar 2003a). All data in IBIS were acquired using a 20 MHz
Jovus Avanar F/X IVUS catheter (Volcano, Rancho Cordova, CA,
USA), which was connected to an In Vision Gold IVUS console.
Recordings were obtained at a pullback speed of 1 mm/s using a
mechanical pullback device (Trackback II, Volcano, Rancho Cor-
dova, CA, USA). Simultaneously, the ECG and intraluminal pres-
sure signals were recorded. Acquisition was done with a custom
made dedicated workstation connected to the digital interface of
the IVUS machine. Each acquisition was stored on a separate
DVD. Processing and analysis of the data was done independently
by observers unaware of the results of the other techniques. The re-
producibility of three-dimensional palpography at our institution
has been recently reported (Schaar 2003b).
Palpography: 
Definitions
The strain value that best discriminates a plaque at risk of rupture
has a threshold of 1.26% (Schaar 2003). Strain values were classi-
fied according to the ROC classification (Rotterdam Classification)
as low strain spots (ROC I: 0.0–<0.6%), moderate strain spots
(ROC II: 0.6–<0.9%), medium strain spots (ROC III: 0.9–
<1.2%), or high strain spots (ROC IV: >1.2%).
Multislice spiral 
computed tomog-
raphy (MSCT)
Intravenous contrast injection with multislice coronary tomogra-
phy allows non-invasive visualization of coronary arteries including
visualization and evaluation of non-calcified and calcified plaques
(Schroeder 2001) (Nieman 2002). Patients with resting heart rates
>60 beats/minute received a single oral dose of 100 mg metoprolol
(Selokeen, AstraZeneca Pharmaceuticals, UK), 1 h prior to the
MSCT scan. All scans were performed using a true 16-row detector
MSCT scanner (Sensation 16, Straton) with a gantry rotation time
of 375 ms. Other scan parameters were: 16 · 0.75 detector collima-
tion, table feed 3.0 mm/rotation, tube voltage 120 kV, tube current117
 500–600 mAs. A bolus of 140 ml Iodixanol with an Iodine content
of 320 mgI/ml (Visipaque 320, Amersham Health, UK) was intra-
venously injected in an antecubital vein at 4 ml/s. A bolus tracking
technique was used to synchronize the arrival of contrast material
inside the coronary arteries and the start of the scan: a ROI was po-
sitioned inside the ascending aorta and the mean density within the
ROI was monitored at intervals of 1.25 ms after the start of the in-
jection. The patient was instructed, via an automated prerecorded
message, to perform a breath hold when the mean density reached
a predefined threshold (+100 HU), and the scan started 4 s later.
All data were acquired during a single breath hold of 20 s, and im-
ages were reconstructed using retrospective ECG gating. An image
reconstruction algorithm was used, which uses data obtained in half
gantry rotation time resulting in a temporal resolution of up to 188
ms. To obtain motion-free images, standard reconstruction win-
dows were selected during the mid-to-end diastolic phase (350,
400, and 450 ms prior to the next R-wave), but additional image
reconstruction windows were explored when deemed necessary.
The dataset with least motion-artefacts was selected and loaded into
an off-line workstation (Leonardo, Siemens, Forchheim, Germa-
ny). Then, a ROI in the study vessel was selected on multiplanar re-
constructed (MPR) images, using easily identified anatomic
landmarks (sidebranches or the ostium). Thereafter, the dataset was
loaded into a semi-automated vessel-tracking software program and
a central lumen line was created throughout the ROI. Ten, twenty,
or thirty cross-sectional MPR images (depending on the length of
the ROI) were reconstructed orthogonal to this central lumenline,
and used for image analysis. A cardiologist and a radiologist, una-
ware of the results of other imaging modalities, independently eval-
uated the cross-sectional images. Disagreements were resolved by
consensus. The image quality of all cross-sectional images was clas-
sified as reliable, adequate, or unreliable. Images with unreliable im-
age quality were excluded from further analysis.
MSCT: Defini-
tions
Reliable cross-sectional MSCT images were visually evaluated for
the presence of plaque; plaque was further classified based on size –
as small, medium, or large-and composition – non-calcified, calci-
fied, or mixed. A plaque was defined as a visually apparent abnor-
mal space-occupying lesion, within the wall of the coronary artery
that was clearly distinguishable both from the adjacent epicardal fat
and from the coronary lumen. The mean Hounsfield unit (HU) of118
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tions with plaque. Plaque size was further classified, based on their
measured maximal thickness, as small (<1 mm), medium (1–2
mm),
or large (>2 mm). Plaque was defined as calcified if it contained
high-density (>130 HU) components (Figure 6). Plaque tissue with
both calcified and non-calcified components was classified as
mixed. HU of non-calcified and calcified tissue components were
measured in all cross-sections with medium and large plaques by
positioning a ROI as far as possible from the lumen and adjacent
epicardial fat. The j-values in our institution for inter- and intra-ob-
server agreement regarding plaque size, using the 16-row detector
MSCT scanner, have been determined in a group of 78 patients
and are 72% and 74%, respectively. 
Finally, the total plaque burden of the entire coronary tree was as-
sessed on MSCT. All coronary segments were assessed. Where not
possible (vessel <2 mm, vessel segment distal to an apparent total
occlusion, motion or other artefact rendering interpretation unreli-
able), this was noted. Plaque was defined as mentioned above and
was further classified as non-calcified, mixed, or calcified. Where
MSCT was performed after the intervention, evaluation of plaque
burden in the stented segments was obviously not possible. In these
patients, an independent observer assessed the pre-intervention cor-
onary angiogram as follows: the segments that had been stented
were scored, by imputation. The segment(s) that were the site of the
culprit lesion were classified as having a large plaque. In some pa-
tients, segments that were stented had no significant stenosis on an-
giography. This mainly reflected our practice of stenting from
‘normal’ to ‘normal’ with drug-eluting-stents; in other situations,
multiple stents were implanted to cover a dissection or to protect a
compromised side branch. These segments were considered as non-
assessable or the presence of plaque. Qualitative assessment for cal-
cium was performed, as described above, in all stented segments.
IVUS Virtual 
Histology (IVUS-
VH): An IBIS 
substudy
IVUS VH is an intravascular ultrasound derived technique that
analyses the radio frequency component of the reflected ultrasound
signal. As compared with standard IVUS, this imaging modality
has the potential for more detailed assessment of different plaque
components. In preliminary in vitro studies, four plaque types (fi-
brous, fibrolipidic, lipid core and calcium) as defined by histology119
 could be correlated with a specific spectrum of the radio frequency
signal (Nair 2002) (Moore 1998). The different plaque compo-
nents are assigned colour codes: fibrous, fibrolipidic, lipid core, and
calcified regions are labelled green, light green, red and white, re-
spectively (Figure 7). This technique, given its ability to identify li-
pid-rich plaques, could be of great value in identifying potentially
vulnerable plaque.
IVUS VH derives its data from the RF output of a conventional
IVUS console and is ECG-gated for accurate data analysis. Since
validation of the technique so far only exists for a 30 MHz system,
the same 30 MHz IVUS catheter, used for the acquisition of the
IVUS data, was utilized. The RF and ECG signal were transferred
from the Boston Scientific console to a dedicated IVUS VH (Vol-
cano) platform. The IVUS VH data were stored on a CD-ROM
and sent to the Imaging Core Lab at Cardialysis for off-line analysis
by one independent observer.
IVUS Virtual 
Histology: Defini-
tions and end-
points
In analogy with QCU, the tissue in between the EEM and lumen–
intima interface was defined as the coronary plaque plus media.
Classification of the coronary plaque into its four components
within the ROI was assessed independently from the media. Since
IVUS VH was not incorporated at the start of the IBIS protocol,
the results of this technique will only be reported as a substudy. The
primary endpoints of this substudy are: (1) the volumetric correla-
tion with QCU, (2) the correlation of the different plaque compo-
nents with clinical presentation and biomarkers. (3) the correlation
between plaque composition and strain pattern observed on pal-
pography. Furthermore, the design of the IBIS study provides the
means to address changes in plaque composition.
Biomarker and 
blood analysis
Cardiac enzymes (including troponin), hemoglobin, hematocrit,
red blood cell (RBC) count, white blood cell (WBC) count, platelet
count, urea, creatinine, total cholesterol, HDL cholesterol (HDL-
C) and triglycerides were analyzed by the local laboratory. Plasma
concentration of LDL cholesterol (LDL-C) was calculated by the
use of the Friedewald formula [LDL-C = total cholesterol minus
HDL-C minus (triglycerides/5)].
Plasma and sera used for biomarker analysis was centrifugally sepa-
rated within 30 min of draw and stored at -70 0C. Analytes were120
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where noted. Plasma high sensitivity interleukin 6 (hs IL-6), tumor
necrosis factor alpha (TNFa), serum high sensitivity C-reactive pro-
tein (hsCRP- Diagnostic Systems Laboratories), lipoprotein phos-
pholipase A2 (LpPLA2- GSK), ultra sensitive pregnancy associated
plasma protein A (PAPP-A-Diagnostic Systems Laboratory), ma-
trix metalloproteinase 9 (MMP-9), soluble CD40L (sCD40L-
Bender MedSystems) and monocyte chemoattratact protein
(MCP-1), were measured in the Human Biomarker Centre, Glax-
oSmithKline, using protocols provided by the manufacturer. Re-
sults from the standardized ELISA assays were measured on a MRX
Revelation microplate reader with 4.2 software. Plasma LpPLA2 ac-
tivity assay measures the proportional release of aqueous 3H acetate
resulting from the enzymatic cleavage of the 3H acetyl-platelet ac-
tivating factor substrate using methodology developed at Glaxo-
SmithKline. All simple analyses were done in batches representing
the three time points (baseline, 3 and 6 months follow-up). Inter-
nally developed matrix matched or kit provided controls were in-
corporated to ensure consistency in the assay performance.
NT pro BNP was measured in EDTA plasma by Quest Diagnostics
using a two-site electro-chemiluminescent assay. The lipoprotein
subclass distribution was analyzed by Liposciences Inc. using NMR
based technology. The analysis provided to us for the IBIS trial used
the newest NMR LipoProfile II methodology.
In addition, serum batched by patient sets from all baseline and fol-
low-up visits, were measured using an analyte defined (closed for-
mat protein chip. Protein chips provide capability for the analysis
of between 10 and 157 different chemokines, cytokines and growth
factors depending on the platform. Our analyses to date include the
ZyomyxTM protein chip. The limits of quantification for the
above analytes are as follows: 2.5 uIU/mL for PAPP-A, 0.18 ng/ml
for MMP-9, 0.0048 mg/l for CRP, 6.31 pg/ml for MCP-l, 0.78 ng/
ml for sCD40L, 0.057 pg/ml for IL-6, 0.88 pg/ml for TNF-a, and
3.92 nmols/min/ml for LpPLA2 activity.121
 Off-line analysis 
of imaging tech-
niques: Principles 
and resolution of 
problems
No previous study has attempted to identify and characterize either
coronary atherosclerosis or potentially vulnerable coronary plaques
with such a wide range of invasive and non-invasive imaging tech-
niques (Figure 8) in conjunction with multiple analyses of classic
and novel biomarkers. In the present study all imaging techniques
were analyzed independently. The QCA and QCU were performed
by an independent Core Lab (Cardialysis) using standard operating
procedures and validated methodology. The IVUS based tissue
echogenicity, palpography, and MSCT analyses were performed in-
dependently by the research groups that developed or refined the
techniques in our institution.
Ideally, we aimed to study a common ROI >30 mm long for all
techniques. This was possible for the majority of patients but spe-
cific difficulties related to each technique required either a redefini-
tion of the original ROI, before database lock, or the use of a shorter
ROI within the initially defined region, in some patients. For all pa-
tients, the initial ROI was to be determined on MSCT. However,
in some cases the landmarks on MSCT were not identifiable on
IVUS. This primarily occurred in the RCA when the ostium was
chosen as a landmark on MSCT but was not reliably identified on
IVUS because the distal tip of the guiding catheter was within the
coronary artery. In a few cases, the ROI could not be determined
on MSCT. This was mainly related to un-interpretable images due
to artefact related to high heart rates, irregular heart rates, or cardiac
motion (exclusively in the RCA). Finally, in some cases, MSCT was
not performed.
Imaging techniques: Parameters measured at baseline
IVUS Mean plaque area in the ROI as defined by QCU was used for com-
parisons among imaging techniques and for exploratory analyses on
the relation between clinical and biological variables and the extent
of subclinical atheroma in the ROI. To this end, mean plaque area
(MPA) was calculated as the difference between mean total vessel
area (ATV) and mean total lumen area (ATL). Total plaque volume
(TPV) was calculated as the sum of the differences between external
elastic membrane (EEM) and lumen areas across all frames in the
region of interest (Nissen 2004). The plaque variables we measured
and their definitions are presented in Table 2. Calcified plaque was122
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in each 5 mm segment.
MSCTThe ROI was subdivided into 5 mm segments. Each 5 mm segment
was classified as plaque free or as containing a small, medium, or
large plaque. Each plaque was classified as non-calcified, calcified,
or mixed. Finally the longitudinal extent of calcium was expressed
as an integer score based on the presence or absence of calcium in
each 5 mm segment.
Comparison of 
QCU with 
MSCT
Based on QCU-derived measurements of coronary atheroma (i.e.
plaque and media), the ability of MSCT to detect coronary plaques
resulting in 50% EEM area reduction and to detect calcification
was assessed. To ensure that the same plaques were assessed by the
different techniques and to allow correlations, the ROI within the
study vessel was subdivided into 5 mm segments as outlined above.
The QCU and MSCT data were compared in corresponding 5 mm
segments in the ROI.
Using these definitions, the ability of MSCT to detect plaque (bi-
nary classification; plaque present or absent) was compared with
VOLUMETRIC VARIABLES (MM3)
Absolute plaque volume (mm3)
Total plaque volume (TPV) = 
Relative (percent) plaque volume (%)
Relative plaque volume
(RPV) = 
AREA VARIABLES (MM2)
Mean plaque area (MPA) = Mean total Vessel Area (ATV) -
Mean total Lumen Area (ATL)
Table 2. IVUS Coronary Plaque Measurements
EEMCSA( ) LumenCSA( )–∑
EEMCSA( ) LumenCSA( )–∑
EEMCSA
----------------------------------------------------------------------- x100123
 that of IVUS (binary classification, coronary plaque area >50% of
area enclosed by the EEM, yes/no). The effect of the presence or ab-
sence of calcium detected on IVUS on the specificity and sensitivity
of MSCT plaque detection was also assessed, using a binary classi-
fication: calcium present/absent on MSCT or IVUS within the 5
mm segments.
QCA The overall mean and minimal lumen diameters of the ROI were
measured. The number of plaques, defined as luminal narrowing
that resulted in >20% diameter stenosis within the ROI, was also
assessed.
Tissue echogenici-
ty
The major variables measured using the tissue echogenicity pro-
gram were absolute hypo-echogenic and hyper-echogenic plaque
volume (mm3). Other variables measured, defined in the methods
section, were upper volume and unknown volume (mm3). These
variables were also assessed for contiguous 5 mm segments within
ROI.
Palpography The number of ROC III and IV scores was measured in the ROI
and in individual 10 mm segments of the ROI (ROC 3/4 density).
Safety The occurrence of Major Adverse Cardiac and Cerebral Events
(MACCE) was assessed after the procedure, at discharge, and at 3
and 6 months, as were the individual components: death, MI,
revascularization by PCI or CABG, hospitalization for ischaemia
and/or anginal symptoms, and stroke. They were classified, where
possible, as related to the ‘study vessel’, the PCI vessel, or a non-
PCI/non-study-vessel. The definition of myocardial infarction was
identical to that defined in the ACC/ESC joint document on the
redefinition of myocardial infarction (Alpers 2000). Major bleeding
and vascular complications were also prospectively recorded using
standard definitions (Serruys 1996).
Statistics For the comparison between and within techniques for each pa-
tient, for each analysis technique, and each time point, the same
ROI, selected by the Core Lab, will be studied. Comparisons be-
tween techniques and within techniques (baseline vs. follow-up)
will be performed with use of either two-by-two tables (sensitivity,
specificity) for qualitative outcomes or linear regression analysis (re-
gression coefficient, scatter plots) for quantitative outcomes. For124
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rameters, and imaging technique results, the data will be summa-
rized by vessel (ROI) and for 5 mm increments of the ROI. For
each 5 mm increment in each technique it was judged whether or
not plaque could be detected. On the vessel level, plaque was de-
fined as plaque in any of the 5 mm increments of the ROI. Circu-
lating biomarkers will be correlated with imaging endpoints using
the univariate Pearson correlation coefficients. We will also use Box
and Whisker plots to compare biomarker distributions in prede-
fined subgroups of the study population (diabetic status, anginal
status, etc.). Statistical analyses will be performed with use of SAS
version 8.
Discussion
Coronary atherosclerosis remains one of the major causes of mor-
tality and morbidity in the Western Hemisphere. Advances in med-
ical research have resulted in the introduction of new
pharmacological agents that have significantly contributed to our
ability to decrease the risk of clinical events related to atherosclero-
Fig 9: Schematic outline
of the remodelling proc-
ess in coronary athero-
sclerosis, as assessed by
IVUS. In theory nine re-
modelling patterns can
be defined, as depicted.
Determinants of the cor-
onary artery lumen di-
ameter are the change in
plaque size and the proc-
ess of vascular remodel-
ling, which is the change
in the size of an artery
over time. The change in
the vascular lumen is in-
dicated in the figure by
the + (increase), - (de-
crease) or = (unchanged)
signs. By taking into ac-
count the, still to be determined, observer related variability of the IVUS data in this study, as indicated
by the (hypothetical) dotted lines, the natural history of the remodelling process can be defined for the
IBIS population. The shaded box in grey indicates a change of 5 mm2 along the x- and y-axis125
 sis. Furthermore, the discipline of interventional cardiology has
evolved from an experimental technology that was an option in
highly selected patients to a discipline that complements and may
soon largely replace coronary artery bypass surgery.
In parallel, advances in our understanding of the mechanisms un-
derlying atherosclerosis have clearly demonstrated that clinical
events are not necessarily related to the severity of luminal narrow-
ing in large epicardial coronary arteries. The potential contribution
of a low-grade inflammation, infectious agents, genetic factors, and
other putative mechanisms to the occurrence of atherosclerosis-re-
lated clinical events is the subject of intense investigation.
Finally, the recognition that death or myocardial infarction is often
related to plaque rupture at the site of non-flow limiting subclinical
atherosclerosis has evolved into the concept of the vulnerable
atherosclerotic plaque. Post-mortem studies have shown that
plaque rupture at the site of thin-cap fibroatheromas is the most
common mechanism that leads to death from atherosclerosis. How-
ever, it has also been clearly shown that such ruptures often remain
clinically silent and contribute to lesion progression. As atheroscle-
rosis is a diffuse process that involves many vascular beds and several
sites within the coronary vasculature, better identification of plaque
compositional characteristics is needed. The quest to identify relia-
ble technique(s) to detect plaques that are at high risk of causing fu-
ture clinical events is currently the subject of intense research
activity. Ideally, biomarkers in peripheral blood, singly or in com-
bination, could be used to identify patients at risk for new or recur-
rent clinical events such as sudden death or acute myocardial
infarction. Appropriate non-invasive or invasive techniques could
then be used to further refine risk stratification.
The aim of the IBIS study is to evaluate the feasibility and safety of
both invasive (quantitative coronary angiography, intravascular ul-
trasound with tissue echogenicity and palpography) and non-inva-
sive (multislice spiral computed tomography) imaging techniques
to characterize non-flow limiting coronary lesions. The perform-
ance of MSCT to identify and characterize coronary plaque will be
directly compared with that of IVUS, the current gold standard.
Multiple classical and novel biomarkers will be measured and their
levels will be correlated with the results of the different imaging126
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such as tissue echogenicity and palpography will be evaluated. Be-
yond these specific goals, the longitudinal character of the IBIS
study will be utilized to assess the natural history of arterial remod-
elling (Figure 9). Serial studies, like IBIS, that measure changes in
vessel area at the same site over time are the ideal way to assess the
remodelling process since they are not subjected to the limitations
of using a reference site (Mintz 2001) (Ward 2000). A few IVUS
studies with serial long-term (>12 months) follow-up in patients
with atherosclerotic coronary artery disease have recently been re-
ported (von Birgelen 2003+2004). They substantiate the earlier
knowledge that changes in the arterial lumen correlate more closely
with the direction and magnitude of the remodelling process than
with plaque size.
Study limitations
We used two different IVUS catheters in the present study. During
the first 3 months of patient inclusion IVUS imaging was done us-
ing a 40-MHZ catheter; all subsequent baseline and all follow-up
analyses were done using the 30-MHZ system. This approach was
driven by the decision to include IVUS VH as an additional imag-
ing technique 3 months after the start of the IBIS study. Ideally, the
same IVUS catheter used at baseline should again be selected for the
follow-up procedure. However, since both IVUS catheters were op-
erated on the same display system (GalaxyTM console, Boston scien-
tific), this should not affect IVUS measurements (Bruining 2004).
Plaque assessment by MSCT was based on visual evaluation. While
automated programs with the possibility of manual contour correc-
tion, such as used for QCA and IVUS, are under development for
MSCT imaging, none are currently available for use.
IVUS examinations performed with a 40-MHZ IVUS catheter will
not be used for evaluation by IVUS VH since validation only exists
for the 30-MHZ system.
Where the initial ROI on MSCT could not be used for correlation
with the other imaging techniques due to a problem with the iden-
tification of the landmarks, a new ROI was defined on MCST by
the Core Lab in conjunction with an independent cardiologist, fa-127
 miliar with but not involved in the analysis of the various tech-
niques. Where MSCT was not performed or could not be
interpreted, a ROI was defined on IVUS using proximal and distal
anatomic landmarks.128
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 CHAPTER 10 IBIS BASELINE RESULTSPotential of novel 
coronary imaging 
techniques
Atherosclerosis is a systemic disease whose clinical sequelae are un-
predictable and only weakly related to its extent or severity. Patho-
logical studies have related specific coronary plaque characteristics
to fatal ischemic events but conventional imaging techniques can-
not reliably identify them prospectively (Virmani 2000). While
population based studies have shown that circulating biomarker
levels predict clinical events in apparently healthy subjects or pa-
tients with coronary disease, individual biomarker profiles are less
useful to guide management (Ridker 2003). Given the limitations
of current methods for risk stratification, the potential of novel cor-
onary imaging techniques to refine risk stratification in individual
patients and ultimately guide local preventive strategies has attract-
ed attention from the medical and scientific community (Casscells
2003b) (Wang 2004). 
Comparison of 
MSCT angiogra-
phy and IVUS
We investigated an integrated approach that included novel inva-
sive and state-of-the-art non-invasive coronary imaging combined
with circulating biomarkers to assess non flow-limiting atheroscle-
rotic lesions in patients, with diverse clinical presentations, referred
for percutaneous coronary intervention (PCI). We compared non-
invasive Multi Slice Computed Tomography (MSCT) angiography
and invasive intravascular ultrasound (IVUS) for detection of clin-
ically silent coronary plaques and used novel invasive IVUS-based
imaging (echogenicity and palpography) to assess plaque character-
istics. Finally, we explored correlations between clinical presenta-
tion, imaging parameters, and circulating biomarkers.
METHODS
This pilot study was a prospective, observational and single center
trial. Briefly, patients with stable angina, unstable angina, non-ST
segment elevation myocardial infarction (NSTEMI), or ST seg-
ment elevation MI (STEMI) referred for PCI were eligible for in-131
 clusion. Major clinical exclusion criteria included significant renal
(creatinine >2mg/dl) dysfunction, life expectancy less than one year
or factors that made follow-up difficult. Major imaging-related ex-
clusion criteria included coronary anatomy that precluded safe
IVUS examination of a suitable region of interest (ROI) or criteria
that precluded acquisition of diagnostic MSCT images (irregular
heart rhythm or inability to breath hold for 20 seconds). The Med-
ical Ethics Committee of the Erasmus MC approved the study pro-
tocol and all patients gave written informed consent. The coronary
study vessel, preferentially a vessel not targeted for PCI, was, in or-
der of preference, the LAD, RCA or LCX. The region of interest
(ROI) was defined on the basis of identifiable landmarks, such as
branches or the vessel origin. 
Quantitative 
Coronary Angiog-
raphy
Coronary angiograms were obtained in multiple views after the in-
tracoronary injection of nitrates. Quantitative analyses were per-
formed by a core laboratory (Cardialysis, Rotterdam, The
Netherlands) with the use of edge-detection techniques. Mean and
minimum luminal diameters and diameter stenosis were measured
in at least two, preferentially orthogonal, projections and averaged. 
Intra Coronary 
Ultrasound
IVUS was performed with commercially available catheters (Ultra-
crossTM or CVIS AtlantisTM SR Pro, Boston Scientific, Santa
Clara, USA) and an automated pullback device (0.5 mm/s). Data
were stored on S-VHS videotape, digitized and transformed into
the DICOM medical image standard, and archived. QCU analysis
was performed by the core laboratory using validated software
(Curad, version 3.1, Wijk bij Duurstede, The Netherlands) and
retrospective image-based gating (de Winter 2004). The borders of
the external elastic membrane (EEM) and of the lumen were traced.
The area they enclosed was defined as the coronary plaque plus me-
dia area (subsequently referred to as plaque area). Significant plaque
was defined as plaque area whose area occupied 50% or more of the
cross-sectional area circumscribed by the EEM. Quantitative pa-
rameters were reported for the entire ROI and for slices with signif-
icant plaque. 132
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genicity
We used a computer-aided, gray-scale value, analysis program for
plaque characterization.6 Based on the mean gray level (brightness)
of the adventitia, plaque was classified as brighter (hyperechogenic)
or less bright (hypoechogenic) than the adventitia. Calcified plaque
was defined as plaque brighter than the adventitia with associated
acoustic shadowing. The percentage of hypoechogenic plaque was
calculated for the entire ROI and for slices with significant plaque,
with use of previously reported methodology (de Winter 2003)
(Schartl 2001). 
Palpography Palpography assesses the relative deformability of coronary plaque
components using data acquired during an IVUS pullback (1 mm/
s) with a commercially available catheter (20MHz Jovus Avanar F/
X, Volcano, Rancho Cordova, CA, USA). Using previously de-
scribed and validated methodology, strain values were classified ac-
cording to the Rotterdam Classification (ROC) (de Korte
2002a+b) (Schaar 2003+2004a).
Multislice Spiral 
Computed Tom-
ography
All scans were performed on a 16-row detector MSCT scanner
(Sensation 16, Straton). The scan protocol and image reconstruc-
tion parameters were recently published (Mollet 2004). Technical
advances allowed us, in this study, to adapt tube output to patient
weight. The dataset with least motion artifacts was loaded on an
off-line workstation (Leonardo, Siemens, Forchheim, Germany)
and the ROI identified on multiplanar reconstructions (MPR), us-
ing anatomic landmarks. Data sets were loaded on a semi-automat-
ed vessel-tracking software program and a central lumen line
created throughout the ROI. Ten through 30 cross-sectional MPR
(depending on ROI length), reconstructed orthogonal to this line,
were analyzed independently by two observers. Disagreements were
resolved by consensus. Plaque was defined as an abnormal mass
within the artery wall, clearly distinguishable from epicardial fat
and the coronary lumen and classified, based on manually meas-
ured maximal thickness, as small (<1 mm), medium (1-2 mm), or
large (>2 mm). Calcification was defined as the presence of high-
density, >130 Hounsfield Unit, components.133
 Biomarkers Blood for biomarker analysis was taken at the time of the interven-
tional procedure, centrifuged within 30 minutes and stored at -
70C. Analytes were measured using commercial ELISA kits from
R&D Systems except where noted. Plasma high sensitivity inter-
leukin 6 (IL-6), and serum high sensitivity C-reactive protein
(hsCRP Diagnostic Systems Laboratories), lipoprotein phospholi-
pase A2 (Lp-PLA2) and tumor necrosis factor-a (TNF-a) were
measured in the Human Biomarker Center (GlaxoSmithKline, PA,
USA) using protocols provided by the manufacturer. Results from
the standardized ELISA assays were measured on a MRX Revela-
tion microplate reader with 4.2 software. Plasma Lp-PLA2 activity
assay measures the proportional release of aqueous 3H acetate re-
Fig 1: Example of imaging findings in a
patient in whom intervention was per-
formed on the right coronary artery.
The study segment was the proximal
left anterior descending coronary ar-
tery. The borders of the region of inter-
est were the ostium of the left anterior
descending and a large septal branch.
These are indicated by the lines on the
angiogram (Panel A) and by the arrows
on the Multiplanar MSCT reconstruc-
tion (Panel B). Panel C shows a gated
longitudinal intravascular ultrasound
reconstruction. The vertical lines mark
the boundaries of the region of interest.
The red line indicates the lumen-inti-
ma interface and the green line the ex-
ternal border of the plaque plus media.
Representative color-coded circumfer-
ential palpography data, superimposed
on the intravascular ultrasound cross-
sections. Strain values are color-coded
from 0% (blue), through yellow (2%)
via red. Panel D shows non-deformable
eccentric plaque with acoustic shadow-
ing compatible with calcification. The
blue line indicates a non-deformable
plaque with 0% strain. Panel E shows eccentric partly calcified plaque with a high strain (yellow) spot on
one shoulder of the plaque (nine o clock). On the other shoulder (four o clock) the blue color (0% strain)
indicates that the plaque is not deformable in this region. The gray color, in the arc without plaque, indi-
cates that no strain value is available. Typical findings on echogenicity are presented in Panels F and G.
The bottom panel (I) shows the MSCT reconstruction and inset a cross-section in an area with calcified
plaque.134
 CHAPTER 10 IBIS BASELINE RESULTSsulting from the enzymatic cleavage of the 3H acetyl-platelet acti-
vating factor substrate using methodology developed at
GlaxoSmithKline. NT pro BNP was measured in EDTA plasma by
Quest Diagnostics using a two site electrochemiluminescent assay.
The limits of quantification were 0.0048 mg/L for hsCRP, 0.057
pg/mL for IL-6, 3.92 nmols/min/mL for Lp-PLA2 activity, 10 pg/
ml for NT pro BNP, and 41 pg/mL for TNF-a.
Statistical Analy-
sis 
Discrete variables are presented as counts and percentages. Contin-
uous variables are presented as means ± SD, unless otherwise indi-
cated. IVUS data were summarized by ROI and for the part of the
ROI with significant plaque. Measurements of systemic biomarkers
are presented as Box-Whisker plots. Comparisons between MSCT
Fig 2: This illustrates
MSCTA and IVUS
findings in a region of
interest in the proximal
right coronary artery.
The conventional angi-
ogram is shown in Pan-
el A and a Multiplanar
Reconstruction (MPR)
of the MSCT in Panel
B; the white spots seen
on the MPR recon-
struction are calcified
areas. Below, the Panels
in 1, 2, and 3 show
cross-sectional IVUS
(a), cross-sectional
MSCT (b), and magni-
fied cross-sectional
MSCT images in the
regions indicated by the
corresponding num-
bered lines in the con-
ventional angiogram
(Panel A). Regions 1
and 3 show plaque with
calcified components,
as shown on the IVUS
by the acoustic shadow-
ing, whereas the plaque
in Region 2 is not calci-
fied. 135
 and IVUS were performed with use of two-by-two tables (sensitiv-
ity, specificity). Comparisons between quantitative outcomes were
performed with use of scatterplots and linear regression analysis (re-
gression coefficient). As biomarker data were not normally distrib-
uted, analyses were performed after natural logarithmic
transformation. We made scatterplots of quantitative angiographic
and IVUS outcomes versus the log-transformed value of the bi-
omarkers and calculated the univariate correlation coefficients. Dif-
ferences in means among groups were analyzed by a two-sample t-
test or by one-way analysis of variance. Adjustment for multiple
comparisons was performed with use of the Bonferroni correction.
A P value of less than 0.05 (two-sided) was considered to indicate
statistical significance. Statistical analyses were performed with use
of SAS Version 8.
RESULTS
Demographic 
data
The demographic, clinical, and angiographic characteristics of the
patients are reported in Table 1. QCA and IVUS parameters in the
ROI, by vessel studied, are reported in Table 2. Although the mean
diameter stenosis on QCA was only 25±11%, IVUS examination
revealed significant plaques (i.e., >50% reduction of vessel cross-
Fig 3: Relation between
the systemic values of
the biomarkers we
measured and the clini-
cal presentation that
prompted referral for
intervention. Data are
presented as box-whisk-
er plots, with 25th and
75th percentiles (box)
and 10th and 90th per-
centiles (I). There were
significant differences
among patient groups
with acute myocardial
infarction (black), un-
stable angina (red), and
stable angina (yellow) for systemic values of hsCRP (P=0.0003), IL-6 (P=0.0001), LpPLA2 (P=0.035),
and NTproBNP (P=0.0012). 136
 CHAPTER 10 IBIS BASELINE RESULTSsectional area) in 75% (61/81) vessels, within the study segment
(mean length: 32.8±15.9 mm). There were 113 discrete significant
plaques. The findings in IVUS slices with significant plaque are also
presented in Table 2. Biomarker data was obtained in 83/84 (99%)
patients. For imaging techniques, data suitable for analysis was ob-
tained for all patients (QCA), 81/84 (96%) patients (IVUS), 80/84
(95%) patients (echogenicity), and 69/84 (82%) patients (palpog-
raphy). MSCT, performed in 70/84 patients, was of diagnostic
quality for plaque imaging in 64/70 (91%). 
Novel Invasive 
Imaging
The results of echogenicity and palpography are reported in Table
3. In the entire ROI and in slices with significant plaque, the pre-
dominant plaque component was hypoechogenic plaque whose
mean brightness was less than that of the adventitia (Table 3). The
percentage of hypoechogenic plaque was 92.7±3.5 for patients
(n=17) undergoing intervention for STEMI, 92.4±4.0 for patients
with unstable angina (n=25), and 89.5±4.6 for stable (n=38) angina
patients (p=0.013 for STEMI vs stable, p=0.09 for STEMI vs un-
stable/stable). On palpography, high strain spots (ROC 3/4), that
reflect abnormal biomechanical plaque characteristics, were com-
mon (4.0±4.1 per ROI, range 0-16) and at least one ROC 3/4
strain spot was detected in 78% of studied segments. The ROC
scores and the density of ROC 3/4 strain spots (mean per 10mm
ROI) were distributed similarly among epicardial coronary arteries
0
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Fig 4: Correlation be-
tween Percentage Val-
ues for Mean Percent
Plaque Obstruction,
defined as EEMarea -
Lumenarea) divided by
EEMarea, in the Region
of Interest and log
transformed Systemic
Values for Lp-PLA2 ac-
tivity. Mean Percent
Plaque Obstruction
was significantly
(P<0.05) correlated
with the Systemic Val-
ues for Lp-PLA2 activi-
ty
y=4.97-1.007 logx, P=0.008
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 (Table 3). However, the density of ROC 3/4 strain spots was
2.1±2.1 for patients (n=14) presenting with STEMI, 1.4±1.7 for
patients with unstable angina (n=21), and 1.2±1.1 for stable (n=33)
angina patients (p=0.003 for STEMI vs stable, p=0.02 for STEMI
vs unstable/stable). Representative imaging findings are presented
in Figure 1. 
MSCTA vs IVUS MSCT and IVUS were compared in 61 patients. The sensitivity
and specificity of MSCT to detect plaque identified on IVUS
(>50% mean cross-sectional area obstruction or the presence of cal-
cification on 2 consecutive slices on IVUS) was calculated per entire
ROI and for 3mm sub-segments (Table 4.). The sensitivity and spe-
cificity of MSCT for detection of plaque in the ROI were 85% and
71%, respectively. The positive and negative predictive values of
MSCT for detection of plaque were 75% and 72% for the entire
ROI, (75%) 71% and (72%) 71% for (5mm) 3mm slices. Repre-
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Fig. 5: Correlation be-
tween Percentage Val-
ues for Hypoechogenic
Plaque in the Region
of Interest and log
transformed Systemic
Values for C-Reactive
Protein and Inter-
leukin-6. The Percent-
age of Hypoechogenic
Plaque was significant-
ly (P<0.05) correlated
with the Systemic Val-
ues for C-Reactive Pro-
tein (Top Panel) and
Interleukin-6 (Bottom
Panel). 
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 CHAPTER 10 IBIS BASELINE RESULTSsentative findings are presented in Figure 2. The sensitivity of
MSCT to detect plaque was 64% (28/44) for small (<1mm), 77%
(73/95) for medium (1-2 mm), and 86% (25/29) for large plaques
(>2 mm). 
BiomarkersThe relation of soluble biomarkers to conventional and novel im-
aging parameters is presented in Table 5 and their relation to clini-
cal status at the time of intervention is presented in Figure 3. There
were significant relationships between systemic levels of hsCRP
(P=0.0003), IL-6 (P=0.0001), Lp-PLA2 (P=0.035), and of NT pro
BNP, (P=0.0012) and clinical presentation. Biomarker levels
showed no significant relationship to any conventional angiograph-
ic (mean MLD or mean percent diameter stenosis) parameter or to
mean plaque area on IVUS. However, mean percent area obstruc-
tion on IVUS was inversely related (P=0.008) to systemic levels of
Lp-PLA2 (Figure 4). There were also significant correlations (Fig-
ure 5) between plaque echogenicity and systemic levels of hsCRP
(p=0.003) and IL6 (p=0.016). 
DISCUSSION
This study is the first to combine novel invasive techniques, state-
of-the-art non-invasive MSCTA, and measurements of multiple bi-
omarkers to characterize sub-clinical coronary atherosclerosis. As
expected, the majority of non-culprit vessels in patients referred for
coronary intervention had large plaques on IVUS, despite only
mild angiographic disease. The majority of these plaques were iden-
tified on non-invasive imaging with use of MSCTA. Most impor-
tantly, features potentially indicative of high-risk plaque were both
widespread and highly prevalent in coronary vessels examined by
NIVUS-based imaging. Although only a short segment of the cor-
onary tree was imaged, several intriguing relationships between
clinical and biological parameters and putative indicators of struc-
tural instability or plaque composition were noted.
Conventional invasive imaging modalities cannot reliably identify
plaques with potential to cause future clinical events. However, sys-
temic levels of inflammatory biomarkers, notably CRP, can refine
risk stratification and CRP adds to coronary risk prediction based
on non-invasive detection of coronary calcification (Ridker 2002)139
 (Reilly 2003). Recommendations that measurement of CRP be in-
corporated into risk stratification algorithms, combined with wide-
spread availability of non-invasive coronary imaging, will likely
result in an increasing number of referrals to cardiologists for fur-
ther evaluation (Pearson 2003). In parallel, the advent of drug-elut-
ing stents has rekindled enthusiasm among interventional
cardiologists for the concept of prophylactic intervention on vul-
nerable plaque (Casscells 2003b)(Wang 2004)(Meier 1995)(Hoye
2004). In this context, the potential of novel imaging techniques to
guide such strategies has stimulated innovative research. 
Subclinical 
Atherosclerosis: 
Insights from 
Novel Invasive 
Techniques
Pathologic studies suggest that rupture of thin-capped fibroathero-
mas is a common substrate for clinical events (Virmani 2000). We
have validated in vitro the potential of palpography to identify thin-
capped fibroatheromas (de Korte 2002a+b). Subsequently, we
showed that the number of high-strain spots in epicardial vessels
was correlated with clinical presentation (Schaar 2004a). The
present study extends these findings by demonstrating that, within
arbitrarily selected segments of non-culprit vessels, structurally vul-
nerable plaques were quite common (mean of 4.0±4.1, range 0-16),
despite only mild angiographic disease. It confirms our previous ob-
servations that patients with STEMI have a significantly higher
number of structurally vulnerable plaques than other patients with
different presentations, in coronary regions remote from the site of
occlusive thrombosis. These findings are consistent with other ob-
servations that there are widespread abnormalities, in non-culprit
vessels or remote myocardium of patients with acute coronary syn-
dromes (Buffon 2002) (Abbate 2004). The high prevalence of
structurally vulnerable plaque found in this study, together with
post-mortem observations showing clinically silent plaque rupture
is relatively common, suggest that isolated rupture is unlikely to ac-
count for rather infrequent ischemic events (Davies 1984).
Several studies have indicated that echogenicity is related to the his-
tological components of both carotid and coronary plaques (El-
Barghouty 1996) (Gronholdt 1998) (Rasheed 1995) (Prati 2001),
and that carotid plaque echolucency (low echogenicity) was associ-
ated with neurological events, both spontaneous and related to per-
cutaneous carotid stent placement (Polak 1998) (Gronholdt 2001)
(Mathiesen 2001). Recent studies suggested a link between carotid140
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(Lombardo 2004). For carotid studies, a highly reproducible quan-
titative computer-assisted index of echogenicity, based on gray-
scale values of blood and of adventitia, has gained widespread ac-
ceptance (Sabetai 2000).
While carotid plaque echogenicity can be assessed non-invasively,
assessment of coronary plaque echogenicity requires invasive tech-
niques and has been restricted to research settings. A recent study
systematically studied, for the first time, coronary plaque echo-
genicity in a protocol with mandated IVUS follow-up and showed
that treatment with atorvastatin resulted in quantifiable changes in
coronary plaque echogenicity, compatible with changes in plaque
composition (Schartl 2001). These findings offered a potential ex-
planation for the clinical efficacy of statins despite only modest ef-
fects on plaque volume (Cannon 2004)(Nissen 2004). In the
present study, we used a quantitative computer-assisted index of
echogenicity, based on gray-scale values of adventitia (de Winter
2003). The predominant plaque component, in the arterial seg-
ment we evaluated, was hypoechogenic plaque. Although we found
significant correlations between plaque echogenicity and clinical
presentation, the preponderance of hypoechogenic plaque in the
vessel we studied suggests that plaque echogenicity lacks the dis-
crimination necessary for robust risk stratification. It might, how-
ever, prove useful as a surrogate indicator of changes in plaque
composition on serial studies (Schartl 2001).
Subclinical 
Atherosclerosis: 
Role of Non-Inva-
sive Imaging
MSCTA can identify significant coronary lesions with high sensi-
tivity and specificity (Nieman 2002). Recent studies have shown its
potential for detecting non-obstructive coronary plaques in highly
selected patients (Achenbach 2004)(Schoenhagen 2003). Our re-
sults extend these findings by showing that non-obstructive coro-
nary plaque can be detected, in an arbitrarily selected ROI, with
moderately high sensitivity and specificity in a less selected popula-
tion and that the size of such plaques can be assessed noninvasively.
As diffuse subclinical coronary atherosclerosis is common, our data
do not support the indiscriminate use of MSCTA as a tool for risk
stratification at the present time, notwithstanding its demonstrated
potential as a diagnostic tool in selected patients. 141
 Assessment of 
Subclinical 
Atherosclerosis: 
Potential of Bi-
omarkers
Population-based studies have demonstrated the predictive value of
circulating biomarkers in evaluating the risk of coronary heart dis-
ease. A few small studies suggested that plasma biomarkers might
reflect plaque composition (Weiss 2001)(Blake 2003). Levels of
soluble biomarkers are affected by many patient-specific (e.g., back-
ground therapy, obesity) and disease-specific factors (e.g., presence
of an acute coronary syndrome). Nevertheless, we found significant
correlations between inflammatory biomarkers (hsCRP, IL-6) and
the IVUS-derived hypoechogenicity index. The extent of hypoe-
chogenic plaque in our study was somewhat higher than previously
reported (Schartl 2001). Although we have no clear explanation for
these findings, it is plausible that increases in systemic levels of these
biomarkers, by altering endothelial permeability, might transiently
affect plaque echogenicity. Overall, these observations raise the pos-
sibility that imaging parameters, in conjunction with measure-
ments of biomarkers, may open new avenues of research that might
elucidate established mechanisms or shed light on novel mecha-
nisms involved in the complex relation between subclinical athero-
sclerosis and ischemic events. 
Limitations Our patient population was intentionally heterogeneous and the
study was not designed to correlate compositional imaging end-
points with clinical outcomes. Second, our attempt to relate sys-
temic biomarkers, measured at a single time point, to imaging in an
arbitrarily selected region of interest can only be regarded as hy-
pothesis generating. Third, while our results underscore the heter-
ogeneity of coronary atheroma, much larger studies are needed to
clarify the role of novel plaque imaging techniques in clinical prac-
tice. 
Implications of 
the Study
Despite considerable advances, patients with documented coronary
atherosclerosis have a significant risk of future ischemic events
(Cannon 2004). Our results demonstrate that abnormal findings
detected by novel invasive plaque imaging are both widespread and
rather frequent in coronary vessels with only mild angiographic dis-
ease. These observations argue against a preventive strategy to treat
vulnerable non-obstructive plaque with catheter-based intervention
such as drug-eluting stent implantation (Wang 2004). First, it is
likely that findings suggestive of plaque vulnerability are not limit-142
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tion; second, neither the clinical benefit nor the cost effectiveness of
such a strategy has been proven. The ability to prospectively iden-
tify structurally vulnerable plaques provides a means to clarify their
natural history. This perspective, coupled with studies of endothe-
lial function and inflammatory biomarkers may increase our under-
standing of the mechanisms of future clinical events. Furthermore,
imaging studies have potential to serve as surrogate endpoints and
to assist in dose selection of emerging pharmacologic interventions
with unprecedented mechanisms of action (Nissen 2003).
DEMOGRAPHICS AND PAST MEDICAL HISTORY
N %
Male 67 79.8
Mean age (range) 58.9 (28 - 77)
Previous MI 35 41.7
Previous CABG 1 1.2
Previous PCI 12 14.3
Diabetes mellitus 11 13.1
History of stroke 1 1.2
Family history of coronary disease 46 54.8
Hypertension* 39 46.4
Hypercholesterolemia** 71 84.5
Previous smoker 29 34.5
Current smoker 30 35.7
CLINICAL STATUS AT ENROLMENT
Stable angina 35 41.7
Silent ischemia 4 4.8
Unstable angina 27 32.1
ST-segment elevation MI 18 21.4
Table 1: Patient characteristics (n = 84)143
 EXTENT OF DISEASE*** 
Non significant 5 5.9
Single-vessel 51 60.7
Two-vessel 25 29.8
Three-vessel 1 1.2
Left Main (plus two-vessel) 2 2.4
*Blood pressure > 160/95 mmHg or treatment for hypertension, ** total cholesterol >
5.5 mmol/l (215 mg/dl) or treatment for hypercholesterolemia, ***Significant disease
was defined as angiographically significant (>50% visual estimation) stenosis in a
major epicardial vessel or in branches > 2.5 mm diameter. MI myocardial infarction;
CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention. 
Table 1: Patient characteristics (n = 84)
VESSEL TOTAL (84)
LAD 
(37)
LCX 
(15)
RCA 
(32) P VALUE
Length (mm) 28.63 ± 14.30 24.20 ± 12.63 25.67 ± 12.31 35.13 ± 14.91 0.004
Mean Diameter (mm) 2.78 ± 0.68 2.55 ± 0.61 2.95 ± 0.62 2.96 ± 0.71 0.02
Minimal Diameter (mm) 2.32 ± 0.64 2.15 ± 0.55 2.43 ± 0.70 2.47 ± 0.67 0.09
DS (%) 25 ± 10 25 ± 11 25 ± 12 24 ± 10 0.95
DS <20% 27 (32%) 12 (32%) 6 (43%) 9 (28%)
DS 20 – 50% 56 (67%) 25 (68%) 8 (53%) 23 (72%) 0.23
DS >50% 1 (1%) 0 1 (7%) 0
Table 2a: Quantitative Angiographic Parameters in the Region of Interest
VESSEL TOTAL (81)
LAD 
(37)
LCX 
(13)
RCA 
(31) P VALUE
R.O.I. length (mm) 32.8 ± 15.9 27.9±14.4 31.1±13.6 39.4±16.6 0.009
Table 2b: Intravascular Ultrasound Parameters in the Region of Interest144
 CHAPTER 10 IBIS BASELINE RESULTSEEM area (mm2) 16.9 ± 4.6 15.6±4.4 17.0±5.1 18.4±4.4 0.04
Lumen area (mm2) 9.9 ± 3.7 8.5±2.6 10.3±3.5 11.6±4.3 0.002
(EEM-Lumen) area (mm2) 6.9 ± 2.7 7.1±2.8 6.6±3.0 6.8±2.4 0.86
‘Plaque’ present* 61 (75%) 32 (86%) 8 (62%) 21 (68%) 0.09
Plaques/ROI 1.4±1.1 1.5±1.0 1.2±1.2 1.4±1.3 0.82
Plaques/ROI (range) 0-5 0-5 0-3 0-5
*'Plaque' is defined as an (EEMarea - Lumenarea)/ EEMarea, expressed as a percentage, > 50%
LAD: left anterior descending, LCX: left circumflex, RCA: right coronary artery
Table 2b: Intravascular Ultrasound Parameters in the Region of Interest
NUMBER OF PLAQUES TOTAL (113)
LAD 
(54)
LCX 
(16)
RCA 
(43)
P 
VALUE
EEM area (mm2) 15.9 ± 4.5 15.3±4.2 17.1±6.6 16.2±4.0 0.32
Lumen area (mm2) 7.0 ± 2.2 6.6±2.1 7.5±3.1 7.3±2.0 0.16
(EEM-Lumen) area (mm2) 8.9 ± 2.6 8.7±2.5 9.5±3.6 8.9±2.2 0.52 
(EEMarea-Lumenarea)/
EEMarea (%)
56.2 ± 4.5 56.9±5.2 56.1±2.8 55.2±3.9 0.18
Mean Length ‘plaque’* (mm) 6.9± 6.2 6.3 ±6.1 7.0±5.1 7.7±6.7 0.53
*'Plaque' is defined as an (EEMarea - Lumenarea)/ EEMarea, expressed as a percentage, > 50%
LAD: left anterior descending, LCX: left circumflex, RCA: right coronary artery
Table 2c: Intravascular Ultrasound Parameters: Plaque-based analysis
ARTERY TOTAL LAD LCX RCA P VALUE
n = 80 n = 36 n = 13 n = 31
Table 3a: Results of Echogenicity For the Entire Region of Interest145
 % Hypo-echogenic Vol-
ume
91.1 ± 4.4 89.9 ± 4.4 90.3 ± 5.2 92.8 ± 3.5 0.001
Calcium present 47 (58%) 22 (61%) 7 (54%) 18 (58%) 0.90
Table 3a: Results of Echogenicity For the Entire Region of Interest
TOTAL LAD LCX RCA P VALUE
N = 60 n = 31 n = 8 n = 21
% Hypoechogenic Vol-
ume
89.5 ± 5.6 89.1± 5.4 87.6 ± 7.3 90.7 ± 5.1 0.12
Calcium present 41 (68%) 20 (65%) 5 (63%) 16 (76%) 0.56
Table 3b: Results of Echogenicity For Intravascular Ultrasound Slices With Significant
Plaque
ARTERY TOTAL LAD LCX RCA P VALUE
n = 68 n = 30 n = 11 n = 27
Any ROC III/IV
spot
53 (78%) 23 (77%) 8 (73%) 22 (81%) 0.45
Number (range) 4.0 ± 4.1 (0-16) 3.6 ± 3.9 (0-16) 3.1 ± 3.2 (0-9) 4.9 ± 4.6 (0-15) 0.33
Number/10mm ROI 1.4 ± 1.5 1.5 ± 1.6 1.5 ± 1.7 1.4 ± 1.4 0.92
ROC: Rotterdam Classification, ROI: Region of Interest
Table 3c: Results for Palpography For the Entire Region of Interest146
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NO YES
MSCT No Plaque 211 86
Plaque 77 189
* Mean Percent Plaque Area > 50% or Calcium Present
Sensitivity: 69%; Specificity: 73%
Table 4a: Performance of Multi Slice Computed Tomography in 3 mm Subsegments of
the Region of Interest versus IVUS for the Detection of Plaque. 
SIGNIFICANT PLAQUE ON IVUS*
NO YES
MSCT No Plaque 119 46
Plaque 42 126
* Mean Percent Plaque Area > 50% or Calcium Present
Sensitivity: 73%; Specificity: 74%
Table 4b: Performance of Multi Slice Computed Tomography in 5 mm Subsegments of
the Region of Interest versus IVUS for the Detection of Plaque. 
QCA IVUS ECHO
GENICITY
PALPO
GRAPHY
Table 5: Overview of the relation of log transformed values of systemic biomarkers to
conventional and novel imaging parameters147
 MEAN PER CENT 
DIAMETER 
STENOSIS
MEAN PER 
CENT AREA 
OBSTRUCTION
PERCENT 
HYPO- 
ECHOGENIC 
PLAQUE
NUMBER OF ROC 
III/IV SPOTS PER 10 
MM ROI
Hs-CRP -0.18 -0.17 0.33** -0.06
IL-6 0.04 0.01 0.27*** 0.10
Lp-PLA2 0.01 -0.30* 0.16 0.21
NT ProBNP 0.03 -0.15 0.18 -0.07
TNF-α. -0.04 0.03 -0.06 0.00
*P=0.008, **P=0.003, ***P=0.016
Table 5: Overview of the relation of log transformed values of systemic biomarkers to
conventional and novel imaging parameters148
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 CHAPTER 11 IBIS FOLLOW UP RESULTSAtherosclerosis is a systemic disease whose clinical sequelae are un-
predictable and only weakly correlated with its extent or severity.
Furthermore, sudden death or acute coronary syndromes are fre-
quently the first manifestation of previously subclinical atheroscle-
rosis and the majority of such events occur as a result of plaque
rupture at sites with noncritical luminal narrowing (Ambrose
1988). Pathologic studies have correlated specific coronary plaque
characteristics with fatal ischemic events, but conventional imaging
techniques such as quantitative angiography and quantitative intra-
vascular ultrasound (IVUS) cannot reliably identify high-risk, rup-
ture-prone, plaques prospectively (Virmani 2000). Thus, the
development of novel invasive coronary imaging modalities, to de-
tect structural and compositional plaque characteristics that might
predict future plaque behavior, has attracted attention from the
medical community (Cassells 2003) (Madjid 2004). In parallel
with the advances in novel invasive imaging, non-invasive multi-
slice computed tomographic angiography (MSCTA) has matured
to the extent that it can reliably identify flow-limiting coronary le-
sions in relatively unselected patients. 
Based on conflicting interpretations of current knowledge, there are
two opposing schools of thought with respect to the potential of
targeted local intervention to improve prognosis in the vulnerable
plaque/patient (Wang 2004) (Buffon 2002). Novel imaging could
provide information both on the incidence of vulnerable plaque
(Schaar 2004) characteristics and on their evolution over time that
would help clarify this debate.
The aim of this study was fourfold. First, to determine the potential
of MSCTA in the detection of subclinical, non-flow limiting coro-
nary atherosclerosis; second to assess, with two novel IVUS-based
imaging modalities (palpography and IVUS echogenicity tissue
characterization) the prevalence of high risk features in such plaque151
 at baseline; third, to assess the potential of both techniques to detect
temporal changes in high risk characteristics. Finally, we attempted
to relate changes in imaging parameters to changes in systemic bi-
omarker levels.
METHODS
Study Design and 
Patient Selection
This was a prospective, observational, and single center, pilot study
involving patients with stable angina, unstable angina, or ST seg-
ment elevation myocardial infarction (STEMI) who were referred
for PCI of one or more lesions in the native coronary circulation.
The study design has been described in detail elsewhere (Van
Mieghem 2005). The Medical Ethics Committee of the Erasmus-
MC Rotterdam approved the study protocol and all patients pro-
vided written informed consent. The study vessel, preferentially a
coronary vessel not targeted for PCI, was, in order of preference, the
left anterior descending, right, and circumflex coronary artery. At
the discretion of the operator, a second artery could be studied. The
region of interest was defined on the MSCTA, using landmarks,
such as branches or the vessel origin. At six months the patient un-
derwent the same invasive imaging procedures (angiography, intra-
vascular ultrasound, palpography and echogenicity) as at baseline.
Patients who had angiography less than three months after inclu-
sion were asked to undergo invasive imaging again at six months.
Quantitative 
Coronary Angiog-
raphy and Intra-
vascular 
Ultrasonography
Coronary angiograms were obtained in multiple views after the in-
tracoronary injection of nitrates. Quantitative analyses were per-
formed by a core laboratory (Cardialysis, Rotterdam, The
Netherlands) with the use of edge-detection techniques (Cass II.).
Mean and minimum luminal diameters and diameter stenosis were
measured in at least two, preferentially orthogonal, projections, and
averaged.
IVUS was performed with commercially available catheters (30
MHz, UltracrossTM,or 40 MHz, AtlantisTM SR Pro, Boston Scien-
tific, Santa Clara, CA) using standard procedures (Van Mieghem
2005) with an automated pullback device (0.5 mm/s). Data were
stored on videotape, transformed into the Digital Imaging and
Communication in Medicine (DICOM) image standard, and ar-
chived.152
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validated software (Curad, version 3.1, Wijk bij Duurstede, The
Netherlands) and retrospective image-based gating (de Winter
2004). The borders of the external elastic membrane and of the lu-
men were traced. The area they enclosed was defined as the coro-
nary plaque plus media area (subsequently referred to as plaque
area). Significant plaque was defined as a plaque that occupied 50%
or more of the cross-sectional vessel area circumscribed by the ex-
ternal elastic membrane (EEM area obstruction). Other IVUS anal-
yses included lumen area, vessel area and plaque volume over the
entire region of interest. The inter observer variability was deter-
mined for a subset of patients in this study. Inter observer variabil-
ity for IVUS was assessed by re-analyzing the baseline and follow-
up IVUS recordings of 16 patients by a different core lab analyst.
The 16 patients (32 recordings) were randomly selected among re-
cordings that fulfilled the following 2 criteria: (1) region of interest
>30 mm long, and (2) both pullbacks were performed with the
same type of IVUS catheter (30 MHz catheter, as all follow-up ex-
aminations were performed with 30 MHz).
Novel IVUS-
based Plaque Im-
aging: Echogenic-
ity 
We used a computer-aided, gray-scale value analysis program for
plaque characterization (de Winter 2003). Based on the mean gray
level (brightness) of the adventitia, plaque was classified as brighter
(hyperechogenic) or less bright (hypoechogenic) than the adventi-
tia. Calcified plaque was defined as plaque brighter than the adven-
titia with associated acoustic shadowing. The variables measured in
the previously defined region of interest included hypoechogenic
plaque volume and hyperechogenic plaque volume (mm3), and rel-
ative plaque echogenicity, calculated as (hypoechogenic plaque vol-
ume/ sum of hypoechogenic and hyperechogenic plaque volume) x
100.
Novel IVUS-
based Plaque Im-
aging: Palpogra-
phy
Palpography data were acquired during an intravascular ultrasonog-
raphy pullback (1 mm/s) with a commercially available catheter
(20MHz Jovus Avanar, Volcano, Rancho Cordova, CA). Using
previously described and validated methodology, plaque strain val-
ues were assigned a ROtterdam Classification (ROC) score ranging
from 1 to 4 (ROC I: 0-0.6%; ROC II: 0.6-<0.9%; ROC III:0.9-
<1.2%; ROC IV: >1.2%).9-12 The vulnerability of a vessel was de-
scribed by the Schaar-Mastik-van der Steen- (SMS)-Index. It was
calculated as the total number of ROC III and IV scores that were153
 counted in all cross sections that were acquired at 1 mm intervals in
the full ROI. This number was divided by the length of the ROI
and multiplied by 10 to normalize to the pullback length. This
SMS-Index describes the longitudinal extent of highly deformable
plaques and is taken as a measure for vulnerability e.g. in a specific
coronary artery.
Multislice Spiral 
Computed Tom-
ography
All scans were performed on a 16-row detector scanner (Sensation
16, Straton, Siemens, Forchheim, Germany). The scan protocol
and image reconstruction parameters were recently published
(Mollet 2004). Technical advances allowed us to adapt tube output
to patient weight. The dataset with least motion artifacts was loaded
on an off-line workstation (Leonardo, Siemens, Forchheim, Ger-
many) and the region of interest identified on multiplanar recon-
structions, based on anatomic landmarks. Data sets were loaded on
a semi-automated vessel-tracking software program and a central
lumen line created throughout the region of interest. Ten through
30 cross-sections were reconstructed orthogonal to the center of the
lumen and analyzed independently by two observers. Disagree-
ments were resolved by consensus. Plaque was defined as an abnor-
mal mass within the artery wall, clearly distinguishable from
epicardial fat and the coronary lumen. Based on manually measured
maximal thickness, plaques were classified as small (<1 mm), medi-
um (1-2 mm), or large (>2 mm). Calcification was defined by the
presence of high-density components (>130 Hounsfield Unit).
Lipoprotein levels 
and Biomarkers
Plasma concentrations of total cholesterol and high-density lipo-
protein cholesterol (HDL-C), and triglycerides were measured in
the local laboratory. The Friedewald formula was used to derive
low-density lipoprotein cholesterol (LDL-C) levels. Blood samples
for additional biomarker analysis were stored at –70°C. Serum C-
reactive protein (Diagnostic Systems Laboratories), plasma inter-
leukin 6 and tumor necrosis factor-α (R&D Systems), were meas-
ured in the Human Biomarker Center (GlaxoSmithKline, PA,
USA) based on protocols provided by the manufacturer. Lipopro-
tein associated phospholipase A2 (Lp-PLA2) activity assay was
measured by the proportional release of aqueous 3H acetate result-
ing from the enzymatic cleavage of the 3H acetyl-platelet activating
factor substrate (100 µM). N-terminal pro brain natriuretic peptide
was measured with use of a two site electro-chemiluminescent as-
say. The limits of quantification were 0.0048 mg/L for C-reactive154
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Lp-PLA2 activity, 10 pg/ml for N-terminal pro brain natriuretic
peptide, and 0.88 pg/mL for tumor necrosis factor-α.
Definition of 
Events and Fol-
low-Up for Major 
Adverse Cardiac 
Events
The occurrence of Major Adverse Cardiovascular Events (MACE)
was assessed after the procedure, at discharge, and at 3 and 6
months, as were the individual components: death, MI, revascular-
ization by PCI or CABG, hospitalization for ischaemia and/or an-
ginal symptoms, and stroke. The diagnosis of myocardial infarction
was consistent with the ACC/ESC definition (Alpert 2000). Major
bleeding and vascular complications were also prospectively record-
ed using standard definitions.
QCA IVUS ECHOGENICITY PALPOGRAPHY
Baseline 67 (74) 63 (69) 63 (67) 53 (58)
Follow up 67 (74) 62 (64) 55 (60) 57 (60)
Matched results 67 (74) 58 (63) 55 (60) 49 (52)
Values in de Table are number of patients (number of vessels)
84 patients with baseline 
invasive imaging
67 patients with invasive follow-up
16 refusals
1  death
90 patients enrolled
6 no imaging performed
QCA IVUS Echogenicity              Palpography
Fig 1: Flow Chart
detailing the imag-
ing procedures at the
different time
points. 155
 Statistical Analy-
sis
Discrete variables are presented as counts and percentages. Contin-
uous variables are presented as means ± SD, unless otherwise indi-
cated. Comparisons between quantitative outcomes were
performed with use of scatterplots and linear regression analysis (re-
gression coefficient). Where appropriate, biomarker analyses were
performed after natural logarithmic transformation. Correlations
between imaging end points and circulating biomarkers were as-
sessed, and univariate Pearson correlation coefficients were calculat-
ed. Comparisons among patient subgroups, grouped by clinical
presentation, with findings on palpography and on echogenicity,
were performed at both vessel and patient level. In the latter case,
the imaging findings from two regions of interest in the same pa-
tient were averaged. Differences in means among groups were ana-
lyzed by a two-sample t-test or by one-way analysis of variance. A P
value of less than 0.05 (two-sided) was considered to indicate statis-
tical significance. No formal hypotheses were tested in this explor-
atory study, therefore p-values are given as such, without any
correction for multiplicity of testing. Statistical analyses were per-
formed with use of SAS Version 8
RESULTS
Patient popula-
tion
A flow diagram detailing the number of patients undergoing mul-
timodality coronary imaging is presented in Figure 1. Sixty-seven
patients underwent serial invasive imaging of non-culprit segments
of coronary artery at baseline and 196+19 days later. Not all pa-
tients (n = 67) had all imaging modalities available for comparison.
Nine patients had one or both IVUS recordings that were not fur-
ther analyzable due to artifact or use of an incorrect scale. An addi-
tional 3 patients could not be analyzed for IVUS echogenicity due
to extensive calcification overshadowing a large part of the adventi-
tia which is used as a reference for the interpretation of gray-scale
values of surrounding tissue. Reasons for inaccurate palpogram
readings (n=18) were related to extensive catheter motion during
data acquisition.
Baseline characteristics of patients who completed the study are
shown in Table 1. They were comparable to those of the entire co-
hort of 84 patients enrolled at baseline (not shown). Medical ther-
apy during 6 months of follow-up included antiplatelet therapy
(aspirin 91%, clopidogrel 94%), statins (99%), ACE-inhibitors or156
 CHAPTER 11 IBIS FOLLOW UP RESULTSangiotensin-2 receptor antagonists (51%) and beta-blockers (24%).
Mean total cholesterol, LDL cholesterol, HDL cholesterol and trig-
lyceride values for patients who completed the study are presented
in Table 2. There were no significant differences in total and LDL
cholesterol parameters in the overall patient population; however,
patients who presented with STEMI had a significant decrease in
mean LDL cholesterol.
Non-invasive An-
giography versus 
Intravascular Ul-
trasonography at 
Baseline
Non-invasive angiography and intravascular ultrasonography were
compared, at baseline, in 61 patients (67 vessels). The sensitivity
and specificity of non-invasive angiography to detect significant
plaque identified on intravascular ultrasonography (> 50% EEM
area obstruction or the presence of calcification on two consecutive
slices) was calculated for the entire ROI and for 5mm sub-segments
(Table 3). The sensitivity, specificity, positive and negative predic-
tive values of non-invasive angiography for detection of any signif-
icant plaque was 86, 69, 90, and 61% respectively. These values
were similar for the sub-segmental analysis. The sensitivity of non-
invasive angiography to detect plaque was 60% (30/50) for small
(<1mm), 76% (80/105) for medium (1 to 2 mm), and 79% (26/
33) for large (>2 mm) plaques. 
Reproducibility of 
IVUS Measure-
ments
Inter observer variability results for IVUS (n= 31 pullbacks) showed
no systematic error, and good reproducibility. Mean differences in
area (mm2) measurements were: –0.04±0.56 for EEM, 0.02±0.50
for lumen, and –0.06±0.59 for plaque. Mean difference in plaque
volume (mm3) was –2.43±22.
Conventional Im-
aging: Quantita-
tive Coronary 
Angiography and 
IVUS Imaging
There were no statistically significant changes, from baseline to fol-
low-up, in the angiographic variables measured in the region of in-
terest (Table 3). Likewise, IVUS-derived measurements (Table 4)
remained unchanged in matched segments, except for a small de-
crease in vessel area (p=0.04). When patients were grouped accord-
ing to initial diagnosis (i.e., STEMI, unstable angina, stable
angina), there were no significant changes in either angiographic or
IVUS measurements between baseline and follow-up (data not
shown). 
Novel IVUS-
based Imaging
Temporal changes in plaque characteristics based on IVUS-based
palpography and echogenicity are shown in Tables 4 and 5. At base-
line, the predominant plaque component was hypoechogenic tissue157
 (91.6% of plaque volume). There was no significant change be-
tween baseline and follow-up in the absolute volume of hypoecho-
genic or hyperechogenic plaque. On palpography recordings, the
SMS-index decreased significantly between baseline and follow-up.
This decrease, in the overall population, was largely driven by
changes in the subgroup of patients with STEMI; this group had
both the highest SMS-index at baseline and the most marked rela-
tive decrease during follow-up, compared to patients with other
clinical presentations. At the 6 month follow-up, the SMS-index
was comparable among clinical subgroups.
Biomarkers and 
Imaging Tech-
niques
Table 6 shows values for the biomarkers measured at baseline and
after 6 months. Not surprisingly, several inflammatory mediators
(CRP, IL-6, Lp-PLA2) and a marker of hemodynamic stress (NT-
proBNP) decreased over time, particularly in patients presenting
with acute coronary syndromes. With palpography there were no
significant correlations noted between circulating biomarkers and
imaging parameters. Among lipid parameters (total cholesterol,
LDL-C, HDL-C, and triglycerides), a correlation with the change
in IVUS-derived plaque area was only noted for the change in
HDL-C (Pearson correlation coefficient 0.37, P<0.05, data not
shown).
Adverse Events There were no deaths during the study and no complications attrib-
utable to invasive imaging of the non-culprit study vessel. 
DISCUSSION
The major findings of the study were fourfold. First, using IVUS as
a gold standard, noninvasive MCST angiography can identify
atherosclerotic plaque, in vessels with only minimal angiographic
disease, with high sensitivity and moderate specificity. Second, fur-
ther investigation of such plaque with novel IVUS-based imaging
techniques (palpography and echogenicity) showed that features
potentially indicative of vulnerable plaques are both widespread
and highly prevalent. Third, while conventional imaging using
quantitative coronary angiography and IVUS demonstrates no sig-
nificant changes in either lumen or plaque dimensions, the biome-
chanical properties of the plaques, assessed by palpography, showed
significant changes over a relatively short (six-month) follow-up pe-158
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correlations with baseline values or temporal changes in novel im-
aging parameters. 
Despite considerable therapeutic advances, patients with docu-
mented coronary atherosclerosis have a significant risk of future
ischemic events. Neither IVUS nor angiographic variables have
proved useful to predict the site of such future clinical events. Fur-
thermore, many adverse cardiac events, such as death or acute MI,
occur as the first presentation of coronary disease due to vessel oc-
clusion at sites with noncritical atherosclerotic narrowing. In this
context, the potential of novel imaging techniques to identify high-
risk plaque and potentially guide management strategies has stimu-
lated innovative research.
Subclinical 
Atherosclerosis: 
Role of Noninva-
sive Imaging
The development of noninvasive angiography, with MSCT, has
reached a stage where it can be used, in selected patients, to reliably
identify significant epicardial coronary atherosclerosis (Nieman
2002). Recent studies have shown its potential for detecting non-
obstructive coronary plaques in highly selected patients (Achenbach
2004) (Schoenhagen 2003). Our results extend these findings by
showing that non-obstructive coronary plaque can be detected, in
an arbitrarily selected region of interest, with moderately high sen-
sitivity and specificity in a broader patient population and show
that the size of such plaques can be assessed noninvasively. Howev-
er, when examined in more detail, with novel invasive techniques,
we found that vulnerable features were very common. This obser-
vation provides additional arguments to support recommendations
discouraging the indiscriminate use of non-invasive coronary imag-
ing to detect subclinical atherosclerosis at the present time
(O'Rourke 2000).
Subclinical 
Atherosclerosis: 
Insights from 
Novel Invasive 
Techniques
Pathologic studies suggest that rupture of thin-capped fibroathero-
mas is a common substrate for clinical events (Virmani 2000). We
have previously validated the potential of palpography to identify
thin-capped fibroatheromas in vitro (de Korte 2002a+b) (Schaar
2003). Subsequently, we showed that the number of high-strain
spots in culprit epicardial vessels was correlated with clinical pres-
entation (Schaar 2004a).The present study extends these findings
by demonstrating that, within arbitrarily selected segments of non-
culprit vessels, structurally vulnerable plaques were quite common,159
 despite only mild angiographic disease. The most marked changes
occurred in patients with an acute MI, most of whom were statin-
naive at the time of the initial presentation (86%). Although acute
MI patients had an extend of high strain spots at baseline, 6 months
later all subgroups were comparable regardless of the initial presen-
tation. The implication of our finding that abnormal strain patterns
persist over time is unclear. Clarification of this question will re-
quire larger studies with longer follow-up. It might be speculated
that it reflects the inadequacy of standard medical care. This hy-
pothesis would be consistent with recent data that indicate the need
for intensive intervention for LDL cholesterol (<70 mg/dL) and in-
flammation (CRP <2mg/L) to achieve the best clinical outcomes in
the course of therapy with statins in post ACS patients (Nissen
2005) (Ridker 2002). 
Prior studies suggested that echogenicity is related to the histologi-
cal components of carotid and coronary plaques, and that carotid
plaque echolucency (low echogenicity) is associated with neurolog-
ical events, both spontaneous and related to percutaneous carotid
stent placement (El-Barghouty 1996) (Gronholdt 1998)(Rasheed
1995)(Polak 1998)(Gronholt 2001)(Mathiesen 2001). For carotid
studies, a highly reproducible quantitative computer-assisted index
of echogenicity, based on gray-scale values of blood and adventitia,
has gained widespread acceptance (Seabatai 2000). While carotid
plaque echogenicity can be assessed non-invasively, assessment of
coronary plaque echogenicity requires invasive techniques and has
been restricted to research settings. A recent study systematically
studied, for the first time, coronary plaque echogenicity in a proto-
col with mandated intravascular ultrasonography follow-up and
showed that treatment with atorvastatin resulted in quantifiable
changes in coronary plaque echogenicity, compatible with changes
in plaque composition (Schartl 2001). In the present study, we used
a quantitative computer-assisted index of echogenicity, based on
gray-scale values of adventitia and demonstrated that hypoechogen-
ic tissue was the predominant plaque component (de Winter
2003). We found no significant change in absolute hypoechogenic
or hyperechogenic plaque volume over the average 6-month period.
At first sight, our findings contradict the observations of Schartl et
al., who found a small but significant increase in the hyperechogen-
ic plaque component (Schartl 2001). However, their study had a
longer follow-up period and patients had intensive, carefully-mon-160
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convincingly demonstrated changes in plaque echogenicity over a
much longer (4 year) follow-up period (Aoki 2005). In any case, the
high preponderance of hypoechogenic plaque (>90% of the plaque
volume) coupled with the lack of significant change during follow-
up suggests that plaque echogenicity lacks the discrimination nec-
essary either for robust risk stratification or for use as a surrogate in-
dicator of changes in plaque composition on serial studies. 
LimitationsOur patient population was intentionally heterogeneous and the
study was underpowered to correlate compositional imaging end
points with clinical outcomes. Follow-up was incomplete (67/84,
80%), but compares favourably with recent serial IVUS stud-
ies.31,32 Moreover, baseline characteristics of the 67 patients with
completed follow-up were the same as in the overall study popula-
tion. The present study did not demonstrate changes in plaque size.
Recently published studies carried out in patients with acute coro-
nary syndrome or in patients with more aggressive lipid-lowering
therapy demonstrated clear regression of coronary atherosclerosis
(Okazaki 2004)(Nissen 2003)(Jensen 2004). Another potential
limitation was the rather modest intensity of therapy with statins,
reflecting clinical practice settings. Data from recent trials, such as
REVERSAL and PROVE-IT, indicate that intensive treatment
with statins affects plaque size and event rates, respectively (Nissen
2004)(Cannon 2004). Whether more intensive statin therapy ap-
plied to the IBIS cohort would further reduce the observed compo-
sitional changes remains to be determined.
ConclusionsThis study confirms the potential of current MSCT technology to
noninvasively detect large coronary plaques within coronary seg-
ments without significant lumen impairment. In contrast to con-
ventional imaging modalities that frequently reveal static luminal
and plaque dimensions, novel IVUS-based plaque palpography can
detect significant alterations in coronary plaque characteristics over
a relatively short time interval. This study highlights the dynamic
changes in the strain of coronary plaques that are remote from the
culprit lesions in patients with myocardial infarction. Whether the
persistence of a high-strain pattern is a harbinger of cardiovascular
events remains to be determined in future much larger studies. The
novel imaging modalities utilized in this study provide insights into
plaque biology, whereas temporal changes detected using these mo-161
 dalities may eventually serve as intermediate end points in interven-
tional trials.162
 CHAPTER 11 IBIS FOLLOW UP RESULTSDEMOGRAPHICS AND CLINICAL HISTORY PATIENTS (N=67)
Male sex - no. (%) 57 (85%)
Age - yr. (SD) 58 + 11 
Previous myocardial infarction - no. (%) 27 (40%) 
Previous coronary bypass surgery - no. (%) 1 (1%)
Previous percutaneous coronary intervention - no. (%) 11 (16%)
History of diabetes - no. (%) 6 (9%)
History of stroke - no. (%) 1 (1%)
Family history of coronary disease - no. (%) 36 (54%)
Hypertension* - no. (%) 29 (43%)
Hypercholesterolemia† - no. (%) 57 (85%)
Previous smoker - no. (%) 23 (34%)
Current smoker - no. (%) 26 (39%)
Statin therapy at baseline – no. (%) 50 (75%)
CLINICAL STATUS AT ENROLMENT 
Stable angina - no. (%) 32 (48%)
Unstable angina - no. (%) 21 (31%)
ST-segment elevation myocardial infarction - no. (%) 14 (21%)
EXTENT OF DISEASE‡ 
Non significant disease– no. (%) 4 (6%)
Single-vessel disease – no. (%) 36 (53.7%)
Two-vessel disease – no. (%) 21 (31.3%)
Three-vessel disease – no. (%) 3 (4.5%)
Left main stem (plus two-vessel) disease – no. (%) 3 (4.5%)
*Blood pressure > 160/95 mmHg or treatment for hypertension, † total cholesterol >215 mg/dl or treatment for
hypercholesterolemia, ‡ Significant disease was defined as >50% (visual estimate) stenosis in a major epicardial
vessel or in branches > 2.5 mm diameter
Table 1: Baseline Characteristics of Patients With Invasive Follow Up Evaluation163
 TOTAL 
CHOLESTEROL LDL HDL
TRIGLYCERID
ES
Entire cohort (n=64)                    (n)                     (n)                     (n)                   (n)
      Baseline 4.58±1.24 (64) 2.93±1.16 (64) 1.03±0.36 (64) 1.62±0.95 (64)
      Follow-up 4.43±0.82 (50) 2.71±0.77 (49) 1.14±0.37 (49) 1.87±0.93 (49)
      Change -0.15±1.32 (50) -0.27±1.15 (49) 0.11±0.23 (49) 0.24±0.90 (49)
      P value NS NS 0.001 0.008
STEMI 
      Baseline 5.44±0.97 (13) 3.76±0.85 (13) 1.13±0.31 (13) 1.62±0.78 (13)
      Follow-up 4.32±0.90 (12) 2.66±0.80 (11) 1.03±0.27 (11) 1.84±0.76 (11)
      Change -1.06±1.02 (12) -0.93±1.06 (11) -0.09±0.16 (11) 0.31±0.66 (11)
      P value 0.003 0.006 NS NS
Unstable angina 
      Baseline (n=21) 4.33±1.17 2.79±0.94 0.95±0.30 1.63±0.91
      Follow-up (n=15) 4.40±0.69 2.60±0.65 1.22±0.41 1.73±0.98
      Change (n=15) 0.19±1.40 -0.12±1.03 0.25±0.17 0.07±0.91
      P value NS NS <0.001 NS
Stable angina 
      Baseline (n=30) 4.38±1.27 2.66±1.27 1.04±0.41 1.61±1.06
      Follow-up (n=23) 4.51±0.89 2.80±0.84 1.14±0.40 1.99±0.99
      Change (n=23) 0.09±1.24 -0.06±1.20 0.12±0.24 0.32±1.01
      P value NS NS 0.026 0.014
Table 2: Changes in lipid parameters 164
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INTRAVASCULAR 
ULTRASONOGRAPH
NO YES
MSCT 
PLAQUE
YES 11 (140) 7 (49)
NO 5 (52) 44 (136)
The values in parentheses are those for 5mm subsegments. 
Sensitivity: 86% (74%); specificity: 69% (73%), positive pre-
dictive value 90% (72%), negative predictive value 61% (74%).
* Significant plaque was defined as mean plaque area obstruc-
tion (Vessel area - Lumen area/ Vessel area) x 100 > 50% or the
presence of calcium on intravascular ultrasound
Table 3a: Multislice computed tomography for the detection of
significant coronary plaque: Comparison with intravascular ultra-
sonography for the entire region of interest and for its 5 mm
subsegments
LENGTH 
(MM)
MEAN 
DIAMETER 
(MM)
MINIMAL 
DIAMETER 
(MM)
DIAMETER 
STENOSIS 
(%)
      Baseline 27.2±13.1 2.78±0.64 2.31±0.64 25±11
      Follow-up 27.2±13.1 2.84±0.76 2.38±0.71 25±11
      Change 0.0±2.5 0.06±0.36 0.06±0.36 0.0±8
      P value NS NS NS NS
Table 3b: Quantitative Angiographic Parameters (n=67)165
 Variable Length VesselArea *
Lumen 
Area 
Plaque 
Area †
Hypo 
Volume
Hyper 
Volume
Plaque 
Volume
Units mm mm2 mm2 mm2 mm3 mm3 mm3
      Baseline 29.3±14.4 16.9±4.8 10.0±3.75 6.9±2.7 171±104 15±11 195±117
      Follow-up 29.2±14.2 16.5±4.6 9.7±3.52 6.8 ±2.6 177±98 12±14 190±107
      Change -0.1±1.62 -0.4±1.7 -0.3±1.57 -0.1±1.1 6±53 -3±13 -5.2±33
      P value NS 0.04 NS NS NS NS NS
* Vessel area denotes the area circumscribed by the external elastic membrane; † Plaque area denotes Vesselarea-
Lumen area including echolucent media.
Table 4. Quantitative Intravascular Ultrasonography (n=58) and Echogenicity (n=55)
Parameters 
BASELINE FOLLOW UP P-VALUE
STEMI (n=12) 2.30 ± 1.80 1.15 ± 1.37 0.0003
Unstable (n=16) 1.78 ± 1.78 1.41 ± 1.69 0.29
Stable (n=24) 1.21 ± 1.06 1.17 ± 1.14 0.56
p-value 0.02 0.91
Table 5: Plaque Characterization Palpography for the Entire Population Classified by
Clinical Presentation (n=52) using the SMS index given as mean ± SD166
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COHORT
(N=65)
CRP IL-6 LP-PLA2 TNF-A PROBNP
      Baseline 13.22 (20.63) 10.34 (30.22) 116.26 (28.74) 2.16 (0.72) 394 (728)
      Follow-up 5.81 (7.41) 5.55 (16.41) 83.82 (26.78) 3.49 (4.72) 158 (183)
      Change -7.58 (20.08) -4.92 (18.26) -32.51 (28.37) 1.29 (4.85) -236 (719)
      P value 0.0014 0.0001 <0.0001 0.16 0.0022
STEMI
(n=14)
      Baseline 12.59 (9.37) 12.70 (22.73) 132.57 (21.24) 2.25 (0.85) 842 (1360)
      Follow-up 5 (3.68) 2.89 (2.27) 89.36 (19.54) 3.75 (8.04) 204 (173)
      Change -7.59 (7.73) -9.82 (23.04) -43.20 (26.87) 1.51 (8.29) -624 (1343)
      P value 0.0040 0.0017 <0.0001 0.64 0.36
Unstable angina
(n=20)
      Baseline 24.69 (31.64) 5.73 (4.89) 114.20 (29.97) 2.22 (0.73) 369 (347)
      Follow-up 5.47 (5.55) 2.77 (2.72) 84.25 (30.50) 2.37 (1.51) 114 (103)
      Change -19.21 (31.22) -2.96 (5.39) -29.95 (30.72) 0.14 (1.38) -262 (384)
      P value 0.0038 0.0062 0.0003 0.65 0.0009
Stable angina
(n=31)
      Baseline 6.12 ((9.80) 12.25 (41.09) 110.22 (28.86) 2.09 (0.67) 217 (369)
      Follow-up 6.42 (9.61) 8.65 (23.64) 80.94 (27.45) 4.23 (3.96) 164 (223)
      Change 0.17 (7.45) -3.94 (21.27) -29.23 (27.12) 2.06 (4.08) -47 (329)
      P value 0.91 0.59 <0.0001 0.0085 0.58
CRP: C-reactive protein, IL-6: interleukin 6, Lp-PLA2; lipoprotein-associated phospholipase A2, NT-proBNP:
N-terminal pro brain natriuretic peptide, TNF-a: tumor necrosis factor alpha. With the exception of LpPLA2 all
p-values were calculated on the log-transformed values. The number in between brackets is the standard deviation.
Table 6: Biomarker results 167
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 CHAPTER 12 PALPOGRAPHY IN IBISThe most common post-mortem histological features in plaques,
which caused myocardial infarction, are the presence of a thin fi-
brous cap, a lipid-rich core, and inflammatory cells. These plaques
are called thin cap fibroatheromas (TCFA) (Virmani 2000)(Schaar
2004b). These TCFA's have certain mechanical properties, which
can be measured by three-dimensional intravascular palpography
(Schaar 2005).
Palpography assesses the local mechanical properties of tissue using
its deformation caused by the intraluminal pressure (Doyley 2001).
The technique was validated in vitro using diseased human coro-
nary and femoral arteries (de Korte 2000). Especially between fi-
brous and fatty tissue, a highly significant difference in strain was
found (de Korte 2000a). Additionally, the predictive value to iden-
tify the vulnerable plaque was investigated. A high strain region at
the lumen vessel wall boundary has an 88% sensitivity and 89%
specificity for identifying these plaques (Schaar 2003a). Patients
with myocardial infarction or unstable angina have more high
strain spots in their coronary arteries than patients with stable angi-
na (Schaar 2004a).
The majority of acute coronary events arises from non-flow limiting
lesions and is often the first clinical manifestation of previously sub-
clinical atherosclerosis (Ambrose 1988). Our knowledge on the
mechanism, how these plaques develop is rather limited.
The Integrated Biomarker and Imaging Study (IBIS) was designed
to investigate non flow-limiting atherosclerotic lesions in patients,
with diverse clinical presentations, referred for percutaneous coro-
nary intervention (Van Mieghem 2005). These plaques were inves-
tigated at baseline and 6 month follow up. To assess plaque171
 characteristics of these lesions, we explored correlations between
clinical presentation and Palpography results. We hypothesize that
there will be no significant difference of the palpographic results be-
tween baseline and follow up since no specific intervention was
done in this observational investigator driven study.
Methods
This study was a single center prospective and observational study,
which was approved by the medical ethics committee of the Eras-
musMC Rotterdam. All patients provided written informed con-
sent. In brief, patients 18 years of age or older with stable angina,
unstable angina, non-ST segment elevation or ST segment eleva-
tion myocardial infarction, who underwent successful percutaneous
coronary intervention (PCI) of one or more lesions in the native
coronary circulation, were eligible for inclusion.
Major clinical exclusion criteria were significant renal dysfunction,
prior coronary intervention in the region of interest, life expectancy
less than one year or factors that made follow-up difficult. Major
imaging-related exclusion criteria were coronary anatomy that pre-
cluded safe intravascular ultrasonographic examination of a suitable
region of interest. The coronary study vessel, preferentially a vessel
not targeted for intervention, was, in order of preference, the left
anterior descending, right and circumflex coronary artery. At the
discretion of the operator, a second artery could be studied.
The region of interest was defined on the basis of identifiable land-
marks, such as side branches or the vessel ostium. Follow up proce-
dures were done at 6 months. All data in IBIS were acquired using
a 20 MHz Jovus Avanar F/X IVUS catheter (Volcano, Rancho Cor-
dova, CA, USA), which was connected to an InVision Gold IVUS
console. Recordings were obtained at a pullback speed of 1 mm/sec
using a mechanical pullback device (Trackback II, Volcano, Ran-
cho Cordova, CA, USA). Simultaneously, the ECG and intralumi-
nal pressure signals were recorded. Acquisition was done with a
custom made dedicated workstation connected to the digital inter-
face of the IVUS machine recording fundamental IVUS data (rf-
data). Each acquisition was stored on a separate DVD. Processing
and analysis of the data were done by different personnel, than
those who did the recording. Analysis was done as previously172
 CHAPTER 12 PALPOGRAPHY IN IBISdescribed7 and unaware of the clinical patient data and other results
of the study. The reproducibility of three-dimensional palpography
has been recently reported (Schaar 2003b+2005).
ROC Classifica-
tion and SMS-In-
dex
Strain values were classified according to the ROC classification
(ROtterdam Classification) as low strain spots (ROC I: 0.0 -
<0.6%), moderate strain spots (ROC II: 0.6 - <0.9%), medium
strain spots (ROC III: 0.9 - <1.2%), or high strain spots (ROC IV:
>1.2%). The vulnerability of a vessel was described by the Schaar-
Mastik-van der Steen- (SMS)-Index. It was calculated as the
number of ROC III and IV scores that was measured in the ROI
every mm and averaged over the length of the ROI and multiplied
by 10 to normalize to the pullback length in cm. This SMS-Index
describes the longitudinal extent of highly deformable plaques and
is taken as a measure for vulnerability e.g. in a specific coronary ar-
tery.
Matching Land-
marks
At follow up analysis first the begin end the end of the region of in-
terest were matched based on the previously described landmarks.
Within the ROI, for every millimeter along the full pullback
length, the matching cross section of the follow up recording was
determined. This matching was done on the fundamental IVUS
frames reconstructed from rf-data unaware of the palpographic re-
sults. The matching included also a correction of the rotational ori-
entation of the follow up registration to allow an analysis not only
for the entire cross section, but also for positions along the circum-
ference of the lumen.
The likelihood ratio test with a PROC MIXED model in SAS
V8.02 was used to analyse the change of ROC scores within the dif-
ferent clinical groups. The SMS index differences between the clin-
ical groups at baseline and at follow up as well as the differences
between baseline and follow up recordings were calculated using
the f-test.
Results
In 48 patients 52 
coronary arteries 
were studied
We studied in 48 patients 52 coronary arteries. Patients were divid-
ed into three groups on the basis of clinical presentation (stable or
unstable angina, AMI). Twelve coronary arteries from patients with173
 STEMI, 16 from patients with unstable angina and 24 from pa-
tients with stable angina were investigated.
SMS index higher 
n the STEMI 
group
Results of the SMS index at baseline and follow up are given in Ta-
ble 1. The main finding is that at baseline the SMS index is signif-
icant different between the groups (p=0.02), while in follow up no
difference could be observed (p=0.91). Furthermore there is a sig-
nificant decrease in the SMS index in the STEMI group at follow
up (p=0.0003), while this could not be seen within the other
groups.
998 cross sections 
at baseline and 
follow up
We scored the highest ROC score at 998 cross sections at baseline
and follow up. The results are given in Table 2. The main finding
is that at baseline the peak ROC score is significant different be-
tween the groups (p=0.002), while in follow up no difference could
be observed (p=0.72). Furthermore there is a significant decrease in
peak ROC scores in the STEMI group at follow up (p=0.0004),
while this effect could not be seen within the other groups. The
BASELINE FOLLOW UP P-VALUE
STEMI (n=12) 2.30 ± 1.80 1.15 ± 1.37 0.0003
Unstable (n=16) 1.78 ± 1.78 1.41 ± 1.69 0.29
Stable (n=24) 1.21 ± 1.06 1.17 ± 1.14 0.56
p-value 0.02 0.91
Table 1: SMS index given as mean ± SD
OBSERVATIONS BASELINE FOLLOW UP P-VALUE
STEMI (n=12) 231 2.10 ± 1.05 1.57 ± 0.87 0.0004
Unstable (n=16) 260 1.83 ± 0.98 1.67 ± 0.95 0.24
Stable (n=24) 507 1.68 ± 0.92 1.54 ± 0.91 0.63
p-value 0.002 0.72
Table 2: Comparison of individual ROC scores is given as mean ± SD174
 CHAPTER 12 PALPOGRAPHY IN IBISmean change of ROC scores in the group with stable angina was
not significant (p = 0.12) with a mean of -0.14 see figure 1. The
mean change of ROC scores in the group with unstable angina was
not significant (p = 0.1577) with a mean of -0.1577 (see figure 2),
while in patients with STEMI the shift was significant (p=0.0099)
in the direction of lower ROC scores (mean = - 0.5325) (see figure
3).
Discussion
This is the first clinical follow up study using 3D palpography. This
pilot study was performed blinded to assess (a) the change of the
SMS-index and (b) the change of individual ROC scores, as well as
(c) their relation to clinical presentation.
Follow up trials 
with palpography 
are feasible
The major findings of this study are that follow up trials with this
new technique are feasible in a blinded matter and plaque deform-
ability changes to a certain extend towards lower strain values pre-
dominantly in the group of patients with myocardial infarction.
Three-dimensional Intravascular palpography, by its capacity to
evaluate the mechanical properties of the plaque, can detect thin-
cap fibroatheromas. Validation studies in vitro and in vivo have
shown that palpography can identify such plaques with high sensi-
tivity and specificity and assess the number of suspected vulnerable
Fig 1: ROC shift of pa-
tients with stable angina
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 plaques in the entire coronary artery or a region of interest (Schaar
2003a + 2004a).
The SMS-index: 
Relation to clini-
cal presentation
At baseline the SMS index was significantly different showing a
higher value for patients with myocardial infarction compared to
the ones with unstable or stable angina. This supports data, which
we have previously reported (Schaar 2004a), but shows in addition
that there is a significant bigger extent of plaque deformability in
patients with myocardial infarction that in patients with stable or
unstable angina. After 6 month the index has not changed for pa-
tients with stable and unstable angina, but is significantly reduced
in the group of patients with myocardial infarction. This may be
due to the fact that patients in the latter group were presented at in-
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 CHAPTER 12 PALPOGRAPHY IN IBISdex with a therapy regime, which was extensively modified after in-
itial interventional treatment. Furthermore this data support the
hypothesis that vulnerability is a pan-artery process (Buffon 2002)
and current treatment regimes can reduce it, but not eliminate it
taking into account that at follow up the SMS index was not signif-
icantly different between the groups.
The ROC-score: 
Local changes of 
plaque deforma-
bility
The development of a method, which enables us to compare
atherosclerosis in coronary arteries per millimeter slices, gives us the
opportunity to assess rather small changes of deformability in a big
number of observations without suffering from longitudinal mo-
tion artifacts. We observed changes in deformability on both sides
of the spectrum: Low strain areas changed into high strain areas and
high strain areas into low strain areas, while in the majority of
plaques no or only minor changes of deformability could be shown.
This can be explained by the fact that atherosclerosis is a dynamic
process dependent on a variety of mechanisms, which may influ-
ence deformability either by enhancing it like chronic inflamma-
tion or decreasing it like treatment with drugs. In the group of
patients with stable and unstable angina the change in ROC scores
was rather balanced, while in the group with myocardial infarction
the change towards lower ROC scores was prevailed. This may be
explained by treatment intensification in this particular patient
group, but this study was certainly not powered to evaluate effect of
certain treatment modalities and the described changes may be also
the consequence of natural causes. Future studies will address this
problem.
Intravascular ultrasound (IVUS) techniques have proven to give
deep insight into plaque morphology (Rioufol 2004) (Nissen
2005). Since palpography is a supplementary technique, it can be
expected that we will gain even deeper insight into plaque develop-
ment in the future. 
Limitations of the 
study
The analysts were aware of the fact that they are looking to follow
up results. This may have induced a bias in the analysis. Neverthe-
less the investigators were blinded towards the clinical patient pres-
entation and interpretation of palpographic parameters allows only
limited degrees of freedom.177
 Conclusion
With intravascular three-dimensional palpography the extend of
deformable plaques can be measured at baseline and follow up pro-
cedures. Patients with myocardial infarctions have a bigger extend
of deformability than patients with unstable or stable angina. In all
groups deformable plaques remain, which leaves room for improve-
ment regarding the therapy of patients with atherosclerosis.178
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 CHAPTER 13 THROMBUS AGEDisruption of coronary atherosclerotic plaques is recognized as the
initial trigger of coronary thrombosis and may lead to acute coro-
nary syndrome (Davies 1996). Although the mechanisms of plaque
rupture and thrombus formation in lesions have been intensively
investigated (Schaar 2004b), the in vivo assessment of thrombus
age in an arterial system was not performed yet. It is well known
that thrombi harden by aging (Browse 1999). It can be assumed
that this mechanical stabilization can be measured by using elastic-
ity measurements and we hypothesize that quantitative strain meas-
urement can determine thrombus age in an animal model of arterial
thrombosis.
This quantitative assessment of strain of biological material is feasi-
ble with intravascular palpography, a new IVUS derived imaging
technique (de Korte 2002a). Palpography assesses the local me-
chanical properties of tissue using its deformation caused by the in-
traluminal pressure (Schaar 2004a).
Materials and Methods
The present experiments were performed conform with the “Guide
for Care and Use of Laboratory Animals” published by the US Na-
tional Institutes of Health (NIH publication No. 85-23, revised
1996) and under the regulations of the Erasmus Medical Center
Rotterdam.
Eight overnight-fasted crossbred Landrace Yorkshire pigs of either
sex (46±2 kg) were sedated with ketamine (20 mg/kg i.m), and mi-
dazolam (0.5 mg/kg, i.m.), anaesthetized with sodium pentobarbi-
tal (15 mg/kg i.v.) and intubated for ventilation with O2 and N2O
(1:2).183
 Catheters were inserted into the superior caval vein for infusion of
saline and sodium pentobarbital (10-15 mg/kg·h-1) to maintain
anaesthesia. Furthermore 9F sheets were placed one in the right-
and one in the left carotid artery. Through these sheets two 20
MHz phased array intravascular ultrasound catheters (Avanar, Vol-
cano Therapeutics, Rancho Cordova, CA, USA) were positioned in
the right and left femoral artery and left in place over the whole
length of the experiment. The sheets were also used for measuring
arterial pressure and arterial blood sampling to maintain PO2, CO2
and pH within the physiological range.
The femoral arteries were exposed surgically. Thrombosis was in-
duced by placement of an electrode on the outer vessel wall by ap-
plying an electrical field to generate thrombosis formation
(Romson 1980) (Lanza 1996) using a controlled electrical DC cur-
rent (9 mA) for 30 seconds. The site of injury was chosen by the lo-
cation of the tip of the IVUS catheter. The current caused a vessel
injury with the signs of endothelial erosion. Over this erosion a wall
standing thrombus was formed, which left a lumen in which the
blood pressure acted as the driving force to strain the thrombus. Ra-
dio-frequency (RF) ultrasound data were acquired at 30 frames per
second. Data were recorded and stored at 7 time points after throm-
bus introduction (5, 20, 45, 75, 105, 150, 210 min.). Cross-corre-
lation based analysis of the RF data revealed the radial strain of the
lumenal layer of the thrombus as described before (Doyley 2001).
At the end of the study the animals were sacrificed by infusion of
an overdoses pentobarbital.
For statistical analysis SPSS 11.0.1 (SPSS Inc., Chicago, IL, USA)
was used. The continuous variable strain is presented as median val-
ue with corresponding 25th and 75th percentiles in figure 1 and as
mean ± standard deviation in the text. Multiple comparisons were
done using the Bonferroni test.
Results
In 10 out of 13 vessels a thrombus was formed at the side where an
anode caused a DC current through the femoral wall (fig 1 now fig
3). Initially thrombi are soft and stiffened dramatically in the first
20 minutes with a strain reduction of about 50% (fig 2 and 3). The184
 CHAPTER 13 THROMBUS AGEstrain between frames in a thrombus decreased from (0.27 ± 0.17)
at 5 minutes through (0.17 ± 0.08) at 20 minutes to (0.12 ± 0.09)
after 45 minutes. At 75 minutes the strain was 0.13 ± 0.10, at 105
minutes 0.15 ± 0.08. Further stiffening took considerable more
time, but could be observed towards the end of the experiment. The
strain was 0.10 ± 0.07 at 150 min. and the lowest (0.05 ± 0.01) at
240 minutes. The difference in strain was significant between the
time point at 5 minutes vs. all other measurement points (20 min.
p<0.038; 45 min. p<0.0001; 75 min. p<0.003; 105 min. p< 0.018;
150 min. p<0.0001; 240 min. p<0.0001). Other significant differ-
ences could not be found. The inverse relation between the time
and strain over the first 3 hours is highly significant (R2=0.59; p <
0.0001).
Discussion
This is the first time that the generation and organization of an ar-
terial thrombus in vivo is shown (Figure 3). We used an animal
model inducing electric vascular injury, which generates platelet-
rich thrombi similar to that observed in the coronary arteries of pa-
tients with acute myocardial infarction. The major findings of this
study are that a thrombus gets stiffer over time and a vast part of the
organization process takes place within 20 min. after thrombus in-
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 troduction and that this process can be monitored using intravascu-
lar palpography.
Intravascular palpography, by its capacity to evaluate the mechani-
cal properties of biological tissues, can detect e.g. thin-cap fibroath-
eromas. Validation studies in vitro and in vivo have shown that
palpography can identify such plaques with high sensitivity and
specificity. However this thin-cap fibroatheromas cause only 70%
of all myocardial infarction. Plaque erosion, which is the second
most possibility to get a thrombosis (25%), cannot be detected by
current IVUS derived techniques like palpography. However IVUS
is capable to detect thrombosis by using integrated attenuation val-
ues, texture analysis of radio frequency data or video densitometric
data to differentiate between various types of thrombus. All these
approaches give us no information on the age of the thrombus in
the early phase of development. How important this information is
on treatment success is proven by several thrombolysis studies
showing that complete early reperfusion is associated with reduced
in-hospital mortality (Vogt 1993) (Morrison 2000). The scanning
of coronary arteries after stenting the culprit lesion in order to iden-
tify remaining thrombi may help to customize anticoagulation
therapy when the age of the thrombus is known.
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 CHAPTER 13 THROMBUS AGEThe stabilization of thrombi is mainly caused by transformation of
the thrombus. In an animal model it was shown by western analysis
of thrombus extracts that nearly 50% of fibrinogen was cleaved to
fibrin and extensively cross-linked within 30 min. of injury with no
evidence of fibrinolysis (McBane 2000). Our investigation is con-
firming these earlier investigations showing strain reduction of the
thrombus by about 50% in the first 20 minutes suggesting the sta-
bilization of the thrombus due to fibrin cross linking.
Although the constitution of our experimental thrombosis resem-
bles natural fresh thrombi in patients and the time course of stiff-
ening corresponds to fibrin cross-linking, we have no prove that the
time course of our model is identical to natural thrombus forma-
tion. However this study shows that the thrombus stiffens over time
and that this process can be assessed by palpography. A direct trans-
lation between strain in this experimental thrombus and a throm-
bus in a clinical scenario still needs to be assessed.   
The observations in this study open up the stage for more detailed
clinical trials.
Fig 3: At the beginning of the experiment (a) strain is the highest at the thrombus outer side between the
3 and 7 o'clock position. The strain decreases after 20 minutes (b). At the end of the experiment (c) the
thrombus is entirely stiff187
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 CHAPTER 14 PLAQUE COMPOSITIONThe majority of acute coronary syndromes, such as unstable angina,
myocardial infarction or sudden cardiac death, are caused by coro-
nary thrombosis (Davies 2000) (Falk 1995). More than 60% of
these thrombi are caused by rupture of vulnerable, thin-cap fi-
broatheroma (TCFA) plaques (Virmani 2000). Their morphologi-
cal features are a large lipid core, covered by a thin fibrous cap.
Considered as major determinants for their rupture are their mate-
rial composition, geometry, and cap inflammation caused by infil-
tration of macrophages (Davies 2001). As such, identification of
these rupture-determinants is of vital diagnostic importance
(Schaar 2004).
IVUS elasto-
grams cannot be 
interpreted direct-
ly as plaque com-
ponent images
IntraVascular Ultrasound (IVUS) elastography is a technique that
determines arterial radial strain by cross-correlation processing on a
pair of IVUS radio-frequency signals; each signal is measured with
an IVUS catheter at a different intraluminal pressure (de Korte
2003)(Brusseau 2002)(Saijo 2004)(Perry 2003)(Shapo 1996)(Choi
2002)(Ryan 1997)(Talhami 1994). This arterial radial strain is vis-
ualized in a so-called (strain) elastogram. IVUS elastography is clin-
ically available and has proven to be capable of detecting the
presence of human TCFAs in vitro with a sensitivity of 88% and
specificity of 89%, merely by inspecting the elastogram for a specif-
ic strain pattern that consists of high strain with adjacent low strain
on the surface of a plaque (Schaar 2003a). In vivo animal experi-
ments and in vitro human experiments demonstrated that discrim-
ination between fibrous and fatty plaques is possible, merely by
determining the average radial strain value of the plaque (de Korte
2000a + 2002a). The in vivo animal experiments also showed that
the presence of a high strain spot (average radial strain > 1%) at the
plaque surface had a sensitivity of 92% and a specificity of 92% for
identifying macrophages. Although these studies have shown that a
specific radial strain pattern and the average radial strain of a plaque191
 can provide valuable information, there doesn't exist a one-to-one
relation between the local radial strain value in an IVUS elastogram
and the local tissue component type (calcified, fibrous, fatty or tis-
sue infiltrated by macrophages). The underlying reason is that the
local stresses that induce local radial strain depend upon the struc-
tural configuration of the artery and the material properties and ge-
ometry of its plaque components. Furthermore, radial strain
depends on the catheter position used during imaging (Baldewsing
2004a)(de Korte 1996+1999)(Ophir 1996). Thus, IVUS elasto-
grams cannot be interpreted directly as plaque component images.
Image of the 
Young's modulus 
distribution
Such an image can be interpreted as a morphology and material
composition image of a plaque, due to the large differences between
Young's moduli of plaque components, like calcifications, healthy
arterial tissue, lipids or tissues weakened by infiltration of macro-
phages (de Korte 2000a)(Lendon 1991)(Lee 1991+1992)(Fung
1981). Many researchers have used displacement and/or strain
components that were derived from simulated or measured ultra-
sound data or other imaging modalities in combination with tissue
deformation equations, to compute a Young's modulus image.
Usually a 'direct' or 'iterative' reconstruction method is employed.
With a direct reconstruction method the deformation equations are
rewritten to express the moduli as unknowns. Subsequently, they
are solved by means of an analytical formula or by a discretization
or numerical integration approach. With iterative reconstruction,
the moduli values of each individual mesh element or groups of
mesh elements in a finite element model representation of the tissue
are iteratively updated such that the computed model output even-
tually closely matches the experimentally measured data (e.g., dis-
placement and/or strain components). Many groups have applied
these methods on a two dimensional cross-section of a homogene-
ous rectangular medium with a circular or rectangular inclusion us-
ing a direct method (Cohn 2000)(Raghavan 1994)(Skovoroda
1995)(Sumi 2000)(Zhu 2003)(Wellman 1999) or an iterative
method (Bishop 2000)(Doyley 2000)(Kallel 1996)(Fu 2000).
Some applied an iterative method to breast (Plewes 2000)(Samani
2001)(Miga 2003), prostate (Sarvazyan 1998), brain (Van Houten
1999) or heart (Moulton 1995). However, only a few groups con-
sidered arteries. Some of them used an iterative method (Beattie
1998) (Vorp 1995) (Chandran 2003) (Soualmi1997), others a di-
rect method (Bank 1999) (Kanai 2003) (Wan 2001).192
 CHAPTER 14 PLAQUE COMPOSITIONBoth inversion techniques suffer to different degree from stability
problems like non-uniqueness and non-convergence. Various
groups (Skovoroda 1995) (Kallel 1996) (Moulton 1995) (Beattie
1998) (Barbone 2002+2004) (Sumi 1995) have mentioned possi-
ble causes, such as measurement noise, a limited number of meas-
ured displacement or strain components, boundary data that is
erroneous or of an incorrect type, a Finite Element Model (FEM)
with too many (physically not interpretable) parameters, or an in-
appropriate FEM.
A new reconstruc-
tion method spe-
cially suited for 
TCFA
The ultimate clinical goal is to obtain a diagnostically useful and
easily interpretable modulus image of an arbitrary complex athero-
sclerotic plaque using a modulus imaging method, which suffers as
little as possible from stability problems. To proceed towards this
goal and to be able to investigate and quantify reconstruction prob-
lems in a systematic way, we developed a new reconstruction meth-
od specially suited for TCFAs (Davies 2000) (Schaar 2004b)
(Virmani 2003). Our method uses an iterative reconstruction ap-
proach to produce a Young's modulus image. To this end, the de-
formation output, calculated with a Parametric Finite Element
Model (PFEM) representation of a TCFA plaque, is matched to
plaque deformation measured with IVUS elastography. The PFEM
uses a minimum number of morphology and material composition
parameters, but is still able to model a variety of these TCFAs. The
Fig. 1: (A) Experimental set-up consisting of a water column system, water tank, pressure sensor, catheter,
IVUS imaging system and data acquisition system. (B) Photograph of the water tank containing an athero-
sclerotic human artery; all arterial side branches are closed with suture193
 resulting Young's modulus image of the plaque shows both the
morphology and Young's modulus value of three main plaque com-
ponents, namely lipid, cap and media and is therefore fast and easy
to interpret in clinical settings.
Aim of this study The aim of this study is twofold: Firstly, to describe the new recon-
struction method. Secondly, to demonstrate its ability to successful-
ly reconstruct Young's modulus images from elastograms obtained
from five plaques. These elastograms are simulated using finite ele-
ment models, measured from vessel-mimicking material, and meas-
ured from human coronary arteries in vitro and in vivo.
Materials
A. Simulated Arteries with Plaque
Two different finite element models were constructed for a realistic
TCFA; one TCFA was defined using circles, the other by tracing
TCFA histology.
B. Phantom with Plaque
One vessel-mimicking phantom with an eccentric, soft region em-
bedded in a stiff wall was made from 10% PolyVinyl Alcohol
(PVA) Cryogel (Chou 1997) as described in (Baldewsing 2004b).
Carborundum (SiC) particles (3-10 mm) were added as scattering
material. The static Young's moduli were measured in a custom de-
signed tension set up. The static Young's modulus was 4.2 kPa for
the plaque and 16.8 kPa for the wall. The pressure-free phantom
had a length of 150 mm, an outer diameter of 18 mm, and an inner
diameter of approximately 4 mm.
C. Human Coronary Arteries with Plaque
A coronary artery segment with a TCFA was excised from one pa-
tient who died of a non-coronary cause. Furthermore, in vivo meas-
ured IVUS radio-frequency data were obtained from a non-culprit
coronary artery of one patient referred for percutaneous translumi-
nal coronary angioplasty. The IVUS data revealed the presence of a
large eccentric plaque.194
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A. Elastography Simulations and Measurements
Elastography 
Simulations
Elastograms were simulated for two TCFAs using the finite element
package SEPRAN (Sepra Analysis, Technical University Delft, The
Netherlands). Linear elastic, isotropic, nearly incompressible (Pois-
son's ratio n=0.4999), plane strain finite element models were used
for this purpose, because it has been demonstrated (Baldewsing
2004b) that such models are appropriate to simulate radial strain
elastograms that are measured in vitro from human atherosclerotic
coronary arteries using IVUS elastography. The geometry of the
first TCFA was defined by using circles. The geometry of the sec-
ond TCFA was defined by tracing the histology of an excised hu-
man coronary artery with a TCFA. The material properties of the
TCFA components (Table 1) and pressure differential of 20
mmHg were taken from values reported in (Baldewsing 2004a+b).
Histology revealed a layer of collagen and a layer of smooth muscle
cells resulting in the two Young's moduli values for different re-
gions in the cap. The finite element mesh consisted of plane-strain
triangular finite elements with extended quadratic interpolation
functions. The averaged finite element size was approximately 0.1
mm. The radial strain was calculated with respect to the geometric
center of the lumen border.
MATERIAL 
PARAMETER PLAQUE 1 PLAQUE 2
E lipid [kPa] 50 25
E cap [kPa] 2000 1500/1250
E media [kPa] 1500 1000
ν cross section 0.4999 0.4999
Table 1: Young’s modulus (E) and Poisson’s ratio (ν) used in Finite
Element Models for Arterial Plaque Cross-sections.195
 Elastography 
Measurements 
with Phantom 
and In Vitro Ar-
tery
The experimental setup for performing elastography measurements
with the phantom and in vitro artery consisted of a water tank
equipped with two insertion sheaths (fig. 1). The water tank was
connected via the distal sheath to a water column system, which
contained distilled water for the phantom and a de-gassed physio-
logical saline solution for the in vitro artery. The phantom and in
vitro artery were subsequently mounted between the two sheaths.
Also the arterial side-branches were closed with suture material to
prevent leakage (Schaar 2002). The column system was used to ap-
ply intraluminal pressures and to perform preconditioning. Precon-
ditioning of the artery was done by loading the artery with 100
mmHg pressure and subsequently unloading it to ambient pres-
sure, for at least five cycles (Lally 2004). A 20-MHz 64-element
phased array IVUS catheter (Volcano Inc., Rancho Cordova, CA,
USA) connected to an InVision echo apparatus (Volcano Inc., Ran-
cho Cordova, CA, USA) was inserted in the proximal sheath. The
pressure was monitored using a pressure sensor that was also con-
nected to the proximal sheath.
Elastography measurements for the in vitro artery were done within
24 hours post mortem and directly after preconditioning (Schaar
2003a). First, an IVUS echo frame was acquired at an intraluminal
pressure of 5 mmHg for the phantom and 80 mmHg for the artery.
After 10 seconds, another IVUS echo frame was acquired at 6
mmHg for the phantom and 100 mmHg for the in vitro artery.
Each echo frame consisted of 512 angles of raw radio-frequency
(RF) data-lines sampled at 100 MHz in 12 bits. Each line contained
1024 data points (corresponding to 7.6 mm imaging depth). The
intraluminal pressures were chosen to strain the phantom and the
artery up to a maximum of 2.5%. This strain value is an upper limit
Fig. 2: Parametric Finite Element
Model for a Vulnerable Plaque. (A)
Each circle is parameterized by its
center (X,Y) and a radius R. The
dynamic control points P, Q, R, S,
T, and U are used to define the
three plaque components. (B) Fi-
nite element mesh regions corre-
sponding to geometry in A. Letters
L and c denote lipid and cap, re-
spectively.196
 CHAPTER 14 PLAQUE COMPOSITIONfor properly calculating the local radial strain using the cross-corre-
lation method described by de Korte et al. (de Korte 1998) with a
window length of 60 RF data points, 50% window overlap and a
20-MHz center frequency of the ultrasound signal. This cross-cor-
relation technique was applied to the ultrasound data to calculate
the local radial strain. First, the radial tissue displacement along the
ultrasound beam was determined. Then, finite differences of these
displacements resulted in the local radial strain. Since a window
length of 60 RF data points was used with 50% window overlap,
the spatial resolution of the strain determination was 30 RF data
points in the radial direction (approximately 200 µm). Strain esti-
mates of the phantom, in vitro artery and in vivo artery were
clipped respectively between 0% (color coded in black) and an up-
per strain value (color coded in white).
The histology of the in vitro artery was created from the tubular
segment that was elastographically imaged. This segment was pres-
sure-fixed at 80 mmHg, sectioned, and counter-stained for the
presence of collagen and lipid (picro Sirius red and polarized micro-
scopy), smooth muscle cells (a actin) and macrophages (CD 68).
Elastography 
Measurements In 
Vivo
A multiframe averaging method similar to the one described in
Doyley et al. (Doyley 2001) was used to compute a compounded
elastogram. First, IVUS echo frames were acquired at 30 fps. Next,
at the diastolic phase of a cardiac cycle, when catheter motion is
minimal, a consecutive sequence of 7 echo frames was selected.
Each consecutive frame pair was highly correlated, i.e., the sum-of-
absolute-differences between the RF-envelopes of a consecutive
frame pair divided by the sum of RF-envelopes of the first frame
was less than 0.1. Furthermore, the total incremental rotation of the
catheter was less then 1 degree. The measured intraluminal pressure
was 53 mmHg for the first frame and 60 mmHg for the seventh
frame; intraluminal pressure difference between consecutive frames
was 1 mmHg. From each consecutive frame pair an elastogram was
computed using the method describe above for the phantom and in
vitro artery. Finally, a compounded elastogram was computed by
averaging the 6 elastograms; throughout the paper this elastogram
is denoted as 'in vivo measured elastogram'.
B. Parametric Model-Based Reconstruction Method197
 The main components of the reconstruction method were the Par-
ametric Finite Element Model (PFEM) for a plaque, the forward
problem calculation, and minimization algorithm used:
PFEM for a 
Plaque:
1) PFEM for a Plaque: An idealized TCFA (Virmani 2003) was
used as model for a plaque. Our model is a variation of the PFEM
used by Loree et al. (Loree 1992). Our PFEM geometry consisted
of a media area containing a lipid pool, which was covered by a cap.
The borders of the lipid, cap, and media areas were defined using
circles (fig. 2A). Lipid was defined as region QTQ, cap as region
PQTSP and media as the remaining area. Each circle was parame-
terized by its center with Cartesian coordinates (X,Y) and radius R.
Arterial tissue was modelled in the PFEM as linear elastic, isotropic,
nearly incompressible (Poisson's ratio ν=0.4999), plane strain ma-
terial (Baldewsing 2004a+b). The lipid, cap, and media regions
were assumed homogenous. The Young's modulus values of these
regions were denoted as EL, EC, and EM, respectively.
Forward Problem 2) Forward Problem (i.e., Radial Strain Image Calculation): First,
parameters were specified that define the geometry and Young's
modulus values of the PFEM, and pressure boundary conditions.
Then, a mesh topology file was created from these parameters using
MATLAB (release 12.1, the MathWorks, Inc.). Next, the finite el-
ement package SEPRAN used this file to calculate a finite element
mesh consisting of plane-strain triangular elements (e.g., fig. 2B)
with extended quadratic interpolation functions. Then, it calculat-
ed the Cartesian strain tensor components in these mesh points. Fi-
nally, MATLAB converted these Cartesian components to their
polar equivalents using the catheter center as origin. The radial
strain component field was subsequently interpolated onto a refer-
ence grid, i.e., square equidistant grid of 100 by 100 points. This
radial strain field was called a PFEM elastogram. For each recon-
struction, the size of the square reference grid was chosen such that
it tightly surrounded the arterial wall region. The whole process
from defining the PFEM parameters up to the calculation of the
PFEM elastogram was fully automatic. The simulated and meas-
ured elastograms were also interpolated onto the corresponding ref-
erence grid.
Minimization Al-
gorithm
A Constrained Sequential Quadratic Programming minimization
algorithm (Optimization Toolbox, MATLAB) was used, that auto-198
 CHAPTER 14 PLAQUE COMPOSITIONmatically searches a local minimum of a non-linear objective func-
tion, i.e., quantification of the difference between PFEM
elastogram and a simulated or measured input-elastogram, by iter-
atively updating the PFEM parameters. At every iteration the six
PFEM geometry and three PFEM material parameters were all si-
multaneously updated. The objective function was defined as the
Root-Mean-Squared (RMS) error between PFEM elastogram and
input-elastogram. The RMS error was calculated from the strain
values that belong to those reference grid points that are shared by
the input-elastogram (i.e., simulated or measured elastogram) and
the PFEM elastogram. At every iteration the RMS error decreases.
The average time between two iterations was 45 seconds on a com-
puter with a 3 GHz Xeon processor.
A detailed mathematical description of the algorithm can be found
in the Optimization Toolbox of MATLAB. The basic steps were as
follows. At each major iteration a simultaneous update for all pa-
rameters was computed by solving a quadratic subproblem. This
Fig. 3: Reconstruction from a simulated elastogram of a thin-cap fibroatheroma that consists of circles.
(A) Young's modulus image in kPa used for simulating the plaque. (B) Simulated elastogram computed
using A. (C) Reconstructed Young's modulus image in kPa. (D) PFEM elastogram computed using C;
the RMS error is 0.016%. (E) Initial state at start of the reconstruction process: The Young's modulus
of the lipid, cap and media plaque component is 1185 kPa.199
 subproblem was generated by approximating the Hessian matrix of
the Lagrangian function, using a quasi-Newton updating method.
The solution of this subproblem was then used to form a search di-
rection for a line search method, which resulted in the update.
Positioning of 
PFEM Lumen 
and Media Circle
For all reconstructions, the PFEM lumen circle was defined (i.e., its
center coordinates and radius was determined) as the largest circle
within the lumen border. Similarly, the PFEM media circle was de-
fined as the smallest circle enclosing the media contour. For both
the in vitro and in vivo artery, the media contour was defined as the
Fig. 4: PFEM-parameters versus iteration-step curves for the simulated thin-cap fibroatheroma that con-
sists of circles. (A) Material parameters: Young’s moduli for lipid pool (EL), cap (EC) and media (EM).
(B) Geometry parameters: Center coordinates and radius of the lipid pool circle (XL,YL) and RL, and cap
(XC,YC) and RC. The solid lines are the parameters values used to create the simulated thin-cap fibroath-
eroma.
Fig. 5: RMS-error
versus iteration-step
curves for each of
the five reconstruc-
tions presented in
this paper. The ide-
alized plaque de-
notes the simulated
thin-cap fibroath-
eroma that consists
of circles and the
traced plaque de-
notes the simulated
thin-cap fibroath-
eroma that is traced
from arterial histolo-
gy.200
 CHAPTER 14 PLAQUE COMPOSITIONmedia-adventitia border, which was visible in the echogram as an
echolucent contour with distal brightening. In case of the phantom,
whose diameter was 18 mm and thus exceeded the 15.2 mm diam-
eter of the echogram, the part of the wall boundary that was visible
in the echogram was extrapolated. For the two simulated arteries,
the media contour was already defined during their creation.
Nonlinear and 
Linear Con-
straints
In order to maintain the morphology of an idealized TCFA (fig.
2A) and to automatically calculate a proper finite element mesh
(e.g., fig. 2B) during the minimization process, the following non-
linear geometry constraints were enforced upon the PFEM geome-
try parameters: (i) The lipid circle must have exactly two
intersection points with the cap circle (Q and T). (ii) The cap circle
must always contain the lumen circle. (iii) The lipid circle must al-
ways be inside the media circle. The other dynamic mesh-control
points (P, R, S, and U in fig. 2A) were automatically calculated and
used to define the three plaque regions. Point P (and analogously S)
was defined as the projection of point Q onto the lumen circle.
Fig 6: Reconstruction using a simulated elastogram of a thin-cap fibroatheroma that is traced from arte-
rial histology. (A) Young’s modulus image in kPa traced from histology and used for simulating the
plaque. (B) Simulated elastogram computed using A. (C) Reconstructed Young’s modulus image in kPa.
(D) PFEM elastogram computed using C; the RMS error is 0.29%. (E) Initial state at start of the recon-
struction process.201
 Point R and U were located on the media circle such that line QR
and TU bisected the angle between two direction-vectors that were
defined as the outward normal of respectively the lipid and cap cir-
cle at point Q and T. The separation of the media region by the two
line pieces RQ and TU was done to make the finite element mesh-
ing of the media region more robust. 
Minimization 
process
Furthermore, to speed-up the minimization process, the range of
each PFEM parameter was restricted to stay within a user-defined
lower bound and upper bound value. These bounds were, by defi-
nition, linear constraints and chosen as follows. The centers of the
cap and lipid pool circles were restricted to stay within the smallest
square that fitted around the PFEM media circle. The radii of the
cap and lipid pool were non-negative and bounded by the radius of
the PFEM media circle. The Young's moduli were all chosen to be
positive. For the two simulated arteries, the upper bound was set ar-
bitrarily at 500 kPa higher than the Young's modulus of the stiffest
plaque components, namely that of the cap. Similarly, the upper
bound of the phantom was set at 25 kPa, which is arbitrarily higher
than the measured Young's moduli of its components, namely 4.2
and 16.8 kPa. For the in vitro artery, the same upper bound was
Fig. 7: Reconstruction using a measured elastogram from a vessel-mimicking phantom; it has a soft
region embedded in a stiff wall. (A) Young’s modulus image. (B) Echogram. (C) Measured elasto-
gram. (D) Reconstructed Young’s modulus image in kPa. (E) PFEM elastogram computed using D;
the RMS error is 0.54%. (F) Initial state at start of the reconstruction process.202
 CHAPTER 14 PLAQUE COMPOSITIONused as for the simulated artery that was traced from histology, be-
cause they showed resemblance in their geometry and their elasto-
grams showed similar maximal strain at the same pressure
differential of 20 mmHg. Finally, the in vivo artery showed approx-
imately the same maximum strain as the in vitro and the two sim-
ulated arteries, however at a 20 times lower pressure differential,
namely 1 mmHg, therefore the upper bound was set proportionally
lower, at 300 kPa.
The minimization algorithm was terminated after 25 iterations or
if the decrease in RMS error was less than 10^(-8).
Initialization of 
Reconstruction 
Method
At the start of each reconstruction an initial state is required for the
PFEM geometry and material parameters that are varied by the
minimization algorithm, namely the lipid and cap circle parameters
and the Young's modulus of the lipid, cap and media region. Each
initial state was chosen so that it differed from the actual underlying
plaque composition. For all the reconstructions, the cap and lipid
pool circles were put arbitrarily in the direction of the plaque. For
all reconstructions, except the first, an initial modulus contrast was
used between the plaque components, by setting the modulus of the
Fig. 8: Reconstruction using an in vitro measured elastogram from a human coronary artery with a thin-
cap fibroatheroma. (A) Macrophages. (B) Smooth Muscle Cells. (C) Collagen. (D) Echogram. (E) In vitro
measured elastogram. (F) Reconstructed Young’s modulus image in kPa. (G) PFEM elastogram computed
using F; the RMS error is 0.45%. (H) Initial state at start of the reconstruction process.203
 cap and media close to the upper-bound value and the modulus of
the lipid close to the lower-bound value. Finally, the phantom only
consisted of two regions: a soft homogenous region within a stiff
homogenous wall. To model this situation appropriately, the fol-
lowing additional constraints were enforced upon the PFEM dur-
ing the minimization: (i) the cap circle was kept fixed during the
minimization and (ii) the Young's modulus of this cap region was
kept equal to the Young's modulus of the lipid region.
C. Uniqueness Estimation
For the in vivo case, the actual underlying plaque composition was
unknown. Therefore, multiple reconstructions were performed us-
ing a set of different initial states. This was done (i) to enhance the
chance of finding a successful reconstruction, i.e., finding a recon-
struction with a PFEM elastogram that highly resembles the meas-
ured elastogram and (ii) to estimate the uniqueness of a successful
reconstruction. The initial states were defined, as follows: The cap
circle had the same center as the lumen circle and was given a cap
thickness of 100, 200 or 300 µm. The lipid circle was the same for
all initial states, was slightly positioned in the direction of the
plaque and occupied only a small area of the plaque. The initial
Young's modulus values for the lipid pool (EL), cap (EC) and media
(EM), were set at the following values: 0.1 or 10 kPa for EL and 100,
150, 200, 250 or 299 kPa for EC; the initial EM value was set equal
to the initial EC value. These initial parameter values for cap thick-
ness, EL and EC(=EM) resulted in 3*2*5 = 30 different initial states.
RESULTS
A. Simulated Plaques
Plaque 1 Figure 3A shows a simulated arterial TCFA that is defined by cir-
cles. The circumferential geometry and relatively high stiffness of
the cap causes the arterial stress to concentrate on the cap, especially
at its edges and around the corners of the lipid pool (Richardson
1989); this redistribution mechanism causes the typical regions of
high radial strain at the corners of the lipid pool in figure 3B and
the relatively low strain at the center of the lipid pool (Loree 1992).204
 CHAPTER 14 PLAQUE COMPOSITIONThis elastogram shows a perfect example of the specific strain pat-
tern, which consists of high strain with adjacent low strain on the
surface of the plaque, that has proven to detect the presence of hu-
man TCFAs in vitro with a sensitivity of 88% and specificity of
89% (Schaar 2003a). The reconstructed Young’s modulus image
(fig. 3C) highly resembles the morphology and material composi-
tion of the simulated arterial TCFA in figure 3A (respectively,
EL=66, EC=2047, and EM=1484 kPa versus EL=50, EC=2000, and
EM=1500 kPa). Also the input-elastogram (fig. 3B) and the PFEM
elastogram (fig. 3D) show a high resemblance. The initial state (fig.
3E) has no Young’s modulus contrast between the three plaque
components. Figure 4 shows the evolution of the PFEM material
and geometry parameters during the reconstruction process; figure
4B shows quantitatively that the geometry of each plaque compo-
nent is closely approximated. Figure 5B shows for each reconstruc-
tion presented in this paper the RMS error, which always decreases
during the reconstruction process.
Plaque 2Figure 6A shows a simulated TCFA that was traced from arterial
histology. Just as plaque 1 it results in a simulated elastogram (fig.
6B) with similar typical regions of high and low strain. The Young’s
modulus image (fig. 6C) shows that both the morphology (which
is not delineated by circles) and material composition of the simu-
lated TCFA (fig. 6A) are successfully approximated (respectively,
EL=1, EC=1491, and EM=1148 kPa versus EL=25, EC=1500 (and
cap side-regions 1250), and EM=1000 kPa). Also a high resem-
blance between input-elastogram (fig. 6B) and PFEM elastogram
(fig. 6D) is visible. The initial state (fig. 6E) has a large Young’s
modulus contrast between lipid and the other two plaque compo-
nents and both the cap and lipid circle are positioned slightly in the
direction of the plaque.
B. Phantom
Vessel-mimicking 
phantom
Figure 7A shows the composition of the vessel-mimicking phantom
that has a soft region embedded in a stiff wall. The echogram (fig.
7B) cannot discriminate between the two mechanically different re-
gions. However, the measured elastogram (fig. 7C) reveals the pres-
ence of the soft region by means of the high strain region. This
region shows a typical radial strain decay that results from a decreas-205
 ing stress; this natural stress decrease is due to the circumferential
vessel geometry. Only a limited range of phantom material is con-
tained in the elastogram due to the limited imaging depth of the
catheter (approximately 7.6 mm). The heterogeneous strain texture
throughout the elastogram is caused by measurement noise and the
gradient based calculation of strain. The Young’s modulus image in
figure 7D shows that both the circular morphology and material
composition of the phantom are successfully approximated (respec-
tively, EL=4 and EM=16 kPa versus EL=4.8 and EM=16.8 kPa). A
high resemblance is obtained between input-elastogram (fig. 7C)
and PFEM elastogram (fig. 7E). The initial state (fig. 7F) has a large
Young’s modulus contrast between the soft region (i.e., lipid) and
stiff wall (i.e., media) and the lipid circle is positioned near the lo-
cation indicated by the high strain region in the measured elasto-
gram (fig. 7C).
C. Human Coronary Arteries with Plaque
In Vitro Plaque: Figs. 8A-C show that the in vitro plaque is a TCFA with a stiff me-
dia containing an even stiffer cap which overlays a soft lipid pool.
The echogram (fig. 8D) reveals the plaque location but cannot be
used to discriminate between its components, e.g., cap and lipid
pool. Similarly as with plaque 1 and 2, the measured elastogram
(fig. 8E) suggests the presence of the TCFA by means of the specific
strain pattern. The heterogeneous strain texture throughout the
elastogram is due to measurement noise and the gradient-based cal-
culation of the strain. The Young’s modulus image (fig. 8F) shows
that both the morphology and stiffness contrast of the arterial
plaque components are in qualitative agreement with, respectively,
the morphology and stiffness contrast information provided by the
histology of the plaque. Both the measured elastogram (fig. 8E) and
PFEM elastogram (fig. 8G) show a low strain region at the center
of the plaque and a high strain region at both corners of the plaque.
However, both high strain regions in the PFEM elastogram are not
as thin and elongated as in the measured elastogram. The initial
state (fig. 8H) has a large Young’s modulus contrast between lipid
and other two plaque components and both the cap and lipid circle
are positioned slightly in the direction of the plaque.206
 CHAPTER 14 PLAQUE COMPOSITIONIn Vivo PlaqueThe echogram (fig. 9A) reveals the presence of a large eccentric
plaque between 10 and 5 o’clock, but cannot discriminate between
the possible cap and lipid component of the plaque. Similarly as
with plaque 1, plaque 2 and the in vitro plaque, the in vivo meas-
ured elastogram (fig. 9B) shows the specific strain pattern that sug-
gests the presence of a TCFA. The reconstructed Young’s modulus
image (fig. 9C) is a likely candidate for the real underlying plaque
composition, since the measured elastogram (fig. 9B) and PFEM
elastogram (fig. 9D) show two co-localizing regions of high strain
at the corners of the plaque and a region of low strain at the center
of the plaque. The initial state has a large Young’s modulus contrast
between lipid and other plaque components and the lipid circle is
positioned slightly towards the plaque.
D. Uniqueness of In Vivo Plaque Reconstruction
From the 30 reconstructions, only 5 were successful, i.e., five
showed a PFEM elastogram that highly resembled the measured
elastogram. These five PFEM elastograms had the following fea-
tures clearly in common with the measured elastogram (i) a region
of high strain at each corner of the plaque and (ii) a region of low
strain at the center of the plaque (e.g., figs. 9D, 10B, 10C). Their
RMS errors lay between 0.29% and 0.30%, which was lower than
the RMS errors of the 22 unsuccessful reconstructions ranging from
Fig. 9: Reconstruction
using an in vivo meas-
ured elastogram of a
human coronary artery
with a vulnerable
plaque. (A) Echogram.
(B) In vivo measured
elastogram. (C) Re-
constructed Young’s
modulus image in kPa.
(D) PFEM elastogram
computed using C; the
RMS error is 0.29%.
(E) Initial state at start
of the reconstruction
process.207
 0.31% up to 0.37%. The majority of unsuccessful reconstructions
resulted in a PFEM elastogram with only one region of high strain
at the corner of the plaque (e.g., fig 10D) or lacked a region of low
strain at the center of the plaque (e.g., fig 10E). Within each of the
5 successful reconstructions, the morphology (size, shape and posi-
tion) of a plaque component (i.e., lipid pool or cap) was visually al-
most identical (e.g., figs. 9C, 10B, 10C). Furthermore, there was a
consistent large modulus contrast between the lipid pool and the
other two stiffer components (i.e., cap and media). EL varied only
between 1.8 and 2.4 kPa with a mean+/-SD of 2.1+/-0.2 kPa.
There was less consistency in both EC and EM, since EC varied be-
tween 145 and 280 kPa with a mean+/-SD of 209+/-44 kPa and
EM between 137 and 209 kPa with a mean+/-SD of 179+/-27 kPa.
Fig. 10: Typical successful and unsuccessful reconstruction results obtained from the in vivo measured
elastogram of the human coronary artery with a vulnerable plaque. (A) Echogram and in vivo measured
elastogram. Columns (B) and (C) each shows a successful reconstruction; the RMS error for both is
0.29%. (C) An unsuccessful reconstruction whose PFEM elastogram has only one region with high
strain in common with the measured elastogram; the RMS error is 0.32% (D) Another unsuccessful re-
construction whose PFEM elastogram does not have a region of low strain at the centre of the plaque in
common with the measured elastogram; the RMS error is 0.38%. All Young’s moduli are in kPa.208
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A new reconstruc-
tion method to 
image the mor-
phology and ma-
terial composition 
of vulnerable 
plaques
We have described a new reconstruction method to image the mor-
phology and material composition of vulnerable plaques. This
method needs a plaque’s elastogram, i.e., radial strain image, in or-
der to reconstruct the plaque’s Young’s modulus distribution. It ac-
complishes this by iteratively matching the radial strain image
output of a parametric plaque finite element model to the elasto-
gram. Reconstructions using elastograms obtained from simulated
plaques, a vessel-mimicking phantom with a plaque and an in vitro
human coronary plaque demonstrated that this method could
closely approximate the morphology and material composition of
the three main plaque components, namely lipid pool, cap, and me-
dia. Furthermore, the reconstruction of a plaque, using an in vivo
measured elastogram from a patient, was described. Finally, this
elastogram was used as a realistic example to investigate the unique-
ness of the reconstruction method.
Young’s Moduli of Plaque Components
In this study, the sets of Young’s moduli values that were used for
the two simulated plaques (Table 1), for the phantom (EL=4.2 kPa,
EM=16.8 kPa), and those that were reconstructed from the in vitro
plaque (EL=29, EM=647, EC=1784 kPa) and in vivo plaque (EL=2,
EM=188, EC=188 kPa), all had a Young’s modulus value for the
non-fibrous plaque component (e.g., lipid pool) that was much
lower than the fibrous (e.g., media and cap) plaque components:
Such a stiffness difference has been consistently observed by re-
searchers that performed measurements or used a modulus recon-
struction approach to determine static moduli values for human
atherosclerotic plaque components (Table 2).209
 The following methods were applied to obtain the Young’s moduli
values listed in Table 2: Loree et al. (1994b) used uni-axial mechan-
ical tensile testing on specimens at a physiological applied circum-
ferential tensile stress of 187.5 mmHg. Lee et al. (1992) used
uniaxial mechanical compressive testing on specimens that were
classified by their IVUS appearance; the modulus was defined as the
ratio between the increase in equilibrium-stress, namely from 30 to
90 mmHg, to the resulting strain after creep. De Korte et al. (de
Korte 2000a) used IVUS elastography to measure the radial strain
that resulted by increasing the pressure from 80 to 100 mmHg. Ka-
nai et al. (Kanai 2003) used a direct reconstruction method to
measure local thickness changes of vessel wall layers with an ‘ultra-
sonic phased tracking’ method during physiological pressurization.
Moduli were subsequently computed with an analytical formula,
NON-FIBROUS FIBROUS CALCIFIED
Loree et al. (1994b)
Circumferential
tensile E
927 ± 468
(n=12)
2312 ± 2180
(n=9)
1466 ± 1284
(n=5)
Lee et al. (1992)
Radial compressive
EA, D, E
41.2 ± 18.8
(n=14)
81.7 ± 33.2
(n=18)
354 ± 245.4
(n=11)
de Korte et al. (2000a)
Incremental pressure-
strain EA, D
222
(n=13)
493
(n=62)
Kanai et al. (2003)
Incremental
circumferential EB, D
81 ± 40
(n=9)
1000 ± 630
(n=9)
Beattie et al. (1998)
Bi-linear isotropic EB, D
3.81, strain<18.2%
38.8, strain>18.2%
(n=4)
483, strain<8.2%
1820, strain>8.2%
(n=7)
3990, strain<5.3%
10700, strain>5.3%
(n=1)
Young’s moduli (E) are in kPa and given as mean +/- standard deviation (‘n’ = number of samples).
AMeasured, BReconstructed, CIn vivo, DIn vitro, EOnly plaque-cap
Table 2: Measured and Reconstructed Static Young's moduli (E) of Human Atheroscle-
rotic Plaque Components.210
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isotropic and that the arterial pressure decreased linearly with the
distance from lumen to adventitia. Beattie et al. (Beattie 1998) used
an iterative FEM-based reconstruction method in combination
with measured radial displacement fields (one at 40 mmHg and one
at 80 mmHg intraluminal pressure). Plaque regions were assumed
homogeneous and were identified a priori from histology, after hav-
ing measured displacement fields by particle tracking on cross-sec-
tional digital images. The following FEM material deformation
features were used: isotropic, incompressible and plane stress.
This large variation in moduli values for a specific plaque compo-
nent, and also for normal arterial wall (Gow 1979) (Mozersky
1072), can be attributed to factors that differ between research
groups, such as Dobrin (Dobrin 1978) (Fung 1981) (Yamada
1970):
(i) Type of elastic modulus: dynamic, static, visco-elastic, aniso-
tropic, incremental, pressure-strain, compressive, tensile, shear.
(ii) Type and host of artery: coronary, femoral, etc. from animal or
human.
(iii) Environment: in vitro, in vivo, mechanical constraints, temper-
ature.
(iv) History: preconditioning, (duration of) cold storage and age.
(v) Amount of pre-deformation/pressurization or longitudinal pre-
stretch: arterial constituents stiffen with increasing tension.
(vi) Classification protocol: macroscopic classification into catego-
ries like fatty, fibro-fatty, fibrous, calcified etc. or microscopic clas-
sification into individual arterial constituents like smooth muscle
cells, elastin, collagen, etc. In contrast to microscopic arterial con-
stituents, global plaque constituents do not allow a clear and unique
classification, because they are usually not small enough to be con-
sidered homogeneous.211
 (vii) Assumptions regarding the geometry of the arterial plaque
components and the used constitutive material deformation mod-
els.
Despite these variations, discrimination between non-fibrous, fi-
brous and calcified plaque components is possible thanks to several-
fold stiffness differences between these components. These differ-
ences are necessary for a successful application of reconstruction
methods.
A pressure difference of 20 mmHg for the in vitro artery and only
1 mmHg for the in vivo artery resulted in both cases in elastograms
with radial strains up to 2%. This result is in agreement with previ-
ous studies (de Korte 2000a+2003). The difference suggests that ex-
cising an artery may induce mechanical stiffening (Gow 1979)
(Schaar 2002). This is possibly caused by differences in factors be-
tween situations in vitro and in vivo (e.g., cell inactivity or too much
longitudinal pre-stretch). As expected from linear elasticity this
pressure difference of a factor of 20 with similar strain is reflected
in the reconstructed arterial Young’s moduli values.
PFEM Material Deformation Features
In this study, we have used a linear elastic, isotropic, nearly incom-
pressible, plain strain constitutive material model for (i) simulating
the small-strain arterial deformation behaviour (strain<2.5%) at a
level in the physiological intraluminal pressure range (50-150 mm-
Hg) and (ii) for reconstructing the morphologies and Young’s mod-
uli of plaque components. Many other research groups have also
used all, or only a subset, of these constitutive features for describ-
ing arterial deformation at a level in this pressure range, for exam-
ple: linear elasticity (Chandran 2003) (Wan 2001) (Finet 2004)
(Cheng 1993), isotropy (Lee 1994) (Veress 2000), (Huang 2001)
(Lupotti 2003) (Kim 2004), (near) incompressibility (Holzapfel
1998) (Weizsacker 1988) and plane strain (Soualmi 1997) (Wan
2001) (Cheng 1993). The use of most of these modelling features
can be justified, as follows:
Linear elasticity: When performing IVUS elastography, the measured arterial strains
are low, i.e., the strain between two consecutive IVUS RF frames is
less then 2.5%. Consequently, only a small part of the artery’s non-212
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can, therefore, be considered locally linear.
IncompressibilityAccording to Carew et al. (Carew 1968) arteries may be considered
incompressible. Furthermore, our group has demonstrated (Bald-
ewsing 2004a) that Poisson’s ratio variations of vulnerable plaques,
in the range 0.49-0.49999, had no significant influence on the
strain pattern and strain values in simulated elastograms of those
plaques.
IsotropyAlthough arteries are anisotropic (i.e., their radial, circumferential
and/or longitudinal Young’s modulus values are different) when
their deformation is considered over an intraluminal pressure range
of 0 mmHg up to 200 mmHg (Yamada 1970), anisotropy can be
considerably less prevalent when focusing on in vivo physiological
intraluminal pressures. For example, Weizsacker and Pinto (Weiz-
sacker 1988) showed that the overall response of vascular tissue is
highly non-linear and anisotropic. However, they also concluded
that for the range of deformations that occur in vivo, the arterial
wall can be considered as incrementally isotropic. Furthermore, our
group (Baldewsing 2004b) has demonstrated that a linear elastic,
isotropic, nearly incompressible, plane strain constitutive material
model can appropriately simulate the arterial small-strain behaviour
within the physiological intraluminal pressure range during IVUS
elastography measurements of atherosclerotic arteries in vitro. Fur-
thermore, when isotropy may not be a good approximation for a
certain artery, it is still likely that the erroneous reconstructed iso-
tropic Young’s moduli show a diagnostically useful stiffness con-
trast between the lipid pool and the media/cap components, merely
because this contrast is large for real plaque components.
2D Plane StrainA deforming 3D arterial tubular segment is in a condition of ‘2D
plain strain’ when those cross-sections that are perpendicular to its
longitudinal axis exhibit only strains in the cross-sectional plane
(e.g., circumferential and radial strain) and no strain in the direc-
tion perpendicular to it (e.g., longitudinal strain). Most large
healthy vessels that do not suffer from external forces, maintain a
constant longitudinal length in vivo due to the constraint provided
by arterial side branches and perivascular connective tissue (Dobrin
1987). Consequently, the condition of ‘2D plane strain’ is defend-
able for such vessels. However, for atherosclerotic coronary arteries213
 wrapped around the heart, this condition may not always be appli-
cable because the following sources may introduce an unknown dis-
tribution of tensile and compressive longitudinal strain throughout
some cross-sections: (i) deformation of the heart (ii) curvature of
the coronary longitudinal axis (iii) longitudinal coronary plaque di-
mensions that are smaller than the diameter of the coronary. These
longitudinal strains may result in an erroneous reconstruction when
assuming a ‘2D plain strain’ condition. Future comparative 3D-
versus-‘2D plane strain’ simulation studies are needed to estimate
the influence of those longitudinal strain sources.
Homogeneity The lipid, cap and media plaque component regions were each as-
sumed to be homogenous, i.e., within a region they had the same
Young’s modulus value. Many other groups have applied this ho-
mogeneity assumption for simulating stress within atherosclerotic
plaques or for reconstructing their material properties, e.g., (Beattie
1998) (Chandran 2003) (Lee 1994) (Cheng 1993) (Hayashi 1997).
We have deliberately required the homogeneity of each plaque
component for the following reasons: (i) The assumption of homo-
geneity makes it possible to characterize each of the three plaque
components by just one material parameter (i.e., Young’s modu-
lus). If this assumption would be dropped, then many moduli
would be required for approximating the arterial Young’s modulus
distribution, namely one modulus for each small finite element in
the arterial cross-section. A low number of reconstruction parame-
ters is needed to increase the chance for obtaining a stable (i.e.,
highly unique and not overly sensitive to local minima) reconstruc-
tion (ii) For clinical applications, a clinician is aided by an arterial
stiffness image that is fast and easy to interpret. The assumption of
homogeneity contributes to that purpose. Of course, the drawback
of the homogeneity assumption is that it narrows the class of
plaques that can be reconstructed.
PFEM Geometric Features
In this study we have used an idealized thin-cap fibroatheroma as
PFEM for a plaque; the borders of its plaque components are delin-
eated with circles. This PFEM is a variation of the PFEM model
used by Loree et al. (Loree 1992). It has only 15 parameters (i.e.,
three for each of the four PFEM circles and a Young’s modulus for
the each of the three plaque components), but can still model the214
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phological features a media area containing a lipid pool which is
covered by a cap (Virmani 2002+2003). Although there exist other
types of vulnerable plaques, such as eroded plaques or plaques con-
taining calcified nodules, the idealized thin-cap fibroatheroma
(TCFA) has been used as geometric model for the PFEM for the
following reasons.
(i) TCFAs are considered to be the precursor lesion of rupture and
they account for the majority of plaque rupture (Virmani 2002). 
(ii) The use of an idealized thin-cap fibroatheroma PFEM, should
be considered as a trade-off between (a) an important class of stably
reconstructable plaques, namely the TCFAs and (b) a large class of
non-stable reconstructable plaques.
(iii) The use of a circle for the PFEM lumen is an approximation
for the lumen geometries of vulnerable plaques.
Non-obstructing 
vulnerable 
plaques have an 
almost perfect cir-
cular lumen
This approximation is not only practical for computational purpos-
es (i.e., closed-form, analytical formulas are available for computing
the dynamic control points of the PFEM in fig. 2A), but it is also
often a good approximation for the shape of the lumen: IVUS stud-
ies have shown that normal arteries have an almost perfect circular
lumen border (Nissen 1991). Furthermore, IVUS and pathological
studies (Losorodo 1994) (Glagov 1987) have shown that during the
accumulation of plaque within the normal vessel wall, arteries ex-
hibit ‘compensatory enlargement’ or ‘outward/positive remodel-
ling’, i.e., the lumen cross-sectional area is maintained while plaque
accumulates; this compensation is maintained up to the point were
the plaque area occupies approximately 40% of the (vessel wall + lu-
men) area. These observations, may partly explain why, during clin-
ical trials, our group often observes that the majority of non-
obstructing vulnerable plaques have an almost perfect circular lu-
men. Indeed, there does exist a small class of vulnerable plaques
whose lumen shape is far from perfectly circular. For such plaques
the application of a different, advanced PFEM model, whose lumen
and/or media borders are manually traced or automatically con-
tour-detected from the IVUS echogram, might be an appropriate
solution. This is, however, at the expense of more processing, since215
 no closed-form solutions are then available for computing the dy-
namic control points P, R, S and U of the PFEM in fig. 2A.
(iv) Delineation of PFEM plaque component borders by curve-pa-
rameterizations other than circles (e.g., ellipses) potentially allows a
closer approximation of arbitrarily shaped plaque components.
However, the use of such parameterizations requires more defining
parameters (e.g., an ellipse is described by 5 defining parameters, a
circle by only 3). This will decrease the chance for obtaining a suc-
cessful reconstruction, i.e., finding a reconstruction with a PFEM
elastogram that highly resembles the measured elastogram, since a
PFEM with more parameters, will introduce more local minima
and will increase the non-uniqueness of a reconstruction.
The more non-
circular the real 
lumen is, the more 
unreliable the re-
constructed mod-
uli are
The more non-circular the real lumen is, the more unreliable the re-
constructed moduli are when using a circle for the PFEM lumen.
This is due to local eccentricities that may cause local circumferen-
tial stress concentrations/spreading and, consequently, result in lo-
cal increases/decreases of radial strain values, an effect that cannot
be accounted for by the current PFEM. Nevertheless, the recon-
struction results from the phantom and the simulated plaque that
was traced from histology, demonstrated that a good approxima-
tion of both the geometry and Young’s moduli for each plaque
component was still possible, despite the fact that these compo-
nents, including the lumen and media border, were not delineated
by circles. A discrepancy in circularity between media borders is not
expected to be of much impact, since the stress and strain are there
much lower than near the lumen (due to natural stress decay caused
by the circumferential geometry of the vessel wall).
Initialization Strategy
To maximize the chance for obtaining a successful reconstruction,
all practically available a priori information in echograms and elas-
tograms should be used to define an initial state for the PFEM: the
lipid circle should be positioned towards the direction of plaque
thickening. This strategy was applied for all reconstructions. Radial
strain patterns in elastograms also indicate possible configurations
for the PFEM components that will likely produce a PFEM elasto-
gram that resembles the measured elastogram. This strategy was ap-216
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modulus contrast between the lipid and media/cap plaque compo-
nents was used in all reconstructions (in fig. 3, the reconstruction
was also successful without using initial Young’s modulus contrast).
The closer the initial Young’s modulus values are chosen to the ac-
tual values of the plaque components, the higher the chance for ob-
taining a successful and correct reconstruction. However, a
reasonable initial choice is not practically retrievable from litera-
ture, since those values are too widespread (e.g., table 2). Thus, to
determine reasonable initial values for a specific in vitro or in vivo
situation, first multiple reconstructions should be performed for
one plaque, using a wide range of different initial values for each
plaque component, similar as was done for the in vivo human cor-
onary plaque reconstruction. Then, the moduli of the most success-
ful reconstruction can be used as a practical initial choice for
reconstructions with other plaques.
Judgment of Reconstruction
The reconstruc-
tion method uses a 
minimization al-
gorithm
The reconstruction method uses a minimization algorithm to find
a local minimum of the RMS error between the simulated or meas-
ured elastogram and the PFEM elastogram. Without knowing the
actual plaque composition one does not know how good a success-
ful reconstruction approximates it or if a global minimum has been
found. To get an indication if a global minimum has been found
one may perform multiple reconstructions with different initial
states and check if the majority of successful reconstructions ap-
proximate one Young’s modulus image. The only way to judge how
good a reconstruction approximates the actual unknown plaque
composition is by comparing the similarity of structural patterns
(e.g., regions of high and low radial strain) in both elastograms.
This strategy was applied for the reconstruction using the in vivo
measured elastogram
.217
 Uniqueness
A low RMS error 
might be a good 
criterion for select-
ing a successful re-
construction
The reconstruction results for the first three plaques (i.e., two sim-
ulated arteries and the phantom) have demonstrated that the recon-
struction method can successfully approximate the geometry and
stiffness of plaque components. However, it was not demonstrated
or proven that these reconstructions were unique. Theoretically it
is possible that different PFEM geometries and/or moduli of the
plaque components give a similar PFEM strain elastogram or a very
different PFEM strain elastogram that has the same RMS error
(Barbone 2004). Practically, this seems highly unlikely because of
the strong geometrical constraints that are imposed upon the
PFEM model. The results from the in vivo case support this hy-
pothesis because they demonstrated that the level of uniqueness for
a successful reconstruction was high with respect to (i) the mor-
phology of the reconstructed plaque components and (ii) the recon-
structed stiffness contrast between the lipid pool and other two
stiffer components. However, with respect to the absolute values of
the reconstructed moduli of the stiff plaque components, the
uniqueness level was only moderately high. Furthermore, from the
30 reconstructions that were performed, only those reconstructions
with the lowest RMS errors were successful; this suggests that a low
RMS error might be a good criterion for automatically selecting the
most successful reconstruction(s) from a set of reconstructions.
Clinical implications and applications
A new way of in-
travascular tissue 
characterization
The current results suggest that our reconstruction method is a new
way of intravascular tissue characterization that may be suitable for
clinical applications, such as (i) tissue characterization: to allow the
selection of proper interventional procedures and (ii) monitoring of
atherosclerosis: to quantify the effect of pharmaceutical treatments
aimed at stabilizing plaques, e.g., by stiffening (Loree 1994b)
(Aikawa 1998) or reducing the lipids (Schartl 2001). Furthermore,
this method allows investigation and explanation of strain artifacts
in elastograms and it may be applied to quantify the amount of
stiffening of arterial plaque components within the physiological
intraluminal pressure range. Finally, this method only needs an
elastogram as input. Therefore, any imaging modality capable of
measuring elastograms may be used. Our reconstruction method218
 CHAPTER 14 PLAQUE COMPOSITIONmay potentially also be applied in other clinically relevant situations
where circular objects are present in an almost homogeneous medi-
um that is strained, e.g., superficial atherosclerotic arteries, such as
the carotid or femoral.
Limitations 
Although the presented reconstruction results are promising, there
are still some issues related to the robustness of the reconstruction
method that have to be quantified in future studies, such as
Measurement 
noise
(i) measurement noise: the results from the phantom and in vitro
plaque showed that in the presence of measurement noise it was still
possible to obtain a successful reconstruction. However, the contri-
bution of measurement noise upon the degradation of a reconstruc-
tion has not been quantified. 
Catheter position(ii) Catheter position: the radial strain distribution in a simulated
or measured elastogram depends upon the position of the catheter
within the lumen (de Korte 1999). Consequently, different catheter
positions within the same plaque result in different radial strain
elastograms. Because these elastograms are different, it seems rea-
sonable to expect that the corresponding reconstructions are differ-
ent. However, this is unlikely, since the position of the catheter that
is used for a simulation or measurement of an elastogram is also
used in the PFEM.
CONCLUSION
A new reconstruction method is described for obtaining morphol-
ogy and material composition images of arterial vulnerable plaques.
This method reconstructs a Young’s modulus image from a meas-
ured elastogram, i.e. radial strain image of a plaque, by iteratively
matching an elastogram calculated with a parametric plaque finite
element model to the measured elastogram. This method has suc-
cessfully reconstructed Young’s modulus images from elastograms
that were 
(i) simulated with finite element models of plaques, 219
 (ii) measured from a synthetic plaque and 
(iii) measured from an in vitro human coronary plaque. It has also
been applied on an elastogram of a plaque measured in vivo in a pa-
tient.220
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 CHAPTER 15 CONSENSUS STATEMENTA conference was held in which 75 participants from 12 countries
spent two days reviewing progress in the field of research on the vul-
nerable atherosclerotic plaque. The discussions covered the patho-
physiology, epidemiology, detection and treatment of this leading
cause of cardiovascular morbidity and mortality.
The growing volume of research on this topic was apparent, as was
substantial progress in many areas. There was general agreement
that continued work in this area is essential because of the major
progress in prevention of sudden cardiac death, non-fatal myocar-
dial infarction, and stroke, that could be achieved, among those in
the general population, and those already afflicted with cardiovas-
cular disease. For those who are free of overt cardiovascular disease,
the goal of this research is the identification of risk and preventive
treatment of a first cardiac event. In those who have suffered a car-
diac event and are studied in the catheterization laboratory, the goal
is to lower their risk of a subsequent cardiac event to that of the gen-
eral population. Prevention would be facilitated by improved deter-
mination of risk and initiatiation of treatment, including lifestyle
changes, to stabilize vulnerable plaques that would otherwise be re-
sponsible for future events.
The participants identified the following areas in which research ef-
forts should be accelerated:
Animal ModelsIncreased studies in existing animal models, especially the athero-
sclerotic Apo E deficient mouse, rabbit and pig.
Novel, robust animal models are needed to increase understanding
of processes leading to formation and disruption of vulnerable
plaques. This would facilitate identification of mechanism-based
biomarkers, imaging and intervention strategies.223
 Characterization 
of the epidemiolo-
gy
Improved characterization of the epidemiology of the disorder, in-
cluding studies of autopsy material and plaques obtained at ender-
arterectomy
Development of 
diagnostic capa-
bilities
Continued development of diagnostic capabilities using plasma
markers, proteomics, gene expression and other non-invasive ap-
proaches that might be useful for screening, and invasive devices for
precise evaluation of plaque characteristics.
Acceleration of 
Clinical Trials of 
Non-invasive Di-
agnostic Methods 
Progress with, MSCT, MRI, PET/CT, EBCT and cardiovascular
ultrasound enhanced with contrast agents now justifies more exten-
sive study of these methods in patients to fully identify their poten-
tial for screening of the general population, identification of high-
risk/vulnerable patients, and monitoring of therapy. Large trials in
over 1,000s of individuals with follow-up studies to determine fre-
quency of cardiovascular events are needed. The risks versus bene-
fits of radiation exposure must be carefully considered for PET and
CT methods.
Acceleration of 
Clinical Trials of 
Invasive Diagnos-
tic Methods
Progress with many catheter-based invasive diagnostic devices, in-
cluding those capable of assessing vascular function, was noted.
These devices, which are in various stages of development, require
further validation in clinical studies. The first level of validation re-
quired is the ability to differentiate signals from a disrupted (previ-
ously vulnerable) plaque from other plaques. 
Once this capability is achieved, these devices should be tested for
their ability to identify prospectively coronary artery plaques that
are at increased risk of disruption, as determined by follow-up nat-
ural history studies. The most important endpoints for these studies
are overall mortality, cardiovascular mortality, and documented
non-fatal myocardial infarction. Other events such as unstable an-
gina, PCI due to the presumed vulnerable plaque, and progression
of stenosis and plaque volume are also of importance. These natural
history trials will require studies in thousands of individuals fol-
lowed for one or more years. They will be aided by the selection of
individuals judged to be at high risk by other characteristics such as
Framingham criteria, plasma markers and non-invasive findings. It
is likely that successful identification of vulnerable plaque will re-
quire information from more than one modality. The focus of these224
 CHAPTER 15 CONSENSUS STATEMENTnatural history trials should be on sites suspected to be vulnerable
that are not associated with a flow limiting stenosis.
Features of Clini-
cal Trials of 
Treatment of Vul-
nerable Plaque
It was noted that prior efforts to prevent cardiovascular disease
through various pharmacologic treatments are likely to have
achieved at least part of their positive effects through stabilization
of vulnerable plaques, although these studies were conducted prior
to availability of methods to characterize plaque vulnerability. Re-
search is needed on novel pharmacologic approaches to stabilize
vulnerable plaque.
The new vulnerable plaque diagnostic devices that are under devel-
opment may assist pharmacologic studies by identifying high-risk
groups in which randomized evaluation of a new therapy can be
performed in a smaller number of patients.
It is possible that successful treatment of vulnerable plaque will re-
quire local as well as systemic therapy since focal areas of risk appear
to be present. Stents offer promise for the treatment of vulnerable
plaque, but their use for lesions producing less than 70% stenosis
must take into account potential stent-related complications of su-
bacute thrombosis and restenosis.
If an intracoronary diagnostic device could identify plaques at in-
creased risk of disruption, treatment of the plaques with a stent or
standard pharmacologic therapy could be randomly evaluated. At
present, the available evidence does not justify routine stenting of
non-flow limiting lesions because they are suspected to be vulnera-
ble.
SummaryThere has been considerable progress on vulnerable plaque research
in the year since the First International Vulnerable Plaque Confer-
ence.   Positive results in many areas indicate an increased likeli-
hood that the goal of detection and treatment of vulnerable
atherosclerotic plaque can be achieved. The goal is of increased im-
portance because of the aging of the population.
An optimal rate of progress will require investment in the clinical
trials that are now possible. The financial support and effort re-
quired to conduct these trials will be significant. Due to the magni-
tude of the disease public founding is recommended. However, if225
 these plaques, which are responsible for vast numbers of sudden
deaths, myocardial infarctions and strokes, could be detected and
treated before they cause disease, the costs of the trials, which
should be supported by public funds as well as industry, would be
more than justified by the great improvement in health throughout
the world that would be achieved.226
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 CHAPTER 16 DISCUSSION AND CONCLUSIONIntravascular ultrasound palpography is a new imaging technique
that allows visualization of the deformation of atherosclerotic
plaques. The technique is based on principle of elastography that
the strain as response of tissue to a mechanical force is dependent
on its mechanical properties. Several techniques had been investi-
gated (van der Steen 1998) to strain the vessel wall. Leaving the me-
chanical deformation to the intravascular pressure, which is
reproducible, is occurring about sixty times per minute and is for
free, seemed to be a reasonable idea.
Prior to this thesis it was formulated (de Korte 1998a) that elastog-
raphy may have a place in detecting vulnerable plaques. The detec-
tion of vulnerable plaques is currently one of the major challenges
in cardiology. Invasive and non-invasive techniques are currently
evaluated and try to de-mystify the field. These techniques are re-
viewed in chapter 1.
Definitions
Agreement on no-
menclature
The need for a well-accepted terminology and the outgrowth of the
accompanying discussion is described in chapter 2. A group of in-
vestigators met for two days in Santorini, Greece, to discuss
progress in the field of identification and treatment of high risk/vul-
nerable atherosclerotic plaques and patients. It was recognized that
increased understanding of the pathophysiology of coronary
thrombosis and onset of acute coronary syndromes has created the
need for agreement on nomenclature. The participants spent con-
siderable time discussing the topic and reached consensus on their
own usage of the terms as described below. A culprit lesion in a cor-231
 onary artery can be considered, on the basis of angiographic, autop-
sy or other findings, to be responsible for the clinical event. In
unstable angina, myocardial infarction and sudden coronary death,
the culprit lesion is often a plaque complicated by thrombosis ex-
tending into the lumen.
Several forms of 
vulnerable 
plaques
Responsible for this event are several forms of plaques. An eroded
plaque with loss and/or dysfunction of the lumenal endothelial cells
leading to thrombosis. There is usually no additional defect or gap
in the plaque, which is often rich in smooth muscle cells and prote-
oglycans. An inflamed thin-cap fibroatheroma (TCFA) is a plaque
with a thin cap covering a lipid-rich, necrotic core. An inflamed
TCFA is suspected to be a vulnerable plaque. A heavily calcified
plaque, with the loss and/or dysfunction of endothelial cells over a
calcified nodule makes the plaque vulnerable. This is the least com-
mon of the three types of suspected vulnerable plaques. The most
common cause of thrombosis is an already ruptured plaque with
deep injury with a real defect or gap in the fibrous cap that had sep-
arated its lipid-rich atheromatous core from the flowing blood,
thereby exposing the thrombogenic core of the plaque. It was
agreed that the terms high-risk plaque, vulnerable and thrombosis-
prone plaque can be used as synonyms to describe a plaque that is
at increased risk of thrombosis (or re-thrombosis). Since there is
consensus on this terminology among several major scientists in the
field, it is hoped that widespread adoption of this terminology may
help communication between scientists throughout the field.
Validation in vitro
Human coronary 
and femoral ar-
teries were used 
for in vitro vali-
dation
The foundation of this thesis was prepared by elastographic exper-
iments, which were performed in excised human coronary (n=4)
and femoral (n=9) arteries (de Korte 2000a). Data were acquired at
room temperature at intraluminal pressures of 80 and 100 mmHg.
Coronary arteries were measured using a solid state 20 MHz array
catheter (Volcano, Rancho Cordova, CA, USA). Femoral arteries
were investigated using a single element 30 MHz catheter (DuMed/
EndoSonics, Rijswijk, The Netherlands). The rf-data were stored.
The processing was done off-line. The visualized segments were
stained on the presence of collagen, smooth muscle cells and mac-
rophages. Matching of elastographic data and histology was per-
formed using the IVUS echogram. The cross-sections were232
 CHAPTER 16 DISCUSSION AND CONCLUSIONsegmented in regions (n=125) based on the strain value on the elas-
togram. The dominant plaque types in these regions (fibrous, fibro-
fatty or fatty) were obtained from histology and correlated with the
average strain and echo-intensity.
High strain values 
were co-localised 
with increased 
concentrations of 
macrophages
Mean strain values of 0.27%, 0.45% and 0.60% were found for fi-
brous, fibro/fatty and fatty plaque components. The strain for the
three plaque types as determined by histology differed significantly
(p=0.0002). This difference was independent on the type of artery
(coronary or femoral) and was mainly evident between fibrous and
fatty tissue (p=0.0004). The plaque types did not reveal echo-inten-
sity differences in the IVUS echogram (p=0.992). Conversion of
the strain into Young's modulus values resulted in 493kPa, 296 kPa
and 222 kPa for fibrous, fibro/fatty and fatty plaques. Although
these values are higher than values measured by Lee et al. (Lee
1992), the ratio between fibrous and fatty material is similar. Since
fibrous and fatty tissue demonstrated a different strain value and
high strain values were often co-localised with increased concentra-
tions of macrophages, these results reveal the potential of identifi-
cation of the vulnerable plaque features. This early validation work
was done at room temperature, which rose continuously the ques-
tion if this experiments could be translated into the “real world”
since biological tissues may have at room temperature different ma-
terial properties than in body temperature. We performed experi-
ments (chapter 3) on specimens to determine the influence of
freezing and measuring the tissues at room temperature (23 °C in-
stead of 37 °C) on the elastic properties. Four human coronary, one
carotid and one femoral arteries were first measured at 23 °C and
next at 37 °C. Additionally they were stored at -80 °C for up to 24
h and finally measured at 23 °C. Qualitative and quantitative anal-
ysis of the elastograms obtained from fresh and frozen specimens
measured at 23 °C revealed that storage of the specimen at -80 °C
has no significant influence.
We concluded that in vitro experiments can be performed at room
temperature after storage of the tissue at -80 °C without significant
affection of the information with respect to measuring fresh ex vivo
material at body temperature.
The most important step in the development of a vulnerable plaque
is the rupturing process, which takes place at the surface of the tis-233
 sue. Since this acting force is applied on the lumen boundaries, a
surface based assessment of the mechanical properties was devel-
oped. This robust technique is easier to interpret then elastograms
and called palpography. Palpography derives mechanical informa-
tion of the surface of the plaque, where the rupture may happen.
This information is colour-coded and superimposed on the IVUS
echogram.
Plaques, which 
are declared vul-
nerable in elasto-
graphy, have a 
thinner cap than 
non-vulnerable 
plaques
From this point the identification of vulnerable plaques was of
main interest making it necessary to perform additional validation
(chapter 4). Diseased coronary arteries (n=24) were measured in
vitro. Palpographic data was acquired at intracoronary pressures of
80 and 100 mmHg. After the ultrasound experiments, the cross-
sections were stained for collagen and fat, smooth muscle cells
(SMC), and macrophages. In histology, a vulnerable plaque was de-
fined as a TCFA. A plaque was considered vulnerable in elastogra-
phy when a high strain region was present at the lumen-plaque
boundary that was surrounded by low strain values. Using this def-
inition, the vulnerability of the regions was assessed. We studied 54
cross sections. In histology, 26 vulnerable plaques and 28 non-vul-
nerable plaques were found; elastography was positive in 23 cases
but negative in 3 cases. Non-vulnerable plaque were seen by histol-
ogy in 28 cases and detected by elastography in 25 cases, but were
falsely diagnosed as positive in 3 cases resulting in a sensitivity of
88%, and the specificity of 89% to detect vulnerable plaques de-
fined as TCFA. Linear regression showed high correlation between
the strain in caps and the amount of macrophages (P<0.006) and
an inverse relation between the amount of smooth muscle cells and
strain (P<0.0001). Plaques, which are declared vulnerable in elas-
tography, have a thinner cap than non-vulnerable plaques
(P<0.0001) (Schaar 2003a). 
Taking together the evidence to detect tissue structures, which rep-
resent vulnerable plaques, we thought it is ethically justifiable to go
into in vivo validation scenarios. 234
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Iliac and femoral 
arteries of pigs 
were used for in 
vitro validation
IVUS elastography was validated in vivo (chapter 5) using an
atherosclerotic Yucatan minipig (de Korte 2002a). External iliac
and femoral arteries were made atherosclerotic by endothelial Fog-
arty denudation and subsequent atherosclerotic diet for the dura-
tion of 7 months. Balloon dilatation was performed in the femoral
arteries and the diet was discontinued. Before termination, 6 weeks
after balloon dilation and discontinuation of the diet, data were ac-
quired in the external iliac and femoral artery in 6 Yucatan pigs. In
total, 20 cross-sections were investigated. The tissue was strained by
the pulsatile blood pressure. After the ultrasound experiments and
before dissection, X-ray was used to identify the arterial segments
that had been investigated by ultrasound. The specimens were fro-
zen in liquid nitrogen. The cross-sections (7µm) were stained for
collagen and macrophages. Plaques were classified as absent, as early
fibrous lesion, as early fatty lesion or as advanced fibrous plaque.
The mean strain in these plaques and normal cross-sections was de-
termined to assess the tissue characterisation properties of the tech-
nique. Furthermore, the deformability of the acquisition was
correlated with the presence of fat and macrophages. The deforma-
bility was characterised by the presence of a high strain region
(strain is higher than 1%) at the lumen vessel-wall boundary.
High strain region 
had a high sensi-
tivity (92%) and 
specificity (92%) 
to identify the 
presence of macro-
phages 
Strains were similar in the plaque free arterial wall and the early and
advanced fibrous plaques. Univariate Analysis of Variance revealed
significantly higher strain values in cross-sections with early fatty le-
sions than in fibrous plaques (p=0.02) independently on the pres-
ence of macrophages. Although a higher strain value was found in
plaques with macrophages than in plaques without macrophages,
this difference was not significant after correction for fatty compo-
nents. However, the presence of a high strain region had a high sen-
sitivity (92%) and specificity (92%) to identify the presence of
macrophages. Therefore, it was concluded that the tissue type dom-
inates the mean strain value. Localised high strain values are related
to local phenomena like inflammation. 235
 Three-dimensional Palpography
During longitudi-
nal monitoring of 
patients it is ex-
tremely difficult to 
find back the 
same spot
The distribution of the strain in the three dimensional geometry of
an artery is an important tool to identify the presence of high strain
spots (chapter 6), the amount and the distribution. Especially,
since the correlation between plaque vulnerability and parameters
provided by the echogram is low, selection of cross-sections based
on the IVUS echogram introduces selection bias and increases the
chance to miss the vulnerable part. Additionally, during longitudi-
nal monitoring of patients it is extremely difficult to find back the
same spot after some months. Therefore, an acquisition method to
get strain information of the full 3D coronary artery was developed. 
Palpography has 
revealed excellent 
reproducibility
Experiments in rabbit aortas revealed that three-dimensional pal-
pography is feasible in vivo. Despite the introduction of out-of-
plane motion by the continuous pull back of the catheter, the sim-
ilarity between successive frames acquired in the diastolic phase is
high enough to calculate several palpograms per heart cycle. By
combining these palpograms, one compound palpogram per heart
cycle is determined (Doyley 2001). Furthermore palpography has
revealed excellent reproducibility (chapter 7). The region, in which
palpography was performed two times, was defined on the basis of
identifiable landmarks, such as side branches or edges of stents.
This matching of these consecutive regions was done on the funda-
mental IVUS frames reconstructed from rf-data unaware of the pal-
pographic results. In 14 patients 19 recordings with a length of 1.8
cm were done resulting in 909 sections to compare. Next to other
statistical tests, which showed a good reproducibility the Blant-Alt-
man test revealed a mean of 0.042 of strain differences with a stand-
ard deviation of 0.07. This data add evidence that palpography is a
robust method to detect high strain spots in vivo.
Clinical application
AMI patients 
have significantly 
more high strain 
spots than stable 
patients
In a recent study in humans (chapter 8) three-dimensional palpo-
grams were derived from continuous intravascular ultrasound pull-
backs of entire coronary arteries. Patients (n=55) were classified by
clinical presentation as having stable angina, unstable angina, or
AMI. In every patient, one coronary artery was scanned (culprit ves-
sel in stable and unstable angina, non-culprit vessel in AMI), and236
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had significantly fewer deformable plaques per vessel (0.6±0.6) than
unstable angina patients (p<0.0019) (1.6±0.7) or AMI patients
(p<0.0001) (2.0±0.7). Levels of C-reactive protein were positively
correlated with the number of mechanically deformable plaques
(R2=0.65, p<0.0001) (Schaar 2004a).
For further qualification in the clinical setting palpography took
part in the IBIS (Integrated Biomarker and Imaging Study) trial
(chapter 9).
The SMS-Index 
describes the ex-
tent of highly de-
formable plaques 
and is taken as a 
measure for vul-
nerability
IBIS is a prospective, single-center, non-randomized, observational
study The aim of the study was to evaluate both invasive (quantita-
tive coronary angiography, intravascular ultrasound (IVUS) and
palpography) and non-invasive (multislice spiral computed tomog-
raphy) imaging techniques to characterize non-flow limiting coro-
nary lesions. In addition, multiple classical and novel biomarkers
were measured and their levels correlated with the results of the dif-
ferent imaging techniques. Strain values were classified according to
the ROC classification (ROtterdam Classification) as low strain
spots (ROC I: 0.0 - <0.6%), moderate strain spots (ROC II: 0.6 -
<0.9%), medium strain spots (ROC III: 0.9 - <1.2%), or high
strain spots (ROC IV: >1.2%). In the region of interest (ROI) the
number of ROC III and IV scores were characterized using the
Schaar-Mastik-van der Steen- (SMS)-Index. It was calculated as the
number of ROC III and IV scores that were measured in the ROI
at cross-sections positioned uniformly over the length of the ROI
and averaged over the number of those cross-sections and finally
multiplied by 10 to arrive at a value with an appealing range. This
SMS-Index describes the extent of highly deformable plaques and
is taken as a measure for vulnerability e.g. in a specific coronary ar-
tery.
The main findings of this trial (chapter 10) regarding palpography
were consistent with other observations that there are widespread
abnormalities, in non-culprit vessels or remote myocardium of pa-
tients with acute coronary syndromes. The high prevalence of struc-
turally vulnerable plaque found in this study, together with post-
mortem observations showing clinically silent plaque rupture is rel-
atively common suggesting that isolated rupture is unlikely to ac-
count for rather infrequent ischemic events. Furthermore this study237
 demonstrates that, within arbitrarily selected segments of non-cul-
prit vessels, structurally vulnerable plaques were quite common, de-
spite only mild angiographic disease. It confirms our previous
observations that patients with STEMI have a significantly higher
number of structurally vulnerable plaques than other patients with
different presentations, in coronary regions remote from the site of
occlusive thrombosis.
After 6 month the 
SMS-index has 
not changed for 
patients with sta-
ble and unstable 
angina, but is sig-
nificantly re-
duced in the 
group of patients 
with myocardial 
infarction.
After 6 month we have investigated the patients of IBIS again
(chapter 11 and chapter 12). This is the first clinical follow up
study using 3D palpography. This pilot study was performed blind-
ed to assess (a) the change of the SMS-index and (b) the change of
individual ROC scores, as well as (c) their relation to clinical pres-
entation. After 6 month the SMS-index has not changed for pa-
tients with stable and unstable angina, but is significantly reduced
in the group of patients with myocardial infarction. This may be
due to the fact that patients in the latter group were presented at in-
dex with a therapy regime, which was extensively modified after in-
itial interventional treatment. Furthermore this data support the
hypothesis that vulnerability is a pan-artery process (Buffon 2002)
and current treatment regimes can reduce it, but not eliminate it
taking into account that at follow up the SMS index was not signif-
icantly different between the groups.
Future applications
The process of 
plaque stiffening 
can be monitored 
using intravascu-
lar palpography
On the end all acute coronary syndromes are related to thrombotic
events. Intravascular palpography, by its capacity to evaluate the
mechanical properties of biological tissues, can detect e.g. thin-cap
fibroatheromas, but 25% of all myocardial infarctions are caused by
wall standing thrombi. We used an animal model (chapter 13) in-
ducing electric vascular injury, which generates platelet-rich throm-
bi similar to that observed in the coronary arteries of patients with
acute myocardial infarction. The major findings of this study are
that a thrombus gets stiffer over time and a vast part of the organi-
zation process takes place within 20 min. after thrombus introduc-
tion and that this process can be monitored using intravascular
palpography. The clinical application of this in vivo animal model
has yet to be defined.238
 CHAPTER 16 DISCUSSION AND CONCLUSIONPalpography can 
not be used for tis-
sue characteriza-
tion
The future of intravascular diagnostic ultrasound will be tissue
characterization. This can not be done by conventional IVUS or an
IVUS related technique like palpography or elastography. This is
mainly due to the fact that the arterial stress distribution is un-
known and data cannot be directly translated into a morphological
and compositional image. To overcome this limitation we have de-
veloped a method that reconstructs a Young's modulus image from
an elastogram (chapter 14). The reconstruction of the plaque is
done by a minimization algorithm that matches the strain image
output, calculated with a Parametric Finite Element Model
(PFEM) representation of a TCFA, to an elastogram by iteratively
updating the PFEM geometry and material parameters. This meth-
od has successfully reconstructed Young's modulus images from
elastograms that were (i) simulated with finite element models of
plaques, (ii) measured from a synthetic plaque and (iii) measured
from an in vitro human coronary plaque. It has also been applied
on an elastogram of a plaque measured in vivo in a patient. This
new technique called modulography may develop into a reliable
and robust technique to give us information about plaque content.
Vulnerable Plaque: Quo Vadis?
The directions along which the vulnerable plaque field may move
into the future are expressed in a consensus statement of the leading
vulnerable plaque experts (chapter 15). There has been considera-
ble progress on vulnerable plaque research in the last years.   Positive
results in many areas indicate an increased likelihood that the goal
of detection and treatment of vulnerable atherosclerotic plaque can
be achieved. The goal is of increased importance because of the ag-
ing of the population. Novel, robust animal models are needed to
increase understanding of processes leading to formation and dis-
ruption of vulnerable plaques. These models could be tested for
new invasive and non-invasive detection modalities and would
serve as a base for clinical trials. These clinical trials have to address
the stabilization process of plaques, e.g. by local as well as systemic
therapy, but also their natural history. An optimal rate of progress
will require investment in the clinical trials that are now possible.
The financial support and effort required to conduct these trials will
be significant.239
 Palpography: Quo Vadis?
The current limitations of the technique will guide us to further de-
velopment of the technique. An issue is motion artifacts, which are
caused by longitudinal motion of the catheter along the coronary
artery, but also by rotational motion along the axis of the catheter.
Furthermore motion is created by the pull-back procedure. Since
the palpogram is calculated from two different radio frequency lines
that are obtained from the same Region Of Interest (ROI) at differ-
ent pressures, motion may inhibit finding the same ROI in both
images. If this is the case there will be a missing value at this location
in the palpogram. Motion detection and compensation will play an
important role in near future palpography development. Using pro-
cedures like balloon inflation to stabilize the catheter seem to be
clinically too complicated and may hinder the use in the daily prac-
tice.
Palpograms may be difficult to interpret by users since it gives a new
parameter, which was not yet used in the clinic. A more objective
way and simplified way to describe strain data may be useful to de-
velop, which only highlights the high strains spots, which relate to
vulnerable plaques. This may enhance practicability and reduce in-
tra- and inter observer variability. 
Furthermore, like all new evolving techniques, it will be fully inte-
grated into the catheterization laboratory. A fully integrated cath
lab will allow data and image fusion between modalities and the
concomitant opportunities for clinical and pathophysiological car-
diovascular research. 
Palpography is an extensively validated technique, but so far the
validation has been performed in just one centre. At present it is ex-
tended to multiple centres, which will reveal shortcomings, but also
new opportunities for this technology. 
Conclusion
Intravascular ultrasound palpography is a new technique capable to
provide strain data of the vessel surface. Palpography:240
 CHAPTER 16 DISCUSSION AND CONCLUSION• can detect inflamed thin cap fibroatheromas in vitro with a 
high sensitivity and specificity
• can detect fatty plaques with an increased mean strain value.
• can detect high-strain spots that are associated with the pres-
ence of macrophages
• can measure strain in three-dimensions in the coronary artery
• is reproducible
• can be applied in the clinic and detect high strains spots in fol-
low up trials
• can detect thrombus age241
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 CHAPTER 17 DISCUSSIE EN SAMENVATTINGIntravasculair ultrageluid palpografie is een nieuwe afbeeldings-
techniek die visualisatie toelaat van de deformatie van atherosclero-
tische plaques. De techniek is gebaseerd op het principe van
elastografie, dat de deformatie van weefsel als gevolg van een me-
chanische kracht afhangt van zijn mechanische eigenschappen. Ver-
schillende technieken zijn onderzocht   om de vaatwand te
vervormen. Het leek een redelijke gedachte om de mechanische ver-
vorming over te laten aan de intravasculaire druk, die reproduceer-
baar is, ongeveer zestig keer per minuut op treedt en kosteloos
beschikbaar is. 
Voorafgaand aan dit proefschrift, was reeds gesteld (de Korte
1998a) dat elastografie mogelijkerwijs een rol kan spelen in de de-
tectie van vulnerabele plaques. Detectie van vulnerabele plaques is
tegenwoordig een van de grootste uitdagingen in de cardiologie. In-
vasieve en niet-invasieve technieken worden op dit moment geeva-
lueerd en deze proberen het onderzoeksgebied te de-mystificeren.
Deze technieken worden nader bekeken in hoofdstuk 1.
 
Definities
Overeenstem-
ming nomenclat-
uur
De vraag naar een algemeen geaccepteerde terminologie en de bij-
behorende discussie wordt beschreven in hoofdstuk 2. Een groep
van onderzoekers ontmoette elkaar voor twee dagen in Santorini
Griekenland, om de voortgang in het veld van identificatie en be-
handeling van hoge risico/vulnerabele atherosclerotische plaques en
patiënten te bediscussiëren. Het werd onderkend dat een verbeterd
begrip van de pathofysiologie van coronair trombosis en het begin
van acute coronair syndromen de vraag naar overeenstemming over
nomenclatuur had gecreëerd.245
 De deelnemers besteden aanzienlijke tijd om het onderwerp te be-
discussiëren en bereikten consensus over hun eigen gebruik van de
termen zoals hieronder beschreven. Op basis van angiografie, au-
topsie of andere bevindingen, kan een verdachte laesie in een coro-
nair vaatwand worden beschouwd als verantwoordelijk voor een
klinische gebeurtenis. Bij onstabiele angina, myocard infarct en
plotselinge dood door hartfalen, is de verdachte laesie vaak een pla-
que gecompliceerd door trombosis die doorloopt tot in het lumen.
Verschillende ver-
schijningsvormen 
van vulnerabele 
plaques
Een aantal typen plaques zijn verantwoordelijk voor deze gebeurte-
nis. Een geërodeerde plaque met verlies en/of ontregeling van de lu-
minale endotheelcellen leidend tot trombosis. Er is meestal geen
additioneel defect of gat in de plaque die vaak rijk is aan gladde
spiercellen en proteoglycans. Een ontstoken dunne-kap fibroather-
ma (TCFA) is een plaque met een dunne kap die een vet-rijk, ne-
crotisch gebied bedekt. Een ontstoken TCFA wordt ervan verdacht
een vulnerabele plaque te zijn. Een zwaar gecalcificeerde plaque,
met verlies en/of ontregeling van endotheel cellen over een gecalci-
ficeerde nodule maken de plaque kwetsbaar. Dit is het minst vaak
voorkomende van de drie types plaque die ervan verdacht worden
vulnerabel te zijn. De meest voorkomende oorzaak van trombosis is
de ruptuur van een plaque met diepe schade waarbij een echte de-
fect of gat in de fibreuze kap is ontstaan, die de lipide-rijke athero-
mateuze kern niet meer scheidt van de bloedbaan en dus de
trombogene kern van de plaque bloot legt. Er werd overeengeko-
men dat de termen hoge-risico plaque, vulnerabele en trombosis-
vatbare plaque als synoniemen te gebruiken zijn voor de beschrij-
ving van een plaque die een verhoogd risico van trombosis (of her-
trombosis) heeft. Aangezien er een overeenstemming is bereikt over
deze terminologie, tussen een aantal belangrijke wetenschappers in
dit onderzoeksgebied, wordt er gehoopt dat een wijdverbreide inge-
bruikname van deze terminologie de communicatie tussen weten-
schappers over het gehele onderzoeksgebied zal verbeteren.246
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Humane coro-
nairen en femo-
raal arteriën 
werden gebruikt 
voor invitro vali-
datie
De basis van dit proefschrift werd voorbereid door elastografische
experimenten, die ex-vivo werden uitgevoerd op humane coronair
(n=4) en femoraal (n=9) arteriën(de Korte 2000a). Data werd ver-
kregen bij kamertemperatuur bij een intraluminale druk van 80 en
100 mmHg. Coronair arteriën werden gemeten met een elektro-
nisch gestuurde 20 MHz array catheter (Volcano, Rancho Cordo-
va, CA, USA). Femoraal arteriën werden onderzocht met een enkel-
elements 30 MHz catheter. De rf-data werd opgeslagen. De proces-
sing werd off-line gedaan. De gevisualiseerde segmenten werden
histologisch gekleurd voor de aanwezigheid van collagen, gladde
spiercellen en macrofagen. Vergelijken van de elastografische data
en histologie werd gedaan met behulp van het IVUS echogram. De
doorsneden werden gesegmenteerd in gebieden (n=125) op basis
van de strain waarde in het elastogram. De dominante plaque typen
in deze gebieden (fibreus, fibreus-lipoïde of lipoïde) werden be-
paald met de histologie en gecorreleerd met de gemiddelde strain en
echo-intensiteit. 
Hoge strain 
waarden vielen 
samen met ver-
hoogde concentra-
ties van 
macrofagen
Gemiddelde strain waarden van 0.27%, 0.45% en 0.60% werden
gevonden voor fibreuze, fibreus-lipoïde of lipoïde plaque compo-
nenten. De strain waarde voor de drie plaque typen zoals bepaald
met histologie verschilden significant (p=0.0002). Dit verschil was
onafhankelijk van het type vaatwand (coronair of femoraal) en was
hoofdzakelijk duidelijk tussen fibreus en lipoïde weefsel
(p=0.0004). De plaque typen lieten geen echo-intensiteit verschil-
len in het IVUS echogram (p=0.992) zien. Omzetting van de strain
naar Young's modulus resulteerde in 493kPa, 296 kPa en 222 kPa
voor fibreuze, fibreus-lipoïde of lipoïde plaque componenten. Al-
hoewel deze waarden hoger zijn dan de waarden gemeten door Lee
et al (Lee 1992), is de ratio tussen fibreus en lipoïde materiaal on-
geveer hetzelfde. Aangezien fibreus en lipoïde weefsel een verschil-
lende strain waarde toonden en hoge strain waarden vaak co-
lokaliseerden met een verhoogde concentratie van macrofagen, la-
ten deze resultaten de potentie zien om de eigenschappen van vul-
nerabele plaques te identificeren. Dit eerste validatie werk was
uitgevoerd bij kamertemperatuur, hetgeen herhaaldelijk de vraag
opperde of deze experimenten konden worden vertaald naar de
“echte wereld”, aangezien biologisch weefsel bij kamertemperatuur
andere materiaal eigenschappen kan hebben dan bij lichaamstem-247
 peratuur. Experimenten werden uitgevoerd (hoofdstuk 3) op spe-
cimens om de invloed te bepalen, op de elastische eigenschappen,
van het bevriezen en van het meten van de weefsels op kamertem-
peratuur (23°C in plaats van 37 °C). Vier humane coronairen, een
carotid en een femoraal arterie werden eerst gemeten bij 23°C en
daarna bij 37 °C. Daarnaast werden ze voor 24 uur opgeslagen bij -
80 °C en uiteindelijk gemeten bij 23 °C. Kwalitatieve en kwantita-
tieve analyse van de elastogrammen verkregen van verse en bevroren
specimens gemeten bij 23 °C toonden aan dat het opslaan van de
specimens bij -80 °C geen significante invloed had.
We concludeerden dat in vitro experimenten kunnen worden uit-
gevoerd bij kamertemperatuur na opslag van weefsel bij -80 °C zon-
der daarbij een significante invloed te hebben op de informatie ten
aanzien van het meten van vers ex vivo materiaal bij lichaamstem-
peratuur.
De belangrijkste stap in de ontwikkeling van een vulnerabele pla-
que is het scheurings proces, hetgeen plaatsvindt aan het oppervlak
van het weefsel. Aangezien de krachten die optreden aangrijpen op
het lumen oppervlak, werd er een oppervlakte gebaseerde techniek
ontwikkeld om de mechanische eigenschappen te meten. Deze ro-
buuste techniek is gemakkelijker te interpreten dan een elastogram
en wordt palpografie genoemd. Palpografie leid mechanische infor-
matie af van het opppervlak van de plaque, daar waar de scheuring
kan optreden. Deze informatie wordt kleur-gecodeerd en gesuper-
poneerd op het IVUS echogram.
Plaques die vul-
nerabel waren in 
elastografie, heb-
ben een dunnere 
kap dan niet vul-
nerabele plaques
Vanaf dit moment was het de hoofdzaak om vulnerabele plaques te
identificeren, hetgeen een additionele validatie vereiste (hoofdstuk
4). Zieke coronairen (n=24) werden gemeten in vitro. Palpografi-
sche data werd verkregen bij een intra-coronaire druk van 80 en
100 mmHg. Na de ultrageluid experimenten, werden de cross-sec-
ties gekleurd voor collageen en vet, gladde spiercellen (SMC), en
macrofagen. In histologie werd een vulnerabele plaque gedefinieerd
als een TCFA. Een plaque werd beschouwd als vulnerabel in elas-
tografie wanneer een hoog strain gebied aanwezig op de lumen-pla-
que grens en dit hoge strain gebied werd omringd door lage strain
waarden. Met gebruikmaking van deze definitie werd de vulnerabi-
liteit van de gebieden bepaald. We bestudeerden 54 cross-secties. In
histologie werden 26 vulnerabele plaques en 28 niet-vulnerabele248
 CHAPTER 17 DISCUSSIE EN SAMENVATTINGplaques gevonden; elastografie was positief in 23 gevallen maar ne-
gatief in 3 gevallen. Niet-vulnerabele plaques werden gezien in his-
tologie in 28 gevallen en gedetecteerd door elastografie in 25
gevallen, maar vals gediagnostiseerd als positief in 3 gevallen, het-
geen resulteerde in een sensitiviteit van 88% en een specificiteit van
89% om een vulnerabele plaque, gedefinieerd als een TCFA, te de-
tecteren. Lineaire regressie toonde hoge correlatie tussen de strain
in kappen en de hoeveelheid macrofagen (P<0.006) en een inverse
relatie tussen de hoeveelheid gladde spiercellen en strain
(P<0.0001). Plaques, die werden geclassificeerd als vunerabel in
elastografie, hebben een dunnere kap dan niet-vulnerabele plaques
(P<0.0001)(Schaar 2003a). 
Alle bewijs materiaal, om weefsel structuren te detecteren die vul-
nerabele plaques representeren, bij elkaar genomen, leek het ons
ethisch verantwoord om ons naar in vivo validatie scenario’s te be-
geven.
Validatie in vivo
Iliac en femoraal 
arteriën van vark-
ens werden ge-
bruikt voor in 
vitro validatie
IVUS elastografie werd gevalideerd in vivo (hoofdstuk 5) met be-
hulp van het atherosclerotische Yucatan dwergvarken(de Korte
2002a). Externe iliac en femoraal bloedvaten werden atherosclero-
tisch gemaakt door middel van endotheel Fogarty denudatie en het
daaropvolgende atherosclerotische dieet voor de duur van 7 maan-
den. Ballon dilatatie werd uitgevoerd in de femoraal vaten en het
dieet werd gestopt. Voor het einde van het experiment, 6 weken na
ballon dilatatie en het stoppen van het dieet, werd data opgenomen
van de iliac en femoraal vaten in 6 Yucatan varkens. In totaal wer-
den 20 cross-secties onderzocht. Het weefsel werd gedeformeerd
door de pulserende bloeddruk. Na de ultrageluid experimenten en
voordat er dissectie plaatsvond werd X-ray gebuikt om de vaatwand
segmenten te identificeren die onderzocht waren met ultrageluid.
De weefsel specimens werden bevroren in vloeibaar stikstof. De
doorsneden (7µm) werden gekleurd voor collageen en macrofagen.
Plaques werden geclassificeerd als afwezig, als vroeg fibreuze laesie,
als vroeg lipoïde laesie of als een ontwikkelde fibreuze plaque. De
gemiddelde strain in deze plaques en normale cross-secties werden
bepaald om de weefsel karakteriserings eigenschappen van de tech-
niek te bepalen. Daarnaast, werd de deformeerbaarheid van de ac-
quisitie gecorreleerd met de aanwezigheid van vet en macrofagen.249
 De deformeerbaarheid werd gekarakteriseerd door de aanwezigheid
van een hoog straingebied (strain hoger dan 1%) bij de lumen-vaat-
wand grens.
Hoge strain ge-
bieden hadden 
een hoge sensitiv-
iteit (92%) en 
specificiteit 
(92%) om de 
aanwezigheid van 
macrofagen te 
identificeren
Strain waarden waren vergelijkbaar in het plaque-vrije vaatwand en
de vroege en ontwikkelde fibreuze plaques. Univariate analyse van
variantie toonde een significant hogere strain waarde in cross-secties
met vroege lipoïde laesies dan in fibreuze plaques (p=0.02) onaf-
hankelijk van de aanwezigheid van macrofagen. Alhoewel een ho-
gere strain waarde werd gevonden in plaques met macrofagen dan
in plaques zonder macrofagen, was dit verschil niet significant na
correctie voor lipoïde componenten. Echter, de aanwezigheid van
een hoog straingebied had een hoge sensitiviteit (92%) en specifici-
teit (92%) om de aanwezigheid van macrofagen te identificeren.
Daarom werd er geconcludeerd dat het weefsel type de gemiddelde
strain waarde domineert. Gelokaliseerde hoge strain waarden zijn
gerelateerd aan lokale verschijnselen zoals ontsteking.
Drie-dimensionale Palpografie
Gedurende longi-
tudinale monitor-
ing van patiënten 
is het extreem 
moeilijk om 
dezelfde plek terug 
te vinden
De verdeling van de strain in de drie dimensionale geometrie van
een bloedvat is een belangrijk instrument om de aanwezigheid
(hoofdstuk 6), het aantal en de verdeling van hoge straingebieden
te identificeren. De selectie van cross-secties gebaseerd op het IVUS
echogram introduceert selectie bias en verhoogt de kans om een
vulnerabele plaque te missen, vooral omdat de correlatie tussen de
kwetsbaarheid van een plaque en de parameters die uit het echo-
gram kunnen worden gehaald laag is. Bovendien is het extreem
moeilijk om na een aantal maanden dezelfde plek terug te vinden
tijdens het langdurig monitoren van patiënten. Daarom is er een ac-
quisitie methode ontwikkeld om de strain informatie van de volle-
dige 3D coronair arterie te verkrijgen. 
Palpografie heeft 
uitstekende repro-
duceerbaarheid 
laten zien
Experimenten in konijnen aorta’s lieten zien dat drie-dimensionale
palpografie mogelijk is in vivo. Ondanks de introductie van bewe-
ging uit het beeldvlak tijdens de continue terug-trekking van de ca-
theter is de overeenkomst tussen opeenvolgende frames, die
verkregen zijn in de diastolische fase, hoog genoeg om een aantal
palpogrammen te berekenen per hart cyclus. Door het combineren
van deze palpogrammen, word één samengesteld palpogram per
hartcyclus bepaald (Doyley 2001). Verder heeft palpografie een uit-250
 CHAPTER 17 DISCUSSIE EN SAMENVATTINGstekende reproduceerbaarheid laten zien (hoofdstuk 7). Het ge-
bied, waarin palpografie twee keer werd uitgevoerd, was
gedefinieerd op basis van identificeerbare herkenningspunten, zoals
zij-takken of stents. Deze matching van opeenvolgende gebieden
werd gedaan met de onderliggende IVUS frames, die geconstrueerd
waren vanuit de rf-data, zonder daarbij op de hoogte te zijn van de
palpografische resultaten. In 14 patiënten werden 19 opnames ge-
daan met een lengte van 1.8cm hetgeen resulteerde in 909 secties
om te vergelijken. Naast andere statistische tests, die een goede re-
produceerbaarheid toonden, liet de Blant-Altmann test een gemid-
deld strain verschil zien van 0.042 met een standaard deviatie van
0.07. Deze data levert additioneel bewijsmateriaal voor de stelling
dat palpografie een robuuste methode is om in vivo hoge strainge-
bieden te detecteren. 
Klinische toepassing
AMI patiënten 
hebben significant 
meer hoge strain 
spots dan stabiele 
patiënten
In een recente studie in mensen (hoofdstuk 8) werden drie-dimen-
sionale palpogrammen afgeleid van intravasculair ultrageluid opna-
men gedurende een continue terugtrek beweging van de catheter
door de gehele coronair arterie. Patiënten (n=55) werden geclassifi-
ceerd door middel van hun klinische presentatie, namelijk als zijnde
stabiele angina, onstabiele angina of AMI. In elke patient werd een
coronair gescand (het verdachte bloedvat in stabiele en onstabiele
angina, het niet verdachte bloedvat in AMI), en het aantal defor-
meerbare plaques werd vastgesteld. Stabiele angina patiënten had-
den significant minder deformeerbare plaques per bloedvat
(0.6±0.6) dan onstabiele angina patiënten (p<0.0019) (1.6±0.7) of
AMI patiënten (p<0.0001) (2.0±0.7). Het niveau aan C-reactieve
proteine was positief gecorreleerd met het aantal mechanisch defor-
meerbare plaques (R2=0.65, p<0.0001)(Schaar 2004a). 
Voor verdere kwalificatie in de klinische omgeving nam palpografie
deel aan IBIS (Integrated Biomarker and Imaging Study) trial
(hoofdstuk 9).251
 De SMS-index 
beschrijft hoe uit-
gebreid de aan-
wezigheid van 
hoog vervorm-
bare plaques is en 
wordt gebruikt als 
een maat voor 
vulnerabiliteit
IBIS is een prospectieve, enkel centrum, niet gerandomiseerde, ob-
servationele studie. Het doel van de studie was evaluatie van zowel
invasieve (kwantitatieve coronair angiografie, intravasculair ultrage-
luid (IVUS) en palpografie) als wel niet-invasieve afbeeldingstech-
nieken (multislice spiral computed tomography) voor karakterisatie
van niet-stromings reducerende coronair laesies. Daarnaast werden
een aantal klassieke als ook nieuwe biomarkers gemeten en hun ni-
veau gecorreleerd met de resultaten van de verschillende afbeeldings
technieken. Strain waarden werden geclassificeerd volgens de ROC
classificatie (ROtterdam Classificatie) als een laag strain gebied
(ROC I: 0.0 - <0.6%), matig strain gebied (ROC II: 0.6 - <0.9%),
medium strain gebied (ROC III: 0.9 - <1.2%), of hoog strain ge-
bied (ROC IV: >1.2%). In het gebied van interesse (ROI) werd het
aantal ROC III an IV scores gekarakteriseerd met behulp van de
Schaar-Mastik-van der Steen- (SMS)-Index. Deze werd berekend
als het aantal ROC III en IV scores die werden gemeten in de ROI
op regelmatig over de lengte van de ROI gepositioneerde cross-sec-
ties en gemiddeld over het aantal van deze cross-secties en verme-
nigvuldigd met 10 om een waarde te krijgen met een aantrekkelijk
bereik. Deze SMS-index beschrijft de uitgebreidheid van hoog de-
formeerbare plaques en word beschouwd als een maat voor vulner-
abiliteit van bijvoorbeeld een specifieke coronair arterie.
De belangrijkste bevindingen van deze trial (hoofdstuk 10) met be-
trekking tot palpografie waren consistent met andere waarnemin-
gen van wijdverspreide abnormaliteiten in niet-verdachte
bloedvaten of verder verwijderd myocardium van patiënten met
acute coronair aandoeningen. De hoge prevalentie van structureel
vulnerabele plaques die gevonden werden in deze studie, te samen
met het relatief vaak voorkomen van post-mortem waarnemingen
van klinisch onopgemerkte plaquescheuringen, suggereert dat het
onwaarschijnlijk is dat geïsoleerde plaquescheuringen het nogal in-
frequente voorkomen van ischemische gebeurtenissen kan verkla-
ren. Bovendien toonde deze studie aan dat, binnen een beperkte
selectie van segmenten van niet-verdachte bloedvaten, structureel
vulnerabele plaques een redelijk een normaal verschijnsel waren,
ondanks een slechts beperkt angiografische ziektebeeld. Het beves-
tigt onze hypothese dat patiënten met STEMI een significant hoger
aantal structureel vulnerabele plaques hebben dan patiënten met
andere ziektebeelden in coronair gebieden verder weg gelegen van
de plek van de afsluitende trombose.252
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was de SMS-in-
dex niet verand-
erd voor patiënten 
met stabiele en 
onstabiele angina, 
maar was signifi-
cant verlaagd in 
de groep patiënten 
met een myocard 
infarct
Na 6 maanden hadden we de patiënten van IBIS opnieuw onder-
zocht (hoofdstuk 11 en hoofdstuk 12). Dit is de eerste klinische
follow-up studie met 3D palpografie. Deze pilot studie werd blind
uitgevoerd om vast te stellen (a) de verandering van de SMS-index
(b) de verandering van individuele ROC scores, als ook (c) hun kli-
nische presentatie. Na 6 maanden was de SMS-index niet veran-
derd voor patiënten met stabiele en onstabiele angina, maar wel
significant veranderd voor de groep van patiënten met een myocard
infarct. Dit zou verklaard kunnen worden uit het feit dat patiënten
in de laatste groep na de initiële interventionele behandeling op een
uitgebreid veranderd therapeutisch regime werden gesteld. Daar-
naast versterkt deze data de hypothese dat vulnerabiliteit een pan-
arterie proces   is en dat huidige behandelings regimes het kan redu-
ceren, maar niet elimineren, rekening houdend met het feit dat de
SMS-index bij follow-up niet significant verschillend was tussen de
groepen.
Toekomstige toepassingen
Het proces van 
plaque verharding 
kan gemonitord 
worden met intra-
vasculaire pal-
pografie
Uiteindelijk zijn alle acute coronair syndromen gerelateerd aan
trombogene gebeurtenissen. Intravasculair palpografie kan, vanwe-
ge zijn vermogen om de mechanische eigenschappen van biologisch
weefsels te evalueren, dunne-kap fibroatheromas detecteren, echter
25% van alle myocard infarcten worden veroorzaakt door thrombi
die aan de vaatwand hechten. Wij gebruikten een dier model
(hoofdstuk 13) waarbij elektrische vasculaire beschadiging werd
geïnduceerd, hetgeen bloedplaatjes rijke thrombi genereerde, soort-
gelijk aan die zijn geobserveerd in coronair arteriën van patiënten
met een acuut myocard infarct. De belangrijkste bevindingen van
deze studie zijn dat een trombus stijver wordt in de loop der tijd en
dat een groot gedeelte van het organisatie proces plaatsvindt binnen
20 minuten na de introductie van de trombus en dat dit proces ge-
volgd kan worden met intravasculaire palpografie. De klinische toe-
passing van dit in vivo dier model moet nog worden bepaald. 
De toekomst van intravasculair diagnostisch ultrageluid zal weefsel
karakterisatie zijn. Dit kan niet gedaan worden met conventionele
IVUS of een aan IVUS gerelateerde techniek zoals palpografie of
elastografie. Dit is hoofzakelijk te wijten aan het feit dat de span-
ningsverdeling in een vaatwand onbekend is en dat data niet direct
vertaald kan worden naar een morfologisch en compositioneel253
 beeld. Om deze beperking te boven te komen, hebben we een me-
thode ontwikkeld die een Young's modulus beeld vanuit een elas-
togram reconstrueert (hoofdstuk 14). De reconstructie van de
plaque wordt gedaan door een minimaliserings algoritme die het
gemeten elastogram iteratief vergelijkt met het strain beeld bere-
kend met een Parameterisch Eindige Elementen Model (PFEM) re-
presentatie van een TCFA, waarvan de PFEM geometrie en
materiaal parameters worden aangepast. Deze methode heeft suc-
cesvol Young's modulus beelden gereconstrueerd vanuit elasto-
grammen die waren (i) gesimuleerd met eindige elementen
modellen van plaques, (ii) gemeten van een synthetische plaque en
(iii) gemeten in vitro van een humane coronair. Het is ook toege-
past op een in vivo gemeten elastogram van een plaque in een pa-
tient. Deze nieuwe techniek, genaamd modulografie, kan zich
ontwikkelen tot een betrouwbare en robuuste techniek om ons in-
formatie te verschaffen over de samenstelling van de plaque.
Vulnerabele Plaque: Quo Vadis?
De richtingen waarin het vulnerabele plaque onderzoeksgebied zich
kan ontwikkelen in de toekomst worden aangeven in een consensus
verklaring van de leidende vulnerabele plaque experts (hoofdstuk
15). De laatste jaren is er veel vooruitgang geboekt in het onderzoek
aan vulnerabele plaque. Positieve resultaten in veel onderzoeksge-
bieden geven aan dat er een verhoogde kans is om het doel, detectie
en behandeling van vulnerabele atherosclerotische plaques, te berei-
ken. Het doel is des te belangrijker vanwege de vergrijzing van de
populatie. Nieuwe, robuuste dier modellen zijn nodig om het pro-
ces te begrijpen dat leid tot de formatie en verstoring van vulnera-
bele plaques. Deze modellen kunnen getest worden door nieuwe
invasieve en niet-invasieve detectie modaliteiten en kunnen dienen
als een basis voor klinische trials. Deze klinische trials dienen het
stabilisatie proces van plaques te onderzoeken, bijv. door lokale en
systemische therapie, maar ook hun natuurlijk verloop. Een opti-
male voortgang zal investeringen vereisen in de klinische trials die
nu mogelijk zijn. De financiële ondersteuning en moeite die vereist
zijn om deze trials uit te voeren zullen aanzienlijk zijn.254
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De beperkingen van de techniek zullen ons leiden om de techniek
verder te ontwikkelen. Een onderwerp is bewegings-artefacten, deze
worden veroorzaakt door longitudinale beweging van de catheter
door de coronair, maar ook door rotatie om de as van de catheter.
Daarnaast wordt beweging geïnduceerd door de terug-trek proce-
dure. Daar het palpogram berekend wordt uit twee rf-signalen die
verkregen zijn uit dezelfde Regio van Interesse(ROI) bij verschillen-
de drukken, kan beweging verhinderen dat de zelfde ROI gevonden
wordt in beide beelden. Wanneer dit het geval is zullen er op deze
locatie in het palpogram missende waarden verschijnen. Bewegings
detectie en compensatie zullen een belangrijke rol spelen in de ont-
wikkeling van palpografie in de naaste toekomst.
Het gebruik van ballon inflatie om de beweging van de catheter te
stabiliseren lijkt klinisch te gecompliceerd en kan het gebruik in de
dagelijkse praktijk hinderen.
Palpogrammen kunnen verschillend worden geïnterpreteerd door
gebruikers aangezien het een nieuwe parameter geeft, die nog niet
gebruikt is in de kliniek. Het kan nuttig zijn een meer objectieve
manier en simpeler manier om strain data weer te geven te ontwik-
kelen, waarbij alleen de hoge strain gebieden worden benadrukt die
gerelateerd zijn aan vulnerabele plaques. Dit zou de praktische
bruikbaarheid verhogen en de intra -en interwaarnemer variabiliteit
reduceren. 
Verder zal het, net als alle nieuwe zich ontwikkelende technieken,
volledig geintegreerd worden in het catheterisatie laboratorium.
Een volledig geïntegreerd cathlab zal het mogelijk maken data en
beelden tussen modaliteiten te fuseren en aanvullende mogelijkhe-
den bieden voor klinisch en pathofysiologisch cardiovasculair on-
derzoek.
Palpografie is een uitvoerig gevalideerde techniek, maar tot nu toe
heeft deze validatie slechts in één centrum plaats gevonden. Mo-
menteel wordt de techniek over meerdere centra gedistribueerd,
hierdoor zullen tekortkomingen aan het licht komen, maar het zal
tevens nieuwe mogelijkheden voor de techniek bieden.255
 Conclusie
Intravasculair ultrageluid palpografie is een nieuwe techniek die in
staat is om strain data van het vaatwand oppervlak te leveren.
Palpografie:
• kan ontstoken dunne kap fibroatheromas detecteren in vitro 
met een hoge sensitiviteit en specificiteit.
• kan lipoïde plaques detecteren, die een verhoogde gemiddelde 
strain waarde hebben.
• kan hoge strain gebieden detecteren, die geassocieerd zijn met 
de aanwezigheid van macrofagen.
• kan in drie dimensies strain in de coronair meten.
• is reproduceerbaar.
• kan toegepast worden in de kliniek en kan hoge strain gebieden 
detecteren in follow-up trials.
• kan de trombus leeftijd detecteren.256
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Michaels-Gymnasium in Metten. After studying medicine in St.
Louis, USA and New York, USA, he earned his M.D. at the Julius-
Maximilians-University Wuerzburg, Germany with cum laude. Af-
ter a character forming internship in Aschaffenburg, Germany he
worked at the University Essen, Germany under the mentorship of
Prof. Raimund Erbel as research fellow. In September 2000, he
started at the Biomedical Engineering of Thorax centre, Erasmus
University Rotterdam, The Netherlands, headed by Prof. Antonius
FW van der Steen, in close cooperation with the intervention car-
diology of the Thorax centre, headed by Professor Dr. Patrick.W.
Serruys His main interest was to develop palpography for clinical
applications. He participated in several projects like NHS 2001-
B191, ICIN 32 and the 2000 NWO PIONIER award, all aiming
at vulnerable plaque detection. He has been awarded several re-
search grants from organizations such as the German Heart Foun-
dation and the Dutch Heart Foundation. He is co-organizer of the
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 CHAPTER 21 ACKNOWLEDGMENTNiemand maakt zijn eigen kind alleen
As I came to Rotterdam I knew that I would meet a conglomeration
of the finest cardiologists in the world. I planned to stay for a year,
than go back with a couple of papers, a new line in my CV and a
bucket full of experience. Somewhere in the back of my brain I was
even dreaming to get a PhD, but I considered this as a dream since
I had only money for one year out of a grant of the German Heart
Foundation.
I knew from the beginning that I would like the Thoraxcenter.
What made me so optimistic were meetings that I had several
months before my arrival. I met a couple of seniors: the first was
colorblind (like me), the second had no time, the third was incred-
ible funny and the last discussed with me the life of Jimmy Hendrix
and the music of AC/DC. I was impressed. I have to admit that
coming from Germany I was surprised to see that professional peo-
ple, like these leading cardiologists can be relaxed and humble,
without losing their aura of professionalism. After all these meet-
ings I was scheduled to meet with the boss. Prof. Serruys was sitting
in a very small room together with his secretary and started to ask
in English with a light French accent looking over his glasses:
“What you want to do?”
I was not sure. At a meeting in Vienna I saw a poster, which de-
scribed a new method, which can measure vessel elasticity. The
poster was optically so prominent that it was hard to overlook. I did
not understand a word, of what was written there, but I liked the
pictures.
I started to tell the professor something about elasticity. He nodded
and left the office. I had time to enjoy the flavour of the room. It
was so packed with files, papers and somewhere in between the sec-
retary. The professor came back and said: “You have to contact
Klaas Bom! He has his office on the 23rd floor. I'll call him.” He317
 took the phone and started in Dutch to talk about me. I understood
nothing, but I got another appointment.
Leaving the office I asked myself: Who is Klaas Bom? And where is
the 23rd floor?
It turned out that Prof. Bom was one of the gentlest people, I have
ever met. After the usual hello, he looked at me and said: “you need
a coffee”, stood up and served me a coffee. Again I was surprised
and again we were talking about a lot of things, but nothing about
research. After a while he introduced me to Chris de Korte and I got
an introduction into elastography. I had no idea what he was talk-
ing about, this was all far to complicated for me, but I had the feel-
ing that the story made a lot of sense. He gave me his PhD book
and I left, not without recognizing a black guy, who was sitting with
headphones in front of a computer, programming and shaking his
head to whatever music. Later I learned that in this lab the first in-
tracardiac echo probe, the first handheld echo, the linear array, the
first TEE, the micromotor based IVUS, and many other things had
been developed.
Back in Germany I started to write a grant (about elastography)
with the support of Prof. Raimund Erbel, submitted the grant and
forgot about it.
Six month later I received a letter saying I could go to Rotterdam
for a year. I was not happy at all. My wife was pregnant and we just
moved into a new apartment. After long discussions we decided
that a year is not that long and I could leave. 
I left in September 2000, Maximilian was meanwhile born and I
was looking forward to an adventure, from which I had no idea
what to expect and what to get.
I learned so much in the last years. I started with a one-year grant
and am now in training to be a cardiologist. Such a development is
only possible in the environment of the Thoraxcenter. I would
compare this center with a huge salt-water aquarium. Somebody
cares for refreshing the water, enough food, some oxygen, but the
swimming has to be done alone. In an aquarium like this the fauna
can be extremely colorful: sharks, snakes, old experienced whales318
 CHAPTER 21 ACKNOWLEDGMENTand very intelligent dolphins, some have found biotopes in the cold
deep and some are behaving like they got a job in SeaWorld. The
beauty of the variety is unbelievable.
Three components make the Thoraxcenter so unique: 
First the clinic, second the 23rd floor and third Cardialysis. I have
the pleasure to be involved in all three of them. It is an honour to
thank a couple of people in these institutions for the support and
the chances they gave me.
The 23rd floor is in the hands of Prof. Anton van der Steen. Ton,
I learned from you so much that I could fill a couple of pages. We
met first in Paris at an Elastography meeting at the EuroPCR. The
conversation lasted about 10 minutes and I walked away with the
feeling that communication with you will be easy, funny and pro-
ductive. You took care that on my arrival I had a shelter (I never will
forget the time in the home hotel), a working space and a project. I
had to learn that engineers work quite different than cardiologists.
Contemplation is more important than un-reflected excitement. I
learned that experiments need time independent from the next
deadline and that science needs good planning. Rutherford had
once stated that science could be either based on physical models or
on the desire to collect stamps. Empirical research has it's beauty,
but model based research is hard to beat. We had long discussions
about science, cooperation with clinicians, industry, patents and
contracts. I learned a big part of diplomacy from you and how im-
portant it is to de-mystify situations, which have caused trouble or
may cause trouble in the future. Your way is the way of patience,
firmness and balance. You motivate people in a very positive way,
never by building up fear and concerns. We share the same taste for
music, which is very important. In general I guess somebody, who
likes Tom Waits cannot be a bad human being.
Ton put me in the beginning in the hands of Chris de Korte. Chris,
you took care that I got a good start. You've been a great mentor.
With your ability to slice problems into slices so thin that they don't
exist anymore or are rather easy to solve, you gave me confidence
enough to survive demands, I learned from you that limitations of
a technique can only be solved by developing a good strategy, not
by creating fears. I will never forget the moment in Stockholm as319
 you went with me to a session in which an opinion leader explained
rhetorically firm how vulnerable plaque detection had to work. I
was after his talk not sure, if we are working in the right direction.
You explained me point by point the physical background of all the
proposed visions and my nervousness was healed. We had great
times sharing hotels at meetings discussing life, faith, family and
many other things more.
Very quickly I came in contact with Frits Mastik. This thesis is part-
ly dedicated to him. We were most of the time the last ones leaving
the lab. Your critical view on methods, techniques and experiments
was of so much importance to the success of palpography that the
technique would not be here without you. You joined me in most
of the experiments, we fought ourselves through countless live cases
and we enjoyed together the curiosity of some situations we had to
face on the road. You are one of the brightest people I have ever met
and one of the most humble. Your helpfulness is legendary in the
lab. Your clear principles, which are the basis of your behaviour, are
influenced by deep humanistic believe. Your knowledge about al-
most everything makes you a most distinguished discussion part-
ner. Thank you standing next to me at the time of the defense.
There are many people more in this lab, who take care that things
stay enjoyable: Mieke, thanx for your help preparing the thesis;
Riekje, the mother of the lab; Frans, the silent organizer; Charles
Lancee, the only genius I have ever met; Rob Krams, the most loyal
basic researcher in the building. Wim and Leo, thanx for making
technical problems a breeze; Jan, thanx for fixing almost everything,
which has to do with current. Marvin Doyley, thanx for learning
palpography how to walk. Radj, for taking care that the rights of the
minorities are taken care of and thanx for explaining me in your
very own style what math is all about. The hemodynamic group
with Cees Slager as boss. Cees you are such a brilliant thinker, with
such a stronghold view on certain things, that I always enjoy dis-
cussing whatever with you, doesn't matter, if we talk about your
boss the Jewish carpenter, science or whatever else. Jolanda, you are
a source of help, an independent thinker and well aware of your tre-
mendous capabilities. You stayed humble, great. Frank, as I said be-
fore: somebody who likes Tom Waits cannot be a bad guy. I admire
your taste regarding pants and shoes.320
 CHAPTER 21 ACKNOWLEDGMENTOn the other side of the hall we got so much help from Dirk
Duncker from experimental cardiology. Thank you Dirk for the
support and thank you Elza for spending the days with us and tak-
ing care that the pigs are doing well.
Let's move from the ivory tower of the lazy and arrogant engineers
on the 23rd floor downstairs to the cath lab. A technique like pal-
pography had sooner or later to be proven to be able to withstand
the pressure of real life. There is no better place for this than the
cath lab of the Thoraxcenter. This is based on the attentiveness and
courage of Patrick Serruys. Patrick, so many things were written
about you in other books like this one. I have to thank you for all
the chances you have given me: Including me in the organizing
team of the vulnerable plaque meeting is only one of them. It is so
much fun to work on this project and you lead me from a distance
towards that we get every year a meeting organized, which is better
than the one before. Writing articles with you on a Sunday after-
noon is an experience I never will forget. I remember the day, when
we wrote an essay about vulnerable plaque detection. You had 38.9
degrees Celsius fever sitting on your sofa at home and discussing
with me this paper. Even with the fever in your head you were
sharp, rhetorically unbeatable and full of ideas. Regarding palpog-
raphy it has to be said that without your patience and fortitude we
would not be, where we are today. At meetings people ask me often
about the secret behind your success. My answer is always: he just
works hard. If anyone thinks from himself he is working hard, I rec-
ommend following you for a week or two. In these weeks one
would see half of the planet, be in 2-3 advisory boards, treating a
couple of patients in the cath lab, giving key note lectures at confer-
ences and finishing some articles. One day I would like to under-
stand, from where you get this energy, which deserves so much
respect.
Behind every strong man stands a strong women, is a saying in Ger-
many. No, I am not talking about your wonderful wife, Patrick. I
am talking about Anja.
Thank you Anja for squeezing me so often in the agenda of Patrick,
which is always full. I admire how you still can organize this man,
who I would declare as not organize-able. Your sometimes-grum-321
 bling way of communicating is often misjudged, but you treat eve-
rybody the same and behind the rough surfaces sits a heart of gold.
The second man in the cath lab, which has taken care that palpog-
raphy is going to be a success is Pim de Feyter. What a man! Silent,
humble, sharp, with a great sense of humour. Pim, your mind stood
independent, which I admire very much. You treat your fellows
with respect and warmth. You are the perfect role model for fellows,
who fall after a while into the ego trap, since you are still a gentle-
man over all this years even after times, when it became a bit stormy
outside.
Palpography needed over the years also support from the group of
people, who will use it in the future in other cath labs. No, I am not
talking about cardiologists. I am talking about the technicians. Two
have contributed a lot: Emile, who likes everything fancy and ec-
centric, and Jurgen. Jurgen is a real IVUS animal. His interpreta-
tions of IVUS recordings are full of great intuition. Thank you for
your help in the different clinical projects taking care that the qual-
ity of the recordings is not going down. There is also Miss OCT
Evelyn Regar. Thanx Evelyn for recording most of the clinical cases.
You have a wonderful pragmatic way dealing with science.
The third entity, which contributes to the success story of the Tho-
raxcenter is undeniable Cardialysis. Regarding Palpography we got
the chance “to play core lab” in the IBIS I trial. We started as the
highly experimental technique and ended as the primary endpoint
of two multicenter trials. This would be not possible without the
help of a couple of people. Let's start with Gerrit-Anne van Es. You
are very open accepting crazy scientists in your environment and
you opened resources for us. You have a great feeling in dealing
with people from different backgrounds and you stay professional
in the most difficult situations. As I said before: Someone who likes
Tom Waits cannot be a bad guy.
Michael Koenders, my favorite secretary of finance. We had a bad
start in our relationship, but this has improved towards a friend-
ship. Organizing with you the vulnerable plaque meeting is pure
fun. Going with you to meetings is always a great mixture of pro-
fessionalism and entertainment. Thank you for all the support and
energy you have given to me.322
 CHAPTER 21 ACKNOWLEDGMENTMarie-angele, the most charming of the women in Cardialysis. You
are involved in so many projects that I wonder how you keep track.
Your communication skills are of indispensable value to everybody.
Thank you for helping the core lab for palpography grow.
This brings us to the hidden expert on palpography: Ravindra Pa-
var. Ravindra, we know that palpography is in good hands when
you work on it. I admired your skills in learning how to analyze pal-
pograms and your way of dealing with Frits and me.
I know I have not mentioned everybody in this list. I tried to con-
centrate on the Thoraxcenter and I limited myself to people, who
joined forces for palpography. My work would not have been pos-
sible without the continuous support of all co-workers at the 23rd
floor, the cathlab and Cardialysis. I have to ask for forgiveness of
everybody that I left unmentioned.
Outside the Thorax center I owe gratitude to the global vulnerable
plaque fighting force that is gathering every year on a sunny Island
in the Mediterranean to discuss life in general and vulcanoes and
vulnerable plaques in particular. These discussions have been an
important source of inspiration, but on top of that have directly re-
sulted in two chapters in this thesis.
I want to acknowledge the institutes that contributed in a financial
manner to the work described in this thesis. The Dutch Heart
Foundation (NHS), der German Heart Foundation (DHS), The
Dutch Technology foundation (STW), The Netherlands Organi-
zation for Scientific Research (NWO), the Interuniversity Cardiol-
ogy Institute of the Netherlands (ICIN), the Royal Academy of Arts
an Sciences (KNAW) and the recent contributions of the industries
that take care of utilization: Glaxo Smith Kline and Volcano corpo-
ration. Furthermore I have to acknowledge that the work in this
book is built on a long lasting framework of cooperation e.g.
through the ICIN (thank you Manja) in particular with the exper-
imental cardiology in Utrecht (thank you Gerard), the Laser Center
of the AMC in Amsterdam (thank you Ton), the cardiology depart-
ment in Leiden, the biomechanical engineering department of the
TU Eindhoven and the seismic and acoustics group of applied phy-
siscs of the TU Delft.323
 Finally, there is one person, who deserves most of the acknowledge-
ments: My wife. Stephanie gave me support and love over the last
years. She is the base of my life. You take care that Maximilian and
Sophia are getting a valuable character. You never complained, but
you've been always critical. Behind every strong man is a strong
woman. The first has still to be proven, the second not. Thank you!324
